Section 59

EurekaMag Full Text Articles Chapter 58,496


Radhouane, M.; Basly, M.; Mounir, C.; Rachdi, R. 2012: PP169. Management of fetal and maternal prognosis during severe toxemia. Pregnancy Hypertension 2(3): 330-331
Gandley, R.; Abramovici, A. 2012: PP170. Prenatal vitamin C and E supplementation is associated with a reduction in placental abruption and preterm birth in smokers. Pregnancy Hypertension 2(3): 331-332
Lewis, D.F.; Armistead, C.; Allison, A.; Wang, Y. 2012: PP171. Hospitalized preterm mild preeclamptics: Is there a difference in outcomes between isolated or superimposed disease?. Pregnancy Hypertension 2(3): 332-333
Jariwala, M.C. 2012: PP172. Indian scenario of preeclampsia and its consequences and early prophylaxis. Pregnancy Hypertension 2(3): 333
Rovida, P.L.; Pagani, G.; Gerosa, V.; Gregorini, M.E.; Platto, C.; Valcamonico, A.; Lojacono, A.; Frusca, T. 2012: PP173. The role of mean artery blood pressure in the prediction of pre-eclampsia in pregnancies complicated with chronic hypertension. Pregnancy Hypertension 2(3): 333-334
Akkermans, J.; Ganzevoort, W.; Payne, B.; Groen, H.; Mol, B.W.; von Dadelszen, P. 2012: PP174. Timely prediction of maternal complications in pre-eclampsia analysis of the fullPIERS model. Pregnancy Hypertension 2(3): 334-335
Amaral, W.T.; Souza, S.S.; Peracoli, J.C. 2012: PP175. Gestational hypertensive syndromes: Risk factors identification and complications in a primiparous population. Pregnancy Hypertension 2(3): 335
Olmos, C.S.; Macedo, M.A.; Pereira, R.M.F.; Augusto, V.; Garcia, J.M.; Panico, V.J.A.; Souza, E.V.; Sato, J.L.; Saito, M.; Sousa, F.L.P.; Sass, N. 2012: PP176. SFLT-1: a possibility of precocious diagnosis of preeclampsia. Pregnancy Hypertension 2(3): 335-336
Kim, J.; Kim, Y.H.; Cho, M.K.; Kim, C.H.; Song, T.-B. 2012: PP177. the usefulness of gestation-corrected hyperuricemia as a predictor of the development of preeclampsia on subsequent pregnancy. Pregnancy Hypertension 2(3): 336
Jantarasaengaram, S.; Tansatit, T.; Samkhoompim, N. 2012: PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report. Pregnancy Hypertension 2(3): 337
Clark, K.; Barton, J.R.; Istwan, N.; Rhea, D.; Desch, C.; Sibai, A.; Sibai, B.M. 2012: PP179. the influence of prior abortion on rates of gestational hypertension/pre-eclampsia and spontaneous preterm delivery in nulliparous women. Pregnancy Hypertension 2(3): 337
Powers, R.; Kotchey, N.; Gandley, R.; Jeyabalan, A.; Hubel, C. 2012: PP180. Maternal plasma endotoxin increases significantly across pregnancy with no association with obesity, inflammation, or insulin sensitivity. Pregnancy Hypertension 2(3): 337-338
Ferreira, D.G.; Cavalhieri, L.T.; Ventura, A.C.A.; Aires, F.T.; Garcia, J.M.; Mesquita, M.R.S.; Chaiwangyen, W.; Ospina Prieto, S.; Sousa, F.L.P.; Sass, N.; Markert, U.R. 2012: PP181. the role of the JAK-STAT pathways and SOCS in preeclampsia. Pregnancy Hypertension 2(3): 338-339
Huang, J.; Lin, Y-Chang.; Hileman, S.; Martin, K.H.; Hull, R.; Yu, H-Gang. 2015: PP2 prevents isoproterenol stimulation of cardiac pacemaker activity. Journal of Cardiovascular Pharmacology 65(2): 193-202
Zhang, Z.; Zhang, G.; Kong, C.; Gong, D. 2016: PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway. Molecular Medicine Reports 13(1): 333-338
Ma, J.; Feng, Y.; Xie, W.; Li, X. 2015: PP2A (PR65) in Silver Carp: cDNA Cloning and Expression Analysis. Journal of Biochemical and Molecular Toxicology 29(9): 399-409
Kaur, A.; Denisova, O.V.; Qiao, X.; Jumppanen, M.; Peuhu, E.; Ahmed, S.U.; Raheem, O.; Haapasalo, H.; Eriksson, J.; Chalmers, A.J.; Laakkonen, P.; Westermarck, J. 2016: PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells. Cancer Research 76(23): 7001-7011
Shang, C.; Huang, S. 2015: PP2A Level in Colorectal Cancer Cells Predicts the Response of p38 Targeted Therapy. Ebiomedicine 2(12): 1848-1849
Rahikainen, M.; Pascual, J.ús.; Alegre, S.; Durian, G.; Kangasjärvi, S. 2016: PP2A Phosphatase as a Regulator of ROS Signaling in Plants. Antioxidants 5(1)
Wlodarchak, N.; Xing, Y. 2016: PP2A as a master regulator of the cell cycle. Critical Reviews in Biochemistry and Molecular Biology 51(3): 162-184
Janssens, V.; Zwaenepoel, K.; Rossé, C.; Petit, M.M.R.; Goris, J.; Parker, P.J. 2016: PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration. Journal of Cell Science 129(8): 1605-1618
Yan, X.; Zhu, X. 2016: PP2A in meiotic oocytes. Cell Cycle 15(15): 1950-1951
González-Alonso, P.; Cristóbal, I.; Manso, R.; Madoz-Gúrpide, J.; García-Foncillas, J.ús.; Rojo, F. 2015: PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(8): 5753-5755
Rincón, R.úl.; Cristóbal, I.; Zazo, S.; Arpí, O.; Menéndez, S.; Manso, R.; Lluch, A.; Eroles, P.; Rovira, A.; Albanell, J.; García-Foncillas, J.ús.; Madoz-Gúrpide, J.; Rojo, F. 2015: PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. Oncotarget 6(6): 4299-4314
Ho, W.S.; Feldman, M.J.; Maric, D.; Amable, L.; Hall, M.D.; Feldman, G.M.; Ray-Chaudhury, A.; Lizak, M.J.; Vera, J.-C.; Robison, R.A.; Zhuang, Z.; Heiss, J.D. 2016: PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells. Oncotarget 7(11): 12447-12463
Gong, F.-R.; Wu, M.-Y.; Shen, M.; Zhi, Q.; Xu, Z.-K.; Wang, R.; Wang, W.-J.; Zong, Y.; Li, Z.-L.; Wu, Y.; Zhou, B.P.; Chen, K.; Tao, M.; Li, W. 2015: PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21. Oncotarget 6(21): 18469-18483
Nicholls, R.E.; Sontag, J.-M.; Zhang, H.; Staniszewski, A.; Yan, S.; Kim, C.Y.; Yim, M.; Woodruff, C.M.; Arning, E.; Wasek, B.; Yin, D.; Bottiglieri, T.; Sontag, E.; Kandel, E.R.; Arancio, O. 2016: PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments. Proceedings of the National Academy of Sciences of the United States of America 113(12): 3347-3352
Cristóbal, I.; Torrejón, B.; Madoz-Gúrpide, J.; Rojo, F.; García-Foncillas, J.ús. 2017: PP2A plays a key role in inflammation and cancer through tristetraprolin activation. Annals of the Rheumatic Diseases 76(5): E11
Tang, A.; Shi, P.; Song, A.; Zou, D.; Zhou, Y.; Gu, P.; Huang, Z.; Wang, Q.; Lin, Z.; Gao, X. 2016: PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. Cell Cycle 15(11): 1450-1461
Yue, K.; Sandal, P.; Williams, E.L.; Murphy, E.; Stes, E.; Nikonorova, N.; Ramakrishna, P.; Czyzewicz, N.; Montero-Morales, L.; Kumpf, R.; Lin, Z.; van de Cotte, B.; Iqbal, M.; Van Bel, M.; Van De Slijke, E.; Meyer, M.R.; Gadeyne, A.; Zipfel, C.; De Jaeger, G.; Van Montagu, M.; Van Damme, Dël.; Gevaert, K.; Rao, A.Gururaj.; Beeckman, T.; De Smet, I. 2016: PP2A-3 interacts with ACR4 and regulates formative cell division in the Arabidopsis root. Proceedings of the National Academy of Sciences of the United States of America 113(5): 1447-1452
Rahikainen, M.; Trotta, A.; Alegre, S.; Pascual, J.ús.; Vuorinen, K.; Overmyer, K.; Moffatt, B.; Ravanel, S.ép.; Glawischnig, E.; Kangasjärvi, S. 2017: PP2A-B'γ modulates foliar trans-methylation capacity and the formation of 4-methoxy-indol-3-yl-methyl glucosinolate in Arabidopsis leaves. Plant Journal: for Cell and Molecular Biology 89(1): 112-127
Li, X.; Nan, A.; Xiao, Y.; Chen, Y.; Lai, Y. 2015: PP2A-B56ϵ complex is involved in dephosphorylation of γ-H2AX in the repair process of CPT-induced DNA double-strand breaks. Toxicology 331: 57-65
Rodriguez Pino, M.; Castillo, B.; Kim, B.; Kim, L.W. 2015: PP2A/B56 and GSK3/Ras suppress PKB activity during Dictyostelium chemotaxis. Molecular Biology of the Cell 26(24): 4347-4357
Kiely, M.; Kiely, P.A. 2015: PP2A: the Wolf in Sheep's Clothing?. Cancers 7(2): 648-669
Kurimchak, A.; Graña, X. 2015: PP2A: more than a reset switch to activate pRB proteins during the cell cycle and in response to signaling cues. Cell Cycle 14(1): 18-30
Zhang, Y.; Wang, X.; Qin, X.; Wang, X.; Liu, F.; White, E.; Zheng, X.F.Steven. 2015: PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer. Ebiomedicine 2(12): 1944-1956
Lai, S.-S.; Zhao, D.-D.; Cao, P.; Lu, K.; Luo, O.-Y.; Chen, W.-B.; Liu, J.; Jiang, E.-Z.; Yu, Z.-H.; Lee, G.; Li, J.; Yu, D.-C.; Xu, X.-J.; Zhu, M.-S.; Gao, X.; Li, C.-J.; Xue, B. 2016: PP2Acα positively regulates the termination of liver regeneration in mice through the AKT/GSK3β/Cyclin D1 pathway. Journal of Hepatology 64(2): 352-360
Katona, Év.; Juhász, T.ás.; Somogyi, C.S.űc.; Hajdú, T.; Szász, C.; Rácz, K.ál.án.; Kókai, E.; Gergely, P.ál.; Zákány, R.óz. 2016: PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines. International Journal of Oncology 48(3): 983-997
Bhalothia, P.; Sangwan, C.; Alok, A.; Mehrotra, S.; Mehrotra, R. 2016: PP2C-like Promoter and its Deletion Variants Are Induced by ABA but not by MeJA and SA in Arabidopsis thaliana. Frontiers in Plant Science 7: 547
Wu, G.; Ma, Z.; Qian, J.; Liu, B. 2015: PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma. Oncotargets and Therapy 8: 2067-2074
Ye, J.; Shi, H.; Shen, Y.; Peng, C.; Liu, Y.; Li, C.; Deng, K.; Geng, J.; Xu, T.; Zhuang, Y.; Zheng, B.; Tao, W. 2015: PP6 controls T cell development and homeostasis by negatively regulating distal TCR signaling. Journal of Immunology 194(4): 1654-1664
McManus, K.A.; McGonigle, K.M.; Engelhard, C.L.; Dillingham, R. 2016: PPACA and Low-Income people Living with HIV: 2014 Qualified Health Plan Enrollment in a Medicaid Nonexpansion State. Southern Medical Journal 109(6): 371-377
Pérez-Serrano, R.M.; González-Dávalos, M.L.; Lozano-Flores, C.; Shimada, A.; Antaramian, A.; Varela-Echavarría, A.; Mora, O. 2017: PPAR Agonists Promote the Differentiation of Porcine Bone Marrow Mesenchymal Stem Cells into the Adipogenic and Myogenic Lineages. Cells Tissues Organs 203(3): 153-172
Blass, B. 2016: PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of use Thereof. Acs Medicinal Chemistry Letters 7(9): 824-825
Blednov, Y.A.; Black, M.; Benavidez, J.M.; Stamatakis, E.E.; Harris, R.A. 2016: PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice. Alcoholism Clinical and Experimental Research 40(3): 553-562
Blednov, Y.A.; Black, M.; Benavidez, J.M.; Stamatakis, E.E.; Harris, R.A. 2016: PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption. Alcoholism Clinical and Experimental Research 40(3): 563-571
Liu, Y.-C.; Gao, X.-X.; Zhang, Z.-G.; Lin, Z.-H.; Zou, Q.-L. 2017: PPAR Gamma Coactivator 1 Beta (PGC-1β) Reduces Mammalian Target of Rapamycin (mTOR) Expression via a SIRT1-Dependent Mechanism in Neurons. Cellular and Molecular Neurobiology 37(5): 879-887
Vella, S.; Conaldi, P.Giulio.; Florio, T.; Pagano, A. 2016: PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs. Ppar Research 2016: 3038164
Ying, S.; Xiao, X.; Chen, T.; Lou, J. 2016: PPAR Ligands Function as Suppressors that Target Biological Actions of HMGB1. Ppar Research 2016: 2612743
Chianese, G.; Yu, H-Bing.; Yang, F.; Sirignano, C.; Luciano, P.; Han, B-Nan.; Khan, S.; Lin, H-Wen.; Taglialatela-Scafati, O. 2016: PPAR Modulating Polyketides from a Chinese Plakortis simplex and Clues on the Origin of Their Chemodiversity. Journal of Organic Chemistry 81(12): 5135-5143
Bugge, A.; Holst, D. 2017: PPAR agonists, - could tissue targeting pave the way?. Biochimie 136: 100-104
Joardar, A.; Menzl, J.; Podolsky, T.C.; Manzo, E.; Estes, P.S.; Ashford, S.; Zarnescu, D.C. 2015: PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43. Human Molecular Genetics 24(6): 1741-1754
Janani, C.; Ranjitha Kumari, B.D. 2015: PPAR gamma gene--a review. Diabetes and Metabolic Syndrome 9(1): 46-50
Orekhov, A.N.; Mukhamedova, N.; Ivanova, E.A.; Rizzo, M. 2016: PPAR in Cardiovascular Disorders. Ppar Research 2016: 6293629
Kurzynska, A.; Chojnowska, K.; Bogacki, M.; Bogacka, I. 2016: PPAR ligand association with prostaglandin F2α and E2 synthesis in the pig corpus luteum-An in vitro study. Animal Reproduction Science 172: 157-163
Picklo, M.J.; Johnson, L.; Idso, J. 2017: PPAR mRNA Levels Are Modified by Dietary n-3 Fatty Acid Restriction and Energy Restriction in the Brain and Liver of Growing Rats. Journal of Nutrition 147(2): 161-169
Gautier, S.; Ouk, T.; Pétrault, M.; Pétrault, O.; Bérézowski, V.; Bordet, R.ég. 2015: PPAR-Alpha Agonist Used at the Acute Phase of Experimental Ischemic Stroke Reduces Occurrence of Thrombolysis-Induced Hemorrhage in Rats. Ppar Research 2015: 246329
Ament, Z.; West, J.A.; Stanley, E.; Ashmore, T.; Roberts, L.D.; Wright, J.; Nicholls, A.W.; Griffin, J.L. 2016: PPAR-pan activation induces hepatic oxidative stress and lipidomic remodelling. Free Radical Biology and Medicine 95: 357-368
Feng, X.; Gao, X.; Jia, Y.; Zhang, H.; Xu, Y.; Wang, G. 2016: PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22: 743-751
Feng, X.; Gao, X.; Jia, Y.; Zhang, H.; Pan, Q.; Yao, Z.; Yang, N.; Liu, J.; Xu, Y.; Wang, G.; Yang, X. 2015: PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. Ppar Research 2015: 924131
Huang, D.; Zhao, Q.; Liu, H.; Guo, Y.; Xu, H. 2016: PPAR-α Agonist WY-14643 Inhibits LPS-Induced Inflammation in Synovial Fibroblasts via NF-kB Pathway. Journal of Molecular Neuroscience: Mn 59(4): 544-553
Paterniti, I.; Campolo, M.; Cordaro, M.; Impellizzeri, D.; Siracusa, R.; Crupi, R.; Esposito, E.; Cuzzocrea, S. 2017: PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury. Molecular Neurobiology 54(8): 5973-5987
Hecker, M.; Behnk, A.; Morty, R.E.; Sommer, N.; Vadász, I.án.; Herold, S.; Seeger, W.; Mayer, K. 2015: PPAR-α activation reduced LPS-induced inflammation in alveolar epithelial cells. Experimental Lung Research 41(7): 393-403
Rachid, T.L.; Penna-de-Carvalho, A.; Bringhenti, I.; Aguila, M.B.; Mandarim-de-Lacerda, C.A.; Souza-Mello, V. 2015: PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice. Cell Biochemistry and Function 33(4): 249-256
Zhang, H.; Gao, Y.; Qiao, P.-f.; Zhao, F.-l.; Yan, Y. 2015: PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene. Molecular and Cellular Biochemistry 408(1-2): 37-46
More, V.R.; Campos, C.R.; Evans, R.A.; Oliver, K.D.; Chan, G.N.; Miller, D.S.; Cannon, R.E. 2017: PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 37(4): 1199-1212
Chehaibi, K.; Cedó, L.íd.; Metso, J.; Palomer, X.; Santos, D.; Quesada, H.; Naceur Slimane, M.; Wahli, W.; Julve, J.; Vázquez-Carrera, M.; Jauhiainen, M.; Blanco-Vaca, F.; Escolà-Gil, J.C. 2015: PPAR-β/δ activation promotes phospholipid transfer protein expression. Biochemical Pharmacology 94(2): 101-108
Wu, J.-S.; Tsai, H.-D.; Cheung, W.-M.; Hsu, C.Y.; Lin, T.-N. 2016: PPAR-γ Ameliorates Neuronal Apoptosis and Ischemic Brain Injury via Suppressing NF-κB-Driven p22phox Transcription. Molecular Neurobiology 53(6): 3626-3645
Ko, J.; Park, J.H.; Park, Y.S.; Koh, H.C. 2016: PPAR-γ activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction. Toxicology Letters 260: 8-17
Zoccal, K.Furlani.; Paula-Silva, F.Wanderley.Garcia.; Bitencourt, C.da.Silva.; Sorgi, C.Artério.; Bordon, K.de.Castro.Figueiredo.; Arantes, E.Candiani.; Faccioli, Lúcia.Helena. 2015: PPAR-γ activation by Tityus serrulatus venom regulates lipid body formation and lipid mediator production. Toxicon: official journal of the International Society on Toxinology 93: 90-97
Motoki, T.; Kurobe, H.; Hirata, Y.; Nakayama, T.; Kinoshita, H.; Rocco, K.A.; Sogabe, H.; Hori, T.; Sata, M.; Kitagawa, T. 2015: PPAR-γ agonist attenuates inflammation in aortic aneurysm patients. General Thoracic and Cardiovascular Surgery 63(10): 565-571
Zhu, W.; Yan, H.; Li, S.; Nie, W.; Fan, F.; Zhu, J. 2016: PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways. International Immunopharmacology 41: 24-34
Liu, J.; Sakurai, R.; Rehan, V.K. 2015: PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring. American Journal of Physiology. Lung Cellular and Molecular Physiology 308(8): L788-L796
Peng, Y.; Zeng, Y.; Xu, J.; Huang, X.Lan.; Zhang, W.; Xu, X.Le. 2016: PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats. European Journal of Pharmacology 791: 105-114
Smith, S.I. 2004: PPAR-γ receptor agonists-a review of their role in diabetic management in Trinidad and Tobago. Molecular and Cellular Biochemistry 263(1): 189-210
Reddy, A.T.; Lakshmi, S.P.; Reddy, R.C. 2016: PPARγ as a Novel Therapeutic Target in Lung Cancer. Ppar Research 2016: 8972570
Reddy, A.T.; Lakshmi, S.P.; Reddy, R.C. 2016: PPARγ in Bacterial Infections: a Friend or Foe?. Ppar Research 2016: 7963540
Botton, M.R.; Bandinelli, E.; Leiria, T.L.L.; Rohde, L.E.P.; Hutz, M.H. 2015: PPARA gene and phenprocoumon: a new predictor of response variability. Pharmacogenetics and Genomics 25(2): 93-95
Luo, C-Yuan.; Liu, C-Wu.; Ge, L.; Pang, G-Fang.; Yang, M.; Hu, C-You.; Lv, Z-Ping.; Chen, N-Yuan.; Li, H-Yan.; Wu, H-Yu.; Wang, Y-Yuan.; Yin, R-Xing.; Pan, S-Ling.; Peng, J-Hua. 2015: PPARD +294C overrepresentation in general and long-lived population in China Bama longevity area and unique relationships between PPARD +294T/C polymorphism and serum lipid profiles. Lipids in health and disease 14: 17
Huang, Y.; Nie, S.; Zhou, S.; Li, K.; Sun, J.; Zhao, J.; Fei, B.; Wang, Z.; Ye, H.; Hong, Q.; Gao, X.; Duan, S. 2015: PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects. Biomedicine and PharmacoTherapy 70: 7-11
Tang, L.; Lü, Q.; Cao, H.; Yang, Q.; Tong, N. 2016: PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults. Gene 585(2): 191-195
Stechschulte, L.A.; Czernik, P.J.; Rotter, Z.C.; Tausif, F.N.; Corzo, C.A.; Marciano, D.P.; Asteian, A.; Zheng, J.; Bruning, J.B.; Kamenecka, T.M.; Rosen, C.J.; Griffin, P.R.; Lecka-Czernik, B. 2016: PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption. Ebiomedicine 10: 174-184
Wei, W-Min.; Wu, X-Yan.; Li, S-Ting.; Shen, Q. 2016: PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong. Neurological Research 38(7): 620-624
Tian, J.; Hu, S.; Wang, F.; Yang, X.; Li, Y.; Huang, C. 2015: PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease. International Journal of Clinical and Experimental Pathology 8(3): 3138-3143
Wen, Y.; Hao, J.; Xiao, X.; Wang, W.; Guo, X.; Lin, W.; Yang, T.; Liu, X.; Shen, H.; Tan, L.; Chen, X.; Tian, Q.; Deng, H.-W.; Zhang, F. 2016: PPARGC1B gene is associated with Kashin-Beck disease in Han Chinese. Functional and Integrative Genomics 16(4): 459-463
Côté, S.; Gagné-Ouellet, V.ér.; Guay, S.-P.; Allard, C.; Houde, A.ée.-A.; Perron, P.; Baillargeon, J.-P.; Gaudet, D.; Guérin, R.ée.; Brisson, D.; Hivert, M.-F.; Bouchard, L. 2016: PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. Clinical Epigenetics 8: 72
Fang, L.; Zhang, M.; Li, Y.; Liu, Y.; Cui, Q.; Wang, N. 2016: PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes. PPAR research 2016: 6042162
Park, J.; Lee, Y.; Yu, H.; Han, M.; Kim, B.; Kim, J. 2016: PPARr agonist, troglitazone induce growth arrest and apoptosis in MDA-MB-231 human breast cancer cell. Journal of Clinical Oncology 24(18_Suppl): 13155-13155
Tain, Y-Lin.; Hsu, C-Ning.; Chan, J.Y.H. 2015: PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome. International Journal of Molecular Sciences 17(1)
Yan, Y.; Wang, Z.-B.; Tang, C.-K. 2016: PPARs Mediate the Regulation of Energy Metabolism by Long-Chain Fatty Acids. Sheng Li Ke Xue Jin Zhan 47(1): 1-6
Fan, W.; Evans, R. 2015: PPARs and ERRs: molecular mediators of mitochondrial metabolism. Current Opinion in Cell Biology 33: 49-54
Liss, K.H.H.; Finck, B.N. 2017: PPARs and nonalcoholic fatty liver disease. Biochimie 136: 65-74
Pol, C.J.; Lieu, M.; Drosatos, K. 2015: PPARs: Protectors or Opponents of Myocardial Function?. Ppar Research 2015: 835985
Ramakrishnan, S.K.; Khuder, S.S.; Al-Share, Q.Y.; Russo, L.; Abdallah, S.L.; Patel, P.R.; Heinrich, G.; Muturi, H.T.; Mopidevi, B.R.; Oyarce, A.M.; Shah, Y.M.; Sanchez, E.R.; Najjar, S.M. 2016: PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition. Journal of Biological Chemistry 291(15): 8121-8129
Liu, J.; Lu, R.; Wang, Y.; Hu, Y.; Jia, Y.; Yang, N.; Fu, J.; Wang, G. 2016: PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance. Ppar Research 2016: 6232036
Pantazi, E.; Folch-Puy, E.; Bejaoui, M.; Panisello, A.; Varela, A.T.; Rolo, A.P.; Palmeira, C.M.; Roselló-Catafau, J. 2015: PPARα Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury. Biomed Research International 2015: 894679
Karahanian, E.; Rivera-Meza, M.; Quintanilla, M.ía.E.; Muñoz, D.; Fernández, K.; Israel, Y. 2015: PPARα Agonists Reduce Alcohol Drinking: do they Act in the Brain or in the Liver?. Alcohol and Alcoholism 50(6): 717-718
Benedetti, E.; d'Angelo, M.; Ammazzalorso, A.; Gravina, G.Luca.; Laezza, C.; Antonosante, A.; Panella, G.; Cinque, B.; Cristiano, L.; Dhez, A.Chloè.; Astarita, C.; Galzio, R.; Cifone, M.Grazia.; Ippoliti, R.; Amoroso, R.; Di Cesare, E.; Giordano, A.; Cimini, A. 2017: PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells. Journal of Cellular Physiology 232(6): 1458-1466
Standage, S.W.; Bennion, B.G.; Knowles, T.O.; Ledee, D.R.; Portman, M.A.; McGuire, J.K.; Liles, W.C.; Olson, A.K. 2017: PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis. American Journal of Physiology. Heart and Circulatory Physiology 312(2): H239-H249
Velázquez-Villegas, L.A.; Charabati, T.; Contreras, A.V.; Alemán, G.; Torres, N.; Tovar, A.R. 2016: PPARα Downregulates Hepatic Glutaminase Expression in Mice Fed Diets with Different Protein:Carbohydrate Ratios. Journal of Nutrition 146(9): 1634-1640
Garbacz, W.G.; Huang, J.T.J.; Higgins, L.G.; Wahli, W.; Palmer, C.N.A. 2015: PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice. PPAR research 2015: 927057
You, M.; Jin, J.; Liu, Q.; Xu, Q.; Shi, J.; Hou, Y. 2017: PPARα Promotes Cancer Cell Glut1 Transcription Repression. Journal of Cellular Biochemistry 118(6): 1556-1562
Li, G.; Wang, J.; Ye, J.; Zhang, Y.; Zhang, Y. 2015: PPARα Protein Expression Was Increased by Four Weeks of Intermittent Hypoxic Training via AMPKα2-Dependent Manner in Mouse Skeletal Muscle. Plos one 10(4): E0122593
Ibarra-Lara, L.; Sánchez-Aguilar, M.ía.; Hong, E.; del Valle-Mondragón, L.; Soria-Castro, E.; Pérez-Severiano, F.; Torres-Narváez, J.C.; Ramírez-Ortega, M.; Pastelín-Hernández, G.S.; Cervantes-Pérez, L.G.; Sánchez-Mendoza, A. 2015: PPARα Stimulation Modulates Myocardial Ischemia-induced Activation of Renin-Angiotensin System. Journal of Cardiovascular Pharmacology 65(5): 430-437
Kim, J.-H.; Wahyudi, L.D.; Kim, K.K.; Gonzalez, F.J. 2016: PPARα activation drives demethylation of the CpG islands of the Gadd45b promoter in the mouse liver. Biochemical and Biophysical Research Communications 476(4): 293-298
Reiss, K.; Urbanska, K.; DelValle, L.; Mencel, P.J. 2016: PPARα agonist fenofibrate inhibits IGF-I - mediated growth and DNA repair responses and sensitizes human glioblastoma cells to cisplatin. Journal of Clinical Oncology 26(15_Suppl): 13020-13020
Kim, E.N.; Lim, J.H.; Kim, M.Y.; Kim, H.W.; Park, C.W.; Chang, Y.S.; Choi, B.S. 2016: PPARα agonist, fenofibrate, ameliorates age-related renal injury. Experimental Gerontology 81: 42-50
Ann, S.-J.; Chung, J.H.; Park, B.H.; Kim, S.H.; Jang, J.; Park, S.; Kang, S.-M.; Lee, S.-H. 2015: PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1. Atherosclerosis 240(2): 389-397
Francque, S.; Verrijken, A.; Caron, S.; Prawitt, J.; Paumelle, R.éj.; Derudas, B.; Lefebvre, P.; Taskinen, M.-R.; Van Hul, W.; Mertens, I.; Hubens, G.; Van Marck, E.; Michielsen, P.; Van Gaal, L.; Staels, B. 2015: PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. Journal of Hepatology 63(1): 164-173
Proia, P.; Bianco, A.; Schiera, G.; Saladino, P.; Contrò, V.; Caramazza, G.; Traina, M.; Grimaldi, K.A.; Palma, A.; Paoli, A. 2014: PPARα gene variants as predicted performance-enhancing polymorphisms in professional Italian soccer players. Open Access Journal of Sports Medicine 5: 273-278
Ghosh, A.; Pahan, K. 2016: PPARα in lysosomal biogenesis: a perspective. Pharmacological Research 103: 144-148
Tanaka, S.; Hosogi, S.; Sawabe, Y.; Shimamoto, C.; Matsumura, H.; Inui, T.; Marunaka, Y.; Nakahari, T. 2016: PPARα induced NOS1 phosphorylation via PI3K/Akt in guinea pig antral mucous cells: NO-enhancement in Ca(2+)-regulated exocytosis. Biomedical Research 37(3): 167-178
Gao, J.; Liu, Q.; Xu, Y.; Gong, X.; Zhang, R.; Zhou, C.; Su, Z.; Jin, J.; Shi, H.; Shi, J.; Hou, Y. 2015: PPARα induces cell apoptosis by destructing Bcl2. Oncotarget 6(42): 44635-44642
Abu Aboud, O.; Donohoe, D.; Bultman, S.; Fitch, M.; Riiff, T.; Hellerstein, M.; Weiss, R.H. 2015: PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth. American Journal of Physiology. Cell Physiology 308(11): C890-C898
Yang, H.; Xiao, L.; Wang, N. 2017: Peroxisome proliferator-activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions. Journal of Diabetes 9(4): 341-352
Huang, Y.-P.; Chang, N.W. 2016: PPARα modulates gene expression profiles of mitochondrial energy metabolism in oral tumorigenesis. Biomedicine 6(1): 3
Scheggi, S.; Melis, M.; De Felice, M.; Aroni, S.; Muntoni, A.L.; Pelliccia, T.; Gambarana, C.; De Montis, M.G.; Pistis, M. 2016: PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology 110(Part A): 251-259
Hu, X.; Tanaka, N.; Guo, R.; Lu, Y.; Nakajima, T.; Gonzalez, F.J.; Aoyama, T. 2017: PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. Journal of Nutritional Biochemistry 39: 77-85
Vergori, L.; Lauret, E.; Gaceb, A.; Beauvillain, C.él.; Andriantsitohaina, R.; Martinez, M.C. 2015: PPARα regulates endothelial progenitor cell maturation and myeloid lineage differentiation through a NADPH oxidase-dependent mechanism in mice. Stem Cells 33(4): 1292-1303
Gao, J.; Yuan, S.; Jin, J.; Shi, J.; Hou, Y. 2015: PPARα regulates tumor progression, foe or friend?. European Journal of Pharmacology 765: 560-564
Qin, W.; Liang, C.N.; Guo, X.; Chu, M.; Pei, J.; Bao, P.J.; Wu, X.Y.; Li, T.K.; Yan, P. 2015: PPARα signal pathway gene expression is associated with fatty acid content in yak and cattle longissimus dorsi muscle. Genetics and Molecular Research: Gmr 14(4): 14469-14478
Roy, A.; Pahan, K. 2015: PPARα signaling in the hippocampus: crosstalk between fat and memory. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 10(1): 30-34
Contreras, A.V.; Rangel-Escareño, C.; Torres, N.; Alemán-Escondrillas, G.; Ortiz, V.; Noriega, L.G.; Torre-Villalvazo, I.; Granados, O.; Velázquez-Villegas, L.A.; Tobon-Cornejo, S.; González-Hirschfeld, D.; Recillas-Targa, F.él.; Tejero-Barrera, E.; Gonzalez, F.J.; Tovar, A.R. 2015: PPARα via HNF4α regulates the expression of genes encoding hepatic amino acid catabolizing enzymes to maintain metabolic homeostasis. Genes and Nutrition 10(2): 452
Shi, Y.; Tao, T.; Liu, N.; Luan, W.; Qian, J.; Li, R.; Hu, Q.; Wei, Y.; Zhang, J.; You, Y. 2016: PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop. Oncotarget 7(51): 84623-84633
Biswas, D.; Ghosh, M.; Kumar, S.; Chakrabarti, P. 2016: PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 30(11): 3822-3834
Gao, Q.; Jia, Y.; Yang, G.; Zhang, X.; Boddu, P.C.; Petersen, B.; Narsingam, S.; Zhu, Y.-J.; Thimmapaya, B.; Kanwar, Y.S.; Reddy, J.K. 2015: PPARα-Deficient ob/ob Obese Mice Become more Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. American Journal of Pathology 185(5): 1396-1408
Harada, Y.; Tanaka, N.; Ichikawa, M.; Kamijo, Y.; Sugiyama, E.; Gonzalez, F.J.; Aoyama, T. 2016: PPARα-dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4-dichlorophenoxyacetic acid-induced testicular toxicity in mice. Archives of Toxicology 90(12): 3061-3071
Song, D.; Luo, M.; Dai, M.; Bu, S.; Wang, W.; Zhang, B.; Gonzalez, F.J.; Liu, A. 2017: PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate. Canadian Journal of Physiology and Pharmacology 95(2): 199-205
Zhang, Y.; Cui, Y.; Wang, X.-L.; Shang, X.; Qi, Z.-G.; Xue, J.; Zhao, X.; Deng, M.; Xie, M.-L. 2015: PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 75(1): 127-135
Tong, Q.; Wu, L.; Gao, Q.; Ou, Z.; Zhu, D.; Zhang, Y. 2016: PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease. Molecular Neurobiology 53(6): 3822-3831
Ji, J.; Zeng, X.-N.; Cao, L.-L.; Zhang, L.; Zhao, Z.; Yang, D.-D.; Sun, X.-L. 2017: PPARβ/δ activation protects against corticosterone-induced ER stress in astrocytes by inhibiting the CpG hypermethylation of microRNA-181a. Neuropharmacology 113(Part A): 396-406
Barroso, E.; Rodríguez-Rodríguez, Ría.; Chacón, M.R.; Maymó-Masip, E.; Ferrer, L.; Salvadó, L.; Salmerón, E.; Wabistch, M.; Palomer, X.; Vendrell, J.; Wahli, W.; Vázquez-Carrera, M. 2015: PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation. Biochimica et Biophysica Acta 1852(5): 1049-1058
Bernal, C.; Araya, C.; Palma, Vónica.; Bronfman, M. 2015: PPARβ/δ and PPARγ maintain undifferentiated phenotypes of mouse adult neural precursor cells from the subventricular zone. Frontiers in cellular neuroscience 9: 78
Palomer, X.; Barroso, E.; Zarei, M.; Botteri, G.; Vázquez-Carrera, M. 2016: PPARβ/δ and lipid metabolism in the heart. Biochimica et Biophysica Acta 1861(10): 1569-1578
Falcone, R.; Florio, T.M.; Di Giacomo, E.; Benedetti, E.; Cristiano, L.; Antonosante, A.; Fidoamore, A.; Massimi, M.; Alecci, M.; Ippoliti, R.; Giordano, A.; Cimini, A. 2015: PPARβ/δ and γ in a rat model of Parkinson's disease: possible involvement in PD symptoms. Journal of Cellular Biochemistry 116(5): 844-855
Luz-Crawford, P.; Ipseiz, N.; Espinosa-Carrasco, G.; Caicedo, A.; Tejedor, G.; Toupet, K.; Loriau, J.; Scholtysek, C.; Stoll, C.; Khoury, M.; Noël, D.; Jorgensen, C.; Krönke, G.; Djouad, F. 2016: PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis. Annals of the Rheumatic Diseases 75(12): 2166-2174
Müller, R. 2017: PPARβ/δ in human cancer. Biochimie 136: 90-99
Choudhary, M.; Ding, J.-D.; Qi, X.; Boulton, M.E.; Yao, P.-L.; Peters, J.M.; Malek, G. 2016: PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. Aging 8(9): 1952-1978
Djouad, F.; Ipseiz, N.; Luz-Crawford, P.; Scholtysek, C.; Krönke, G.; Jorgensen, C. 2017: PPARβ/δ: a master regulator of mesenchymal stem cell functions. Biochimie 136: 55-58
Wu, Y.; Tan, X.; Tian, J.; Liu, X.; Wang, Y.; Zhao, H.; Yan, Z.; Liu, H.; Ma, X. 2017: PPARγ Agonist Ameliorates the Impaired Fluidity of the Myocardial Cell Membrane and Cardiac Injury in Hypercholesterolemic Rats. Cardiovascular Toxicology 17(1): 25-34
Ikeda, J.; Ichiki, T.; Takahara, Y.; Kojima, H.; Sankoda, C.; Kitamoto, S.; Tokunou, T.; Sunagawa, K. 2015: PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages. Plos one 10(6): E0128546
Gómez, D.; Muñoz, N.; Guerrero, R.; Acosta, O.; Guerrero, C.A. 2016: PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal Villi. Ppar Research 2016: 4049373
Choi, S.-S.; Kim, E.-S.; Jung, J.-E.; Marciano, D.P.; Jo, A.; Koo, J.Y.; Choi, S.Y.; Yang, Y.R.; Jang, H.-J.; Kim, E.-K.; Park, J.; Kwon, H.M.; Lee, I.H.; Park, S.B.; Myung, K.-J.; Suh, P.-G.; Griffin, P.R.; Choi, J.H. 2016: PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue. Diabetes 65(4): 829-839
Zhou, Y.; Zhang, M.-J.; Li, B.-H.; Chen, L.; Pi, Y.; Yin, Y.-W.; Long, C.-Y.; Wang, X.; Sun, M.-J.; Chen, X.; Gao, C.-Y.; Li, J.-C.; Zhang, L.-L. 2016: PPARγ Inhibits VSMC Proliferation and Migration via Attenuating Oxidative Stress through Upregulating UCP2. Plos one 11(5): E0154720
Rolland, M.; Li, X.; Sellier, Y.; Martin, H.él.èn.; Perez-Berezo, T.; Rauwel, B.; Benchoua, A.; Bessières, B.; Aziza, J.; Cenac, N.; Luo, M.; Casper, C.; Peschanski, M.; Gonzalez-Dunia, D.; Leruez-Ville, M.; Davrinche, C.; Chavanas, S.ép. 2016: PPARγ Is Activated during Congenital Cytomegalovirus Infection and Inhibits Neuronogenesis from Human Neural Stem Cells. Plos Pathogens 12(4): E1005547
Green, D.E.; Murphy, T.C.; Kang, B.-Y.; Searles, C.D.; Hart, C.M. 2015: PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21. Plos one 10(7): E0133391
Lee, Y.H.; Lee, H.Y.; Kim, T.G.; Lee, N.H.; Yu, M.K.; Yi, H.K. 2015: PPARγ Maintains Homeostasis through Autophagy Regulation in Dental Pulp. Journal of Dental Research 94(5): 729-737
Morgado, M.; Carson, D.D. 2017: PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells. Journal of Cellular Biochemistry 118(1): 163-171
Lee, Y.H.; Song, G.G. 2015: PPARγ Pro12Ala and His447His polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis. Genetics and Molecular Research: Gmr 14(2): 7248-7257
Jester, J.V.; Potma, E.; Brown, D.J. 2016: PPARγ Regulates Mouse Meibocyte Differentiation and Lipid Synthesis. Ocular Surface 14(4): 484-494
Kang, B.-Y.; Park, K.; Kleinhenz, J.M.; Murphy, T.C.; Sutliff, R.L.; Archer, D.; Hart, C.M. 2017: Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung. American Journal of Respiratory Cell and Molecular Biology 56(1): 131-144
Stump, M.; Mukohda, M.; Hu, C.; Sigmund, C.D. 2015: PPARγ Regulation in Hypertension and Metabolic Syndrome. Current Hypertension Reports 17(12): 89
Shavva, V.S.; Mogilenko, D.A.; Bogomolova, A.M.; Nikitin, A.A.; Dizhe, E.B.; Efremov, A.M.; Oleinikova, G.N.; Perevozchikov, A.P.; Orlov, S.V. 2016: PPARγ Represses Apolipoprotein A-i Gene but Impedes TNFα-Mediated ApoA-i Downregulation in HepG2 Cells. Journal of Cellular Biochemistry 117(9): 2010-2022
Sato, D.; Oda, K.; Kusunoki, M.; Nishina, A.; Takahashi, K.; Feng, Z.; Tsutsumi, K.; Nakamura, T. 2016: PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats. European Journal of Pharmacology 773: 71-77
Zhang, Z.; Yuan, H.; Zhao, H.; Qi, B.; Li, F.; An, L. 2017: PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice. International Immunopharmacology 43: 53-61
Liu, Y.I.; Liu, Z.; Chen, Y.; Xu, K.; Dong, J. 2016: PPARγ activation reduces ischemia/reperfusion-induced metastasis in a murine model of hepatocellular carcinoma. Experimental and Therapeutic Medicine 11(2): 387-396
Li, P.; Zhang, D.; Wan, M.; Liu, J. 2016: PPARγ affects nitric oxide in human umbilical vein endothelial cells exposed to Porphyromonas gingivalis. Archives of Oral Biology 68: 116-122
Miller, W.R.; Fox, R.G.; Stutz, S.J.; Lane, S.D.; Denner, L.; Cunningham, K.A.; Dineley, K.T. 2018: PPARγ agonism attenuates cocaine cue reactivity. Addiction Biology 23(1): 55-68
Toba, J.; Nikkuni, M.; Ishizeki, M.; Yoshii, A.; Watamura, N.; Inoue, T.; Ohshima, T. 2016: PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice. Biochemical and Biophysical Research Communications 473(4): 1039-1044
Kwon, E.-J.; Park, E.-J.; Choi, S.; Kim, S.-R.; Cho, M.; Kim, J. 2017: PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes. International Journal of Rheumatic Diseases 20(10): 1499-1509
Fu, Y.; Gerasimova, M.; Batz, F.; Kuczkowski, A.; Alam, Y.; Sanders, P.W.; Ronzaud, C.; Hummler, E.; Vallon, V. 2015: PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules. Nephron 129(1): 68-74
Kim, J.; Lee, Y-Jin.; Kim, J.Min.; Lee, S.Young.; Bae, M-Ae.; Ahn, J.Hee.; Han, D.Cho.; Kwon, B-Mog. 2016: PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase. International Journal of Biochemistry and Cell Biology 81(Pt A): 57-66
Unsworth, A.J.; Kriek, N.; Bye, A.P.; Naran, K.; Sage, T.; Flora, G.D.; Gibbins, J.M. 2017: PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase a activity. Journal of Thrombosis and Haemostasis: Jth 15(2): 356-369
Basu-Roy, U.; Han, E.; Rattanakorn, K.; Gadi, A.; Verma, N.; Maurizi, G.; Gunaratne, P.H.; Coarfa, C.; Kennedy, O.D.; Garabedian, M.J.; Basilico, C.; Mansukhani, A. 2016: PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. Oncotarget 7(38): 60954-60970
Wang, H.; Chen, F.; Zhong, K.L.; Tang, S.S.; Hu, M.; Long, Y.; Miao, M.X.; Liao, J.M.; Sun, H.B.; Hong, H. 2016: PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice. British Journal of Pharmacology 173(2): 372-385
Darehgazani, R.; Peymani, M.; Hashemi, M.-S.; Omrani, M.D.; Movafagh, A.; Ghaedi, K.; Nasr-Esfahani, M.H. 2016: PPARγ ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2. Cytotechnology 68(4): 1337-1348
Bazina, A.; Sertić, J.; Mišmaš, A.; Lovrić, T.; Poljaković, Z.; Miličić, D. 2015: PPARγ and IL-6 - 174G>C gene variants in Croatian patients with ischemic stroke. Gene 560(2): 200-204
Shu, L.; Huang, R.; Wu, S.; Chen, Z.; Sun, K.; Jiang, Y.; Cai, X. 2016: PPARγ and its Ligands: Potential Antitumor Agents in the Digestive System. Current Stem Cell Research and Therapy 11(3): 274-281
Zhang, F.; Deng, B.; Wen, J.; Chen, K.; Liu, W.; Ye, S.; Huang, H.; Jiang, S.; Xiong, Y. 2015: PPARγ and MyoD are differentially regulated by myostatin in adipose-derived stem cells and muscle satellite cells. Biochemical and Biophysical Research Communications 458(2): 375-380
Yuan, Z.; Li, Q.; Luo, S.; Liu, Z.; Luo, D.; Zhang, B.; Zhang, D.; Rao, P.; Xiao, J. 2016: PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells. Current Stem Cell Research and Therapy 11(3): 216-225
Croasdell, A.; Duffney, P.F.; Kim, N.; Lacy, S.H.; Sime, P.J.; Phipps, R.P. 2015: PPARγ and the Innate Immune System Mediate the Resolution of Inflammation. Ppar Research 2015: 549691
Sato, K.; Feng, X.; Chen, J.; Li, J.; Muranski, P.; Desierto, M.J.; Keyvanfar, K.; Malide, D.; Kajigaya, S.; Young, N.S. 2016: PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function. Haematologica 101(1): 57-67
Corona, J.C.; Duchen, M.R. 2016: PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radical Biology and Medicine 100: 153-163
Garnier, V.; Traboulsi, W.; Salomon, A.; Brouillet, S.; Fournier, T.; Winkler, C.; Desvergne, B.; Hoffmann, P.; Zhou, Q.-Y.; Congiu, C.; Onnis, V.; Benharouga, M.; Feige, J.-J.; Alfaidy, N. 2015: PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development. American Journal of Physiology. Endocrinology and Metabolism 309(4): E357-E369
Vasheghani, F.; Zhang, Y.; Li, Y.-H.; Blati, M.; Fahmi, H.; Lussier, B.; Roughley, P.; Lagares, D.; Endisha, H.; Saffar, B.; Lajeunesse, D.; Marshall, W.K.; Rampersaud, Y.R.; Mahomed, N.N.; Gandhi, R.; Pelletier, J.-P.; Martel-Pelletier, J.; Kapoor, M. 2015: PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Annals of the Rheumatic Diseases 74(3): 569-578
Fratev, F. 2016: PPARγ helix 12 exhibits an antagonist conformation. Physical Chemistry Chemical Physics: Pccp 18(13): 9272-9280
Kim, S.Y.; Kim, M.S.; Lee, M.K.; Kim, J.S.; Yi, H.K.; Nam, S.Y.; Lee, D.Y.; Hwang, P.H. 2015: PPARγ induces growth inhibition and apoptosis through upregulation of insulin-like growth factor-binding protein-3 in gastric cancer cells. Brazilian Journal of Medical and Biological Research 48(3): 226-233
Yuan, Z.; Luo, G.; Li, X.; Chen, J.; Wu, J.; Peng, Y. 2016: PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. Cellular Signalling 28(3): 158-164
Luo, S.; Wang, J.; Ma, Y.; Yao, Z.; Pan, H. 2015: PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. Biochemical and Biophysical Research Communications 462(2): 85-90
Song, C.; Yao, J.; Cao, C.; Liang, X.; Huang, J.; Han, Z.; Zhang, Y.; Qin, G.; Tao, C.; Li, C.; Yang, H.; Zhao, J.; Li, K.; Wang, Y. 2016: PPARγ is regulated by miR-27b-3p negatively and plays an important role in porcine oocyte maturation. Biochemical and Biophysical Research Communications 479(2): 224-230
Zheng, J.; Xiao, X.-H.; Zhang, Q.; Yu, M.; Xu, J.-P.; Wang, Z.-X.; Liu, Y.-J.; Li, M.-M. 2015: PPARγ links maternal malnutrition and abnormal glucose and lipid metabolism in the offspring of mice. Yi Chuan 37(1): 70-76
Liu, Y.; Huang, Y.; Lee, S.; Bookout, A.L.; Castorena, C.M.; Wu, H.; Gautron, L. 2015: PPARγ mRNA in the adult mouse hypothalamus: distribution and regulation in response to dietary challenges. Frontiers in Neuroanatomy 9: 120
Astapova, O.; Leff, T. 2014: PPARγ mutations, lipodystrophy and diabetes. Hormone Molecular Biology and Clinical Investigation 20(2): 63-70
Fratev, F. 2017: PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: a case study. Journal of Biomolecular Structure and Dynamics 35(3): 476-485
Milton, F.A.; Cvoro, A.; Amato, A.A.; Sieglaff, D.H.; Filgueira, C.S.; Arumanayagam, A.S.; de Lima, M.d.C.A.; Pitta, I.R.; de Assis Rocha Neves, F.; Webb, P. 2015: PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 464(3): 718-723
Danino, H.; Naor, R.P.-; Fogel, C.; Ben-Harosh, Y.; Kadir, R.; Salem, H.; Birk, R. 2016: PPARγ regulates exocrine pancreas lipase. Biochimica et Biophysica Acta 1861(12 Part A): 1921-1928
Kim, J.-S.; Lee, Y.-H.; Chang, Y.-U.; Yi, H.-K. 2017: PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells. Journal of Physiology and Biochemistry 73(1): 49-57
Wang, S.; Dougherty, E.J.; Danner, R.L. 2016: PPARγ signaling and emerging opportunities for improved therapeutics. Pharmacological Research 111: 76-85
Samokhvalov, V.; Vriend, J.; Jamieson, K.L.; Akhnokh, M.K.; Manne, R.; Falck, J.R.; Seubert, J.M. 2014: PPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS. Frontiers in Pharmacology 5: 242
Ren, X.; Zheng, D.; Guo, F.; Liu, J.; Zhang, B.; Li, H.; Tian, W. 2015: PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells. Medical Oncology 32(4): 91
Qiu, Y.; Yang, J.; Bian, S.; Chen, G.; Yu, J. 2016: PPARγ suppresses the proliferation of cardiac myxoma cells through downregulation of MEF2D in a miR-122-dependent manner. Biochemical and Biophysical Research Communications 474(3): 560-565
Handley, N.; Eide, J.; Taylor, R.; Wuertz, B.; Gaffney, P.; Ondrey, F. 2017: PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques. Laryngoscope 127(4): E124-E131
Jiang, Y.; Li, L.; Liu, B.; Zhang, Y.; Chen, Q.; Li, C. 2015: PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 21: 268-275
Sumiyoshi, M.; Satomi, J.; Kitazato, K.T.; Yagi, K.; Shimada, K.; Kurashiki, Y.; Korai, M.; Miyamoto, T.; Suzue, R.; Kuwayama, K.; Nagahiro, S. 2015: PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 24(6): 1187-1195
Peng, X.; Chen, R.; Wu, Y.; Huang, B.; Tang, C.; Chen, J.; Wang, Q.; Wu, Q.; Yang, J.; Qiu, H.; Jiang, Q. 2015: PPARγ-PI3K/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin. Journal of Diabetes and its Complications 29(6): 755-760
Katsouri, L.; Lim, Y.M.; Blondrath, K.; Eleftheriadou, I.; Lombardero, L.; Birch, A.M.; Mirzaei, N.; Irvine, E.E.; Mazarakis, N.D.; Sastre, M. 2016: PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model. Proceedings of the National Academy of Sciences of the United States of America 113(43): 12292-12297
Flores, J.J.; Klebe, D.; Rolland, W.B.; Lekic, T.; Krafft, P.R.; Zhang, J.H. 2016: PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. Neurobiology of Disease 87: 124-133
Dell'Accio, F.; Sherwood, J. 2015: PPARγ/mTOR signalling: striking the right balance in cartilage homeostasis. Annals of the Rheumatic Diseases 74(3): 477-479
Apsel Winger, B.; Shah, N.P. 2015: PPARγ: Welcoming the new Kid on the CML Stem Cell Block. Cancer Cell 28(4): 409-411
Abbott, M.J.; Krolopp, J.E.; Thornton, S.M.; Kawata, A. 2016: PPARδ Is Required For IL-15-induced Mitochondrial Activity In C2C12 Skeletal Muscle Cells: 1965 Board #117 June 2, 3: 30 PM - 5: 00 PM. Medicine and Science in Sports and Exercise 48(5 Suppl 1): 544-544
Cheang, W.S.; Wong, W.T.; Zhao, L.; Xu, J.; Wang, L.; Lau, C.W.; Chen, Z.Y.; Ma, R.C.W.; Xu, A.; Wang, N.; Tian, X.Y.; Huang, Y. 2017: PPARδ Is Required for Exercise to Attenuate Endoplasmic Reticulum Stress and Endothelial Dysfunction in Diabetic Mice. Diabetes 66(2): 519-528
Kan, C.F.K.; Singh, A.B.; Dong, B.; Shende, V.R.; Liu, J. 2015: PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro. Biochimica et Biophysica Acta 1851(5): 577-587
An, Y.-Q.; Zhang, C.T.; Du, Y.; Zhang, M.; Tang, S.S.; Hu, M.; Long, Y.; Sun, H.B.; Hong, H. 2016: PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice. Metabolic Brain Disease 31(3): 663-671
Wang, D.; DuBois, R.N. 2014: PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer. Inflammation and Cell Signaling 1(6)
Hwang, J.S.; Eun, S.Y.; Ham, S.A.; Yoo, T.; Lee, W.J.; Paek, K.S.; Do, J.T.; Lim, D.-S.; Seo, H.G. 2015: PPARδ modulates oxLDL-induced apoptosis of vascular smooth muscle cells through a TGF-β/FAK signaling axis. International Journal of Biochemistry and Cell Biology 62: 54-61
Kim, J.A.; Roy, R.R.; Zhong, H.; Alaynick, W.A.; Embler, E.; Jang, C.; Gomez, G.; Sonoda, T.; Evans, R.M.; Edgerton, V.Reggie. 2016: PPARδ preserves a high resistance to fatigue in the mouse medial gastrocnemius after spinal cord transection. Muscle and Nerve 53(2): 287-296
Yao, J.; Guo, H.; Yang, X. 2015: PPCM: Combing Multiple Classifiers to Improve Protein-Protein Interaction Prediction. International Journal of Genomics 2015: 608042
Yang, X.; Sun, J.; Fu, W.; Shang, C.; Li, Y.; Chen, Y.; Gan, W.; Fang, J. 2016: PPCP degradation by UV/chlorine treatment and its impact on DBP formation potential in real waters. Water Research 98: 309-318
Sun, Q.; Li, Y.; Li, M.; Ashfaq, M.; Lv, M.; Wang, H.; Hu, A.; Yu, C.-P. 2016: PPCPs in Jiulong River estuary (China): Spatiotemporal distributions, fate, and their use as chemical markers of wastewater. Chemosphere 150: 596-604
Sukhwal, A.; Sowdhamini, R. 2015: PPCheck: a Webserver for the Quantitative Analysis of Protein-Protein Interfaces and Prediction of Residue Hotspots. Bioinformatics and Biology Insights 9: 141-151
Sharma, A.S.; Gupta, H.O.; Prasad, R. 2015: PPDB: a Tool for Investigation of Plants Physiology Based on Gene Ontology. Interdisciplinary Sciences Computational Life Sciences 7(3): 295-308
Su, H.; Kong, C.; Zhu, L.; Huang, Q.; Luo, L.; Wang, H.; Xu, Y. 2015: PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget 6(36): 38517-38537
Xu, Y.; Yang, E.; Huang, Q.; Ni, W.; Kong, C.; Liu, G.; Li, G.; Su, H.; Wang, H. 2015: PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2. Journal of Molecular Medicine 93(6): 645-662
Trapp, S.; Cork, S.C. 2015: PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 309(8): R795-R804
Boote, J.; Julious, S.; Horspool, M.; Elphick, H.; Smithson, W.H.; Norman, P. 2016: PPi in the PLEASANT trial: involving children with asthma and their parents in designing an intervention for a randomised controlled trial based within primary care. Primary Health Care Research and Development 17(6): 536-548
Mo, C.; Sun, G.; Wang, Y-Zhi.; Lu, M-Liang.; Yang, Y-Sheng. 2015: PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis. Plos one 10(7): E0131558
Li, C.-X.; Chen, P.; Wang, R.-J.; Wang, X.-J.; Su, Y.-R.; Li, J. 2014: PPI-IRO: a two-stage method for protein-protein interaction extraction based on interaction relation ontology. International Journal of Data Mining and Bioinformatics 10(1): 98-119
Baldi, F. 2015: PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon. Current Gastroenterology Reports 17(7): 451
Warners, M.J.; van Rhijn, B.D.; Curvers, W.L.; Smout, A.J.P.M.; Bredenoord, A.J. 2015: PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. European Journal of Gastroenterology and Hepatology 27(5): 506-511
Yu, J.; Guerois, R.ël. 2016: PPI4DOCK: large scale assessment of the use of homology models in free docking over more than 1000 realistic targets. Bioinformatics 32(24): 3760-3767
Zhang, L.; Li, Z.; Zhang, B.; He, H.; Bai, Y. 2015: PPIA is a novel adipogenic factor implicated in obesity. Obesity 23(10): 2093-2100
Vinitha, A.; Kutty, V.R.; Vivekanand, A.; Reshmi, G.; Divya, G.; Sumi, S.; Santosh, K.R.; Pratapachandran, N.S.; Ajit, M.S.; Kartha, C.C.; Ramachandran, S. 2016: PPIA rs6850: A > G single-nucleotide polymorphism is associated with raised plasma cyclophilin a levels in patients with coronary artery disease. Molecular and Cellular Biochemistry 412(1-2): 259-268
Gao, Y.-F.; Zhu, T.; Mao, C.-X.; Liu, Z.-X.; Wang, Z.-B.; Mao, X.-Y.; Li, L.; Yin, J.-Y.; Zhou, H.-H.; Liu, Z.-Q. 2016: PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. International Journal of Molecular Sciences 17(11)
Craven, T.W.; Bonneau, R.; Kirshenbaum, K. 2016: PPIi Helical Peptidomimetics Templated by Cation-π Interactions. Chembiochem: a European Journal of Chemical Biology 17(19): 1824-1828
Zhu, G.; Wu, A.; Xu, X.-J.; Xiao, P.-P.; Lu, L.; Liu, J.; Cao, Y.; Chen, L.; Wu, J.; Zhao, X.-M. 2016: PPIM: a Protein-Protein Interaction Database for Maize. Plant Physiology 170(2): 618-626
Machkalyan, G.; Trieu, P.; Pétrin, D.; Hébert, T.E.; Miller, G.J. 2016: PPIP5K1 interacts with the exocyst complex through a C-terminal intrinsically disordered domain and regulates cell motility. Cellular Signalling 28(5): 401-411
Will, T.; Helms, V. 2016: PPIXpress: construction of condition-specific protein interaction networks based on transcript expression. Bioinformatics 32(4): 571-578
Wang, L.; Tang, W.; Wang, X.; Chen, Y.; Wu, Y.; Qiang, Y.; Feng, Y.; Ren, Z.; Chen, S.; Xu, A. 2015: PPIase is associated with the diversity of conotoxins from cone snail venom glands. Biochimie 112: 129-138
Arora, S.; Dellon, E.S. 2016: PPIs and Chronic Kidney Disease: Another Association to Worry About?. Gastroenterology 151(2): 366-368
Moledina, D.G.; Perazella, M.A. 2016: PPIs and kidney disease: from AIN to CKD. Journal of Nephrology 29(5): 611-616
Plantone, D.; Renna, R.; Primiano, G.; Shukralla, A.; Koudriavtseva, T. 2015: PPIs as possible risk factor for copper deficiency myelopathy. Journal of the Neurological Sciences 349(1-2): 258-259
Martín de Argila de Prados, C.; Aguilera Castro, L.; Rodríguez de Santiago, E. 2015: PPIs: between overuse and underprescription when really necessary. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(11): 649-651
Bihani, M.; Bora, P.P.; Verma, A.K.; Baruah, R.; Boruah, H.P.D.; Bez, G. 2015: PPL catalyzed four-component PASE synthesis of 5-monosubstituted barbiturates: Structure and pharmacological properties. Bioorganic and Medicinal Chemistry Letters 25(24): 5732-5736
Krasnov, G.S.; Dmitriev, A.A.; Kudryavtseva, A.V.; Shargunov, A.V.; Karpov, D.S.; Uroshlev, L.A.; Melnikova, N.V.; Blinov, V.M.; Poverennaya, E.V.; Archakov, A.I.; Lisitsa, A.V.; Ponomarenko, E.A. 2015: PPLine: An Automated Pipeline for SNP, SAP, and Splice Variant Detection in the Context of Proteogenomics. Journal of Proteome Research 14(9): 3729-3737
Lin, X.; Duan, X.; Liang, Y.-Y.; Su, Y.; Wrighton, K.H.; Long, J.; Hu, M.; Davis, C.M.; Wang, J.; Brunicardi, F.C.; Shi, Y.; Chen, Y.-G.; Meng, A.; Feng, X.-H. 2016: PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling. Cell 166(6): 1597
Gallego-Fabrega, C.; Carrera, C.; Reny, J.-L.; Fontana, P.; Slowik, A.; Pera, J.; Pezzini, A.; Serrano-Heras, G.; Segura, T.ás.; Bin Dukhyil, A.-A.A.; Martí-Fàbregas, J.; Muiño, E.; Cullell, N.; Montaner, J.; Krupinski, J.; Fernandez-Cadenas, I. 2016: PPM1A Methylation Is Associated with Vascular Recurrence in Aspirin-Treated Patients. Stroke 47(7): 1926-1929
Li, Z.; Liu, G.; Sun, L.; Teng, Y.; Guo, X.; Jia, J.; Sha, J.; Yang, X.; Chen, D.; Sun, Q. 2015: PPM1A regulates antiviral signaling by antagonizing TBK1-mediated STING phosphorylation and aggregation. Plos Pathogens 11(3): E1004783
Xiang, W.; Zhang, Q.; Lin, X.; Wu, S.; Zhou, Y.; Meng, F.; Fan, Y.; Shen, T.; Xiao, M.; Xia, Z.; Zou, J.; Feng, X.-H.; Xu, P. 2016: PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1. Science Advances 2(7): E1501889
Pharoah, P.D.P.; Song, H.; Dicks, E.; Intermaggio, M.P.; Harrington, P.; Baynes, C.; Alsop, K.; Bogdanova, N.; Cicek, M.S.; Cunningham, J.M.; Fridley, B.L.; Gentry-Maharaj, A.; Hillemanns, P.; Lele, S.; Lester, J.; McGuire, V.; Moysich, K.B.; Poblete, S.; Sieh, W.; Sucheston-Campbell, L.; Widschwendter, M.; Whittemore, A.S.; Dörk, T.; Menon, U.; Odunsi, K.; Goode, E.L.; Karlan, B.Y.; Bowtell, D.D.; Gayther, S.A.; Ramus, S.J. 2016: PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. Journal of the National Cancer Institute 108(3)
Wu, B.; Guo, B.-M.; Kang, J.; Deng, X.-Z.; Fan, Y.-B.; Zhang, X.-P.; Ai, K.-X. 2016: PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms. Apoptosis: An International Journal on Programmed Cell Death 21(3): 365-378
Cao, R.; Zhang, J.; Zhang, M.; Chen, X. 2015: PPM1D regulates p21 expression via dephoshporylation at serine 123. Cell Cycle 14(4): 641-647
Gudipaty, S.A.; McNamara, R.P.; Morton, E.L.; D'Orso, I.án. 2015: PPM1G Binds 7SK RNA and Hexim1 to Block P-TEFb Assembly into the 7SK snRNP and Sustain Transcription Elongation. Molecular and Cellular Biology 35(22): 3810-3828
Sheng, Y.; Liu, K.; Wu, Q.; Oi, N.; Chen, H.; Reddy, K.; Jiang, Y.; Yao, K.; Li, H.; Li, W.; Zhang, Y.; Saleem, M.; Ma, W.-Y.; Bode, A.M.; Dong, Z.; Dong, Z. 2016: PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts. Oncotarget 7(21): 30977-30989
Li, D.; Brüschweiler, R. 2015: PPM_One: a static protein structure based chemical shift predictor. Journal of Biomolecular NMR 62(3): 403-409
Welter, M.-L.; Demain, A.; Ewenczyk, C.; Czernecki, V.; Lau, B.; El Helou, A.; Belaid, H.; Yelnik, J.ér.ôm.; François, C.; Bardinet, E.; Karachi, C.; Grabli, D. 2015: PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. Journal of Neurology 262(6): 1515-1525
Shen, C.; Meng, Q.; He, W.; Wang, Q.; Zhang, G. 2014: PPO/PEO modified hollow fiber membranes improved sensitivity of 3D cultured hepatocytes to drug toxicity via suppressing drug adsorption on membranes. Colloids and Surfaces. B Biointerfaces 123: 762-769
Zhang, C.; Li, A.; Li, H.; Peng, K.; Wei, Q.; Lin, M.; Liu, Z.; Yin, L.; Li, J. 2015: PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage IIi CRC Receiving Oxaliplatin-Based Chemotherapy. Mediators of Inflammation 2015: 417184
Beg, M.; Srivastava, A.; Shankar, K.; Varshney, S.; Rajan, S.; Gupta, A.; Kumar, D.; Gaikwad, A.N. 2016: PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance. Molecular and cellular endocrinology 437: 97-107
Cheng, Y.-S.; Seibert, O.; Klöting, N.; Dietrich, A.; Straßburger, K.; Fernández-Veledo, S.; Vendrell, J.J.; Zorzano, A.; Blüher, M.; Herzig, S.; Berriel Diaz, M.; Teleman, A.A. 2015: PPP2R5C Couples Hepatic Glucose and Lipid Homeostasis. Plos Genetics 11(10): E1005561
Guo, R.; Wang, X.; Chou, M.M.; Asmann, Y.; Wenger, D.E.; Al-Ibraheemi, A.; Molavi, D.W.; Aboulafia, A.; Jin, L.; Fritchie, K.; Oliveira, J.L.; Jenkins, R.B.; Westendorf, J.J.; Dong, J.; Oliveira, A.M. 2016: PPP6R3-USP6 amplification: Novel oncogenic mechanism in malignant nodular fasciitis. Genes Chromosomes and Cancer 55(8): 640-649
Zhang, H.-D.; Cui, Y.-L.; Huang, C.; Yin, Q.-Q.; Qin, X.-M.; Xu, T.; He, X.-F.; Zhang, Y.; Li, Z.-R.; Yang, Z.-N. 2015: PPR protein PDM1/SEL1 is involved in RNA editing and splicing of plastid genes in Arabidopsis thaliana. Photosynthesis Research 126(2-3): 311-321
Zapisek, B.; Piątkowski, J. 2015: PPR proteins--modular factors regulating expression of organellar genomes. Postepy Biochemii 61(4): 403-415
George, J.M.; Boyd, R.N.; Colditz, P.B.; Rose, S.E.; Pannek, K.; Fripp, J.; Lingwood, B.E.; Lai, M.M.; Kong, A.H.T.; Ware, R.S.; Coulthard, A.; Finn, C.M.; Bandaranayake, S.E. 2015: PPREMO: a prospective cohort study of preterm infant brain structure and function to predict neurodevelopmental outcome. Bmc Pediatrics 15: 123
Neumann, M.E. 2015: PPS proposed rule: A re-mix of the case-mix--or take them out of the recipe. Nephrology News and Issues 29(11): 8 10
Li, Y.-H.; Zhang, G.; Cui, Q. 2015: PPUS: a web server to predict PUS-specific pseudouridine sites. Bioinformatics 31(20): 3362-3364
Nikolić, J.D.; Wouters, S.; Romanova, J.; Shimizu, A.; Champagne, B.ît.; Junkers, T.; Vanderzande, D.; Van Neck, D.; Waroquier, M.; Van Speybroeck, V.; Catak, S. 2015: PPV Polymerization through the Gilch Route: Diradical Character of Monomers. Chemistry 21(52): 19176-19185
Winters, B.D.; Pronovost, P.J. 2017: PPV and the PSIs/HAC Measures. Medical Care 55(1): 87-88
Ádám, J.; Borsos, Á; Balla, I.; Ittzés, A.; Palkovics, L. 2015: PPV susceptibility of commonly used peach rootstock-scion combinations. Acta Virologica 59(4): 429-433
Peters, M.; Zaquen, N.; D'Olieslaeger, L.; Bové, H.; Vanderzande, D.; Hellings, N.; Junkers, T.; Ethirajan, A. 2016: PPV-Based Conjugated Polymer Nanoparticles as a Versatile Bioimaging Probe: A Closer Look at the Inherent Optical Properties and Nanoparticle-Cell Interactions. Biomacromolecules 17(8): 2562-2571
Besha, X.Sheng.; Spencer, R.J.; Bieliauskas, L.A. 2017: PPVT-I administration rules significantly shorten PPVT-III/IV administration. International journal of neuroscience 127(5): 412-416
Elinzano, H.; Glantz, M.; Mrugala, M.; Kesari, S.; Piccioni, D.E.; Kim, L.; Pan, E.; Yunus, S.; Coyle, T.; Timothy, K.; Evans, D.; Mantripragada, K.; Boxerman, J.; DiPetrillo, T.; Donahue, J.E.; Hebda, N.; Mitchell, K.M.; Rosati, K.L.; Safran, H. 2018: PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: a Randomized Phase Ii Study: BrUOG 244. American Journal of Clinical Oncology 41(2): 159-162
Lichko, L.P.; Eldarov, M.A.; Dumina, M.V.; Kulakovskaya, T.V. 2014: PPX1 gene overexpression has no influence on polyphosphates in Saccharomyces cerevisiae. BIOCHEMISTRY. Biokhimiia 79(11): 1211-1215
Yu, T.-Y.; Wei, H.; Luo, Y.-C.; Wang, Y.; Wang, Z.-Y.; Xu, P.-F. 2016: PPh3O as an Activating Reagent for One-Pot Stereoselective Syntheses of Di- and Polybrominated Esters from Simple Aldehydes. Journal of Organic Chemistry 81(7): 2730-2736
Mal, K.; Kaur, A.; Haque, F.; Das, I. 2015: PPh3·HBr-DMSO: a Reagent System for Diverse Chemoselective Transformations. Journal of Organic Chemistry 80(12): 6400-6410
Zhou, X.; Zhao, X.; Li, X.; Ping, G.; Pei, S.; Chen, M.; Wang, Z.; Zhou, W.; Jin, B. 2016: PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells. Journal of ChemoTherapy 28(1): 44-49
Yoh, S.M.; Schneider, M.; Seifried, J.; Soonthornvacharin, S.; Akleh, R.E.; Olivieri, K.C.; De Jesus, P.D.; Ruan, C.; de Castro, E.; Ruiz, P.A.; Germanaud, D.; des Portes, V.; García-Sastre, A.; König, R.; Chanda, S.K. 2015: PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1. Cell 161(6): 1293-1305
Sorrel, A.Lynn. 2016: PQRS Mess. Texas Medicine 112(3): 59-62
Dowd, B.E.; Swenson, T.; Parashuram, S.; Coulam, R.; Kane, R. 2016: PQRS Participation, Inappropriate Utilization of Health Care Services, and Medicare Expenditures. Medical Care Research and Review: Mcrr 73(1): 106-123
Hirsch, J.A.; Leslie-Mazwi, T.M.; Nicola, G.N.; Bhargavan-Chatfield, M.; Seidenwurm, D.J.; Silva, E.; Manchikanti, L. 2016: PQRS and the MACRA: Value-Based Payments have Moved from Concept to Reality. AJNR. American Journal of Neuroradiology 37(12): 2195-2200
Peltzman, M. 2016: PQRS reporting in 2016 and what the college is doing to help. Bulletin of the American College of Surgeons 101(5): 25-29
Blazer, L.L.; Lima-Fernandes, E.; Gibson, E.; Eram, M.S.; Loppnau, P.; Arrowsmith, C.H.; Schapira, M.; Vedadi, M. 2016: PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase. Journal of Biological Chemistry 291(26): 13509-13519
Bhardwaj, B.; Kapuria, D.; Shamim, S. 2016: PR Interval Prolongation in a Patient with Infective Endocarditis: Subtle Changes of Serious Complications. JAMA Internal Medicine 176(6): 841-843
Mochizuki, H.; Ebihara, Y.; Ugawa, Y.; Ishii, N.; Taniguchi, A.; Nagamachi, S.; Shiomi, K.; Nakazato, M. 2015: PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease. European Neurology 74(1-2): 107-111
Gao, C.; Wang, Z.; Li, X.; Zhang, Z.; Zeng, W. 2016: PR-Index: Using the h-Index and PageRank for Determining True Impact. Plos one 11(9): E0161755
Smith, J.W.; O'Neal, W.T.; Shoemaker, M.B.; Chen, L.Y.; Alonso, A.; Whalen, S.P.; Soliman, E.Z. 2017: PR-Interval Components and Atrial Fibrillation Risk (from the Atherosclerosis Risk in Communities Study). American Journal of Cardiology 119(3): 466-472
Wang, Y.; Xu, Z.; Mao, J.-H.; Hsieh, D.; Au, A.; Jablons, D.M.; Li, H.; You, L. 2015: PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer. Zhongguo Fei Ai Za Zhi 18(6): 345-350
St John, L.S.; Wan, L.; He, H.; Garber, H.R.; Clise-Dwyer, K.; Alatrash, G.; Rezvani, K.; Shpall, E.J.; Bollard, C.M.; Ma, Q.; Molldrem, J.J. 2016: PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia. CytoTherapy 18(8): 995-1001
Kuznetsov, I.B.; McDuffie, M. 2015: PR2ALIGN: a stand-alone software program and a web-server for protein sequence alignment using weighted biochemical properties of amino acids. Bmc Research Notes 8: 187
Biswas, A.K.; Gao, J.X. 2016: PR2S2Clust: Patched RNA-seq read segments' structure-oriented clustering. Journal of Bioinformatics and Computational Biology 14(5): 1650027
Miller, J.; Brahams, G.; Adhya, Z.; Karim, M.Y. 2016: PR3 antibodies: not always an immunological emergency. Clinical and Experimental Rheumatology 34(1 Suppl 95: S25-S26
Çakar, M.; Yilmaz, S.; Çinar, M. 2017: Successful treatment of PR3-ANCA positive vasculitis with pancreatitis as the first manifestation with rituximab. International Journal of Rheumatic Diseases 20(12): 2209-2210
Hein, A.L.; Seshacharyulu, P.; Rachagani, S.; Sheinin, Y.M.; Ouellette, M.M.; Ponnusamy, M.P.; Mumby, M.C.; Batra, S.K.; Yan, Y. 2016: PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling. Cancer Research 76(8): 2243-2253
Kurono, Y. 2015: Practical Guideline for Allergic Rhinitis 2013 (7th Edition): Points for Physician. Arerugi 64(9): 1205-1209
Karash, J.A. 2015: PRACTICE GREEN. Saving costs and resources in the OR. Hospitals and Health Networks 89(12): 20
Bendix, J. 2015: PRACTICE INNOVATORS Unique ways to thrive--and how you can too. Medical Economics 92(12): 20; 22-24
Doly, S.ép.; Marullo, S. 2015: PRAF2, an endoplasmic reticulum gatekeeper, controls the cell-surface export of the GABA(B) receptor in neurons. Medecine Sciences: M/S 31(10): 834-836
Rosenow, T.; Oudraad, M.C.J.; Murray, C.P.; Turkovic, L.; Kuo, W.; de Bruijne, M.; Ranganathan, S.C.; Tiddens, H.A.W.M.; Stick, S.M. 2015: PRAGMA-CF. a Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine 191(10): 1158-1165
Ercolak, V.; Paydas, S.; Bagir, E.; Ergin, M.; Seydaoglu, G.; Celik, H.; Yavu, B.; Tanriverdi, K.; Gunaldi, M.; Afsar, C.U.; Duman, B.B. 2015: PRAME Expression and its Clinical Relevance in Hodgkin's Lymphoma. Acta Haematologica 134(4): 199-207
Field, M.G.; Decatur, C.L.; Kurtenbach, S.; Gezgin, G.ül.çi.; van der Velden, P.A.; Jager, M.J.; Kozak, K.N.; Harbour, J.W. 2016: PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 22(5): 1234-1242
Zhang, W.; Barger, C.J.; Eng, K.H.; Klinkebiel, D.; Link, P.A.; Omilian, A.; Bshara, W.; Odunsi, K.; Karpf, A.R. 2016: PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget 7(29): 45352-45369
Chisholm, K.M.; Rivetta, C.V.; Heerema-McKenney, A. 2015: PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with down syndrome. Annals of Clinical and Laboratory Science 45(2): 121-127
Xu, Y.; Yue, Q.; Wei, H.; Pan, G. 2015: PRAME induces apoptosis and inhibits proliferation of leukemic cells in vitro and in vivo. International Journal of Clinical and Experimental Pathology 8(11): 14549-14555
Sun, Z.; Wu, Z.; Zhang, F.; Guo, Q.; Li, L.; Li, K.; Chen, H.; Zhao, J.; Song, D.; Huang, Q.; Li, L.; Xiao, J. 2016: PRAME is critical for breast cancer growth and metastasis. Gene 594(1): 160-164
Zhang, Y.-H.; Lu, A.-D.; Yang, L.; Li, L.-D.; Chen, W.-M.; Long, L.-Y.; Zhang, L.-P.; Qin, Y.-Z. 2017: PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy. Leukemia Research 52: 43-49
Xu, Y.; Rong, L.-J.; Meng, S.-L.; Hou, F.-L.; Zhang, J.-H.; Pan, G. 2016: PRAME promotes in vitro leukemia cells death by regulating S100A4/p53 signaling. European Review for Medical and Pharmacological Sciences 20(6): 1057-1063
Lv, D.; Liu, J.; Guo, L.; Wu, D.; Matsumoto, K.; Huang, L. 2016: PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways. American Journal of Cancer Research 6(2): 486-497
Ma, X.; Guo, J.; Xiao, K.; Sun, X. 2015: PRBP: Prediction of RNA-Binding Proteins Using a Random Forest Algorithm Combined with an RNA-Binding Residue Predictor. Ieee/Acm Transactions on Computational Biology and Bioinformatics 12(6): 1385-1393
Sanli, I.; Feil, R. 2016: PRC-mediated interaction networks of repressed genes: emerging insights and possible roles. Epigenomics 8(6): 733-735
Merini, W.; Calonje, M. 2015: PRC1 is taking the lead in PcG repression. Plant Journal: for Cell and Molecular Biology 83(1): 110-120
Nagarsheth, N.; Peng, D.; Kryczek, I.; Wu, K.; Li, W.; Zhao, E.; Zhao, L.; Wei, S.; Frankel, T.; Vatan, L.; Szeliga, W.; Dou, Y.; Owens, S.; Marquez, V.; Tao, K.; Huang, E.; Wang, G.; Zou, W. 2016: PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Research 76(2): 275-282
Das, P.Pratim.; Hendrix, D.A.; Apostolou, E.; Buchner, A.H.; Canver, M.C.; Beyaz, S.; Ljuboja, D.; Kuintzle, R.; Kim, W.; Karnik, R.; Shao, Z.; Xie, H.; Xu, J.; De Los Angeles, A.; Zhang, Y.; Choe, J.; Jun, D.Leong.Jia.; Shen, X.; Gregory, R.I.; Daley, G.Q.; Meissner, A.; Kellis, M.; Hochedlinger, K.; Kim, J.; Orkin, S.H. 2015: PRC2 Is Required to Maintain Expression of the Maternal Gtl2-Rian-Mirg Locus by Preventing De Novo DNA Methylation in Mouse Embryonic Stem Cells. Cell Reports 12(9): 1456-1470
Kadoch, C.; Copeland, R.A.; Keilhack, H. 2016: PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease. Biochemistry 55(11): 1600-1614
Conway, E.; Healy, E.; Bracken, A.P. 2015: PRC2 mediated H3K27 methylations in cellular identity and cancer. Current Opinion in Cell Biology 37: 42-48
Chiacchiera, F.; Rossi, A.; Jammula, S.; Zanotti, M.; Pasini, D. 2016: PRC2 preserves intestinal progenitors and restricts secretory lineage commitment. EMBO Journal 35(21): 2301-2314
Liu, C.; Li, S.; Dai, X.; Ma, J.; Wan, J.; Jiang, H.; Wang, P.; Liu, Z.; Zhang, H. 2015: PRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complex. Nucleic Acids Research 43(13): 6270-6284
Wehbe, M.; Chernov, L.; Chen, K.; Bally, M.B. 2016: PRCosomes: pretty reactive complexes formed in liposomes. Journal of Drug Targeting 24(9): 787-796
Adhvaryu, K.; Firoozi, G.; Motavaze, K.; Lakin-Thomas, P. 2016: PRD-1, a Component of the Circadian System of Neurospora crassa, Is a Member of the DEAD-box RNA Helicase Family. Journal of Biological Rhythms 31(3): 258-271
Lopez, A.M.; Chuang, J.-C.; Posey, K.S.; Ohshiro, T.; Tomoda, H.; Rudel, L.L.; Turley, S.D. 2015: PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice. Journal of Pharmacology and Experimental Therapeutics 355(2): 159-167
Dong, S.-W.; Zhang, Y.-W.; Chen, Y.; Wang, S.; Sun, P.; Wang, Y.-G.; Zhang, P. 2015: PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells. Oncology Letters 9(1): 341-346
Wang, L.; Zhang, W.-P.; Yao, L.; Zhang, W.; Zhu, J.; Zhang, W.-C.; Zhang, Y.-H.; Wang, Z.; Yan, Q.-G.; Guo, Y.; Fan, L.-N.; Liu, Y.-X.; Huang, G.-S. 2015: PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis. Human Pathology 46(12): 1913-1921
Wan, Z.; Lu, Y.; Rui, L.; Yu, X.; Li, Z. 2016: PRDM1 overexpression induce G0/G1 arrest in DF-1 cell line. Gene 592(1): 119-127
Kang, H-Bum.; Lee, H-Reum.; Jee, D.Jung.; Shin, S-Hyun.; Nah, S-Su.; Yoon, S.Young.; Kim, J.Wha. 2016: PRDM1, a Tumor-Suppressor Gene, is Induced by Genkwadaphnin in Human Colon Cancer SW620 Cells. Journal of Cellular Biochemistry 117(1): 172-179
Mikedis, M.M.; Downs, K.M. 2017: PRDM1/BLIMP1 is widely distributed to the nascent fetal-placental interface in the mouse gastrula. Developmental Dynamics: An Official Publication of the American Association of Anatomists 246(1): 50-71
Okashita, N.; Suwa, Y.; Nishimura, O.; Sakashita, N.; Kadota, M.; Nagamatsu, G.; Kawaguchi, M.; Kashida, H.; Nakajima, A.; Tachibana, M.; Seki, Y. 2016: PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency. Stem Cell Reports 7(6): 1072-1086
Lu, Y.; Wan, Z.; Zhang, X.; Zhong, X.; Rui, L.; Li, Z. 2016: PRDM14 inhibits 293T cell proliferation by influencing the G1/S phase transition. Gene 595(2): 180-186
Okashita, N.; Sakashita, N.; Ito, K.; Mitsuya, A.; Suwa, Y.; Seki, Y. 2015: PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation. Biochemical and Biophysical Research Communications 466(1): 138-145
Carofino, B.L.; Ayanga, B.; Tracey, L.J.; Brooke-Bisschop, T.; Justice, M.J. 2016: PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biology Open 5(5): 645-653
Bi, H.-X.; Shi, H.-B.; Zhang, T.; Cui, G. 2015: PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro. Chinese Medical Journal 128(3): 373-377
Zhou, B.; Wang, J.; Lee, S.Y.; Xiong, J.; Bhanu, N.; Guo, Q.; Ma, P.; Sun, Y.; Rao, R.C.; Garcia, B.A.; Hess, J.L.; Dou, Y. 2016: PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity. Molecular Cell 62(2): 222-236
Harms, M.J.; Lim, H-Woong.; Ho, Y.; Shapira, S.N.; Ishibashi, J.; Rajakumari, S.; Steger, D.J.; Lazar, M.A.; Won, K-Jae.; Seale, P. 2015: PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program. Genes and Development 29(3): 298-307
Iida, S.; Chen, W.; Nakadai, T.; Ohkuma, Y.; Roeder, R.G. 2015: PRDM16 enhances nuclear receptor-dependent transcription of the brown fat-specific Ucp1 gene through interactions with Mediator subunit MED1. Genes and Development 29(3): 308-321
Zhu, S.; Xu, Y.; Song, M.; Chen, G.; Wang, H.; Zhao, Y.; Wang, Z.; Li, F. 2016: PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screening. Molecular Medicine Reports 14(4): 3357-3361
Moreno-Navarrete, J.é M.ía.; Ortega, F.; Moreno, M.ía.; Xifra, G.; Ricart, W.; Fernández-Real, J.é M. 2015: PRDM16 sustains white fat gene expression profile in human adipocytes in direct relation with insulin action. Molecular and Cellular Endocrinology 405: 84-93
Liu, J.; Wu, W.; Hao, J.; Yu, M.; Liu, J.; Chen, X.; Qian, R.; Zhang, F. 2016: PRDM5 Expression and Essential Role After Acute Spinal Cord Injury in Adult Rat. Neurochemical Research 41(12): 3333-3343
Wang, L.; Ding, Q.-Q.; Gao, S.-S.; Yang, H.-J.; Wang, M.; Shi, Y.; Cheng, B.-F.; Bi, J.-J.; Feng, Z.-W. 2016: PRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression. Cancer Medicine 5(9): 2558-2566
Lu, Z.; Liu, Y.; Ren, Z.; Yan, J. 2016: PRDM8 internal promoter hyperhydroxymethylation correlates with increased expression of the corresponding transcript in Down syndrome. Molecular Medicine Reports 14(2): 1227-1234
Baker, C.L.; Kajita, S.; Walker, M.; Saxl, R.L.; Raghupathy, N.; Choi, K.; Petkov, P.M.; Paigen, K. 2015: PRDM9 drives evolutionary erosion of hotspots in Mus musculus through haplotype-specific initiation of meiotic recombination. Plos Genetics 11(1): E1004916
Parvanov, E.D.; Tian, H.; Billings, T.; Saxl, R.L.; Spruce, C.; Aithal, R.; Krejci, L.; Paigen, K.; Petkov, P.M. 2017: PRDM9 interactions with other proteins provide a link between recombination hotspots and the chromosomal axis in meiosis. Molecular Biology of the Cell 28(3): 488-499
Tang, Z.; Xia, N.; Yuan, X.; Zhu, X.; Xu, G.; Cui, S.; Zhang, T.; Zhang, W.; Zhao, Y.; Wang, S.; Shi, B. 2015: PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells. Biochemical and Biophysical Research Communications 465(4): 670-677
Luo, W.; Chen, I.; Chen, Y.; Alkam, D.; Wang, Y.; Semenza, G.L. 2016: PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia. Oncotarget 7(6): 6379-6397
Zhou, S.; Han, Q.; Wang, R.; Li, X.; Wang, Q.; Wang, H.; Wang, J.; Ma, Y. 2016: PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress. Oncology Letters 12(3): 2217-2221
Senhaji, N.; Zaid, Y.; El Khalfi, B.; Fahimi, M.; Martin, J.; Badre, W.; Nadifi, S.; Soukri, A. 2017: Peroxiredoxin-2 up-regulation in inflammatory bowel disease: Friend or foe?. Journal of Gastroenterology and Hepatology 32(6): 1212-1220
Zha, X.; Wu, G.; Zhao, X.; Zhou, L.; Zhang, H.; Li, J.; Ma, L.; Zhang, Y. 2015: PRDX6 Protects ARPE-19 Cells from Oxidative Damage via PI3K/AKT Signaling. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 36(6): 2217-2228
Yun, H.-M.; Park, K.-R.; Kim, E.-C.; Hong, J.T. 2015: PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption. Oncotarget 6(25): 20875-20884
Yun, H.-M.; Park, K.-R.; Park, M.H.; Kim, D.H.; Jo, M.R.; Kim, J.Y.; Kim, E.-C.; Yoon, D.Y.; Han, S.B.; Hong, J.T. 2015: PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radical Biology and Medicine 80: 136-144
von Dadelszen, P.; Sawchuck, D.; Justus Hofmeyr, G.; Magee, L.A.; Bracken, H.; Mathai, M.; Tsigas, E.Z.; Teela, K.C.; Donnay, F.; Roberts, J.M. 2013: PRE-EMPT (PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment): A low and middle income country initiative to reduce the global burden of maternal, fetal and infant death and disease related to pre-eclampsia. Pregnancy Hypertension 3(4): 199-202
López-Cano, M.; Pereira, Jé.A.; Lozoya, R.; Feliu, X.; Villalobos, R.; Navarro, S.; Arbós, M.Antonia.; Armengol-Carrasco, M. 2014: PREBIOUS trial: a multicenter randomized controlled trial of PREventive midline laparotomy closure with a BIOabsorbable mesh for the prevention of incisional hernia: rationale and design. Contemporary Clinical Trials 39(2): 335-341
Naumann, R.W.; Symanowski, J.T.; Ghamande, S.A.; Gabrail, N.Y.; Gilbert, L.; Teneriello, M.G.; Sutton, G.; Lovejoy, C.; Messmann, R.A. 2016: PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer. Journal of Clinical Oncology 28(18_Suppl): Lba 5012b-Lba 5012b
Paley, D. 2015: PRECICE intramedullary limb lengthening system. Expert Review of Medical Devices 12(3): 231-249
Zuidgeest, M.G.; Goetz, I.; Grobbee, D.E. 2017: PRECIS-2 in perspective: what is next for pragmatic trials?. Journal of Clinical Epidemiology 84: 22-24
Mathieson, S.; Billot, L.; Maher, C.G.; McLachlan, A.J.; Latimer, J.; Koes, B.W.; Hancock, M.J.; Harris, I.; Day, R.O.; Pik, J.; Jan, S.; Lin, C.-W.C. 2016: PRECISE--pregabalin in addition to usual care: statistical analysis plan. Trials 17: 53
Chen, F.; Wang, S.; Mohammed, N.; Cheng, S.; Jiang, X. 2014: PRECISE:PRivacy-prEserving Cloud-assisted quality Improvement Service in hEalthcare. IEEE International Conference on Systems Biology: Proceedings . IEEE International Conference on Systems Biology 2014: 176-183
Fernandez-Ricaud, L.; Kourtchenko, O.; Zackrisson, M.; Warringer, J.; Blomberg, A. 2016: PRECOG: a tool for automated extraction and visualization of fitness components in microbial growth phenomics. Bmc Bioinformatics 17: 249
Patchick, E.; Vail, A.; Wood, A.; Bowen, A. 2016: PRECiS (Patient Reported Evaluation of Cognitive State): psychometric evaluation of a new patient reported outcome measure of the impact of stroke. Clinical Rehabilitation 30(12): 1229-1241
Shinde, P.S.; Lee, H.H.; Lee, S.Y.; Lee, Y.M.; Jang, J.S. 2015: PRED treatment mediated stable and efficient water oxidation performance of the Fe2O3 nano-coral structure. Nanoscale 7(36): 14906-14913
Tsirigos, K.D.; Elofsson, A.; Bagos, P.G. 2016: PRED-TMBB2: improved topology prediction and detection of beta-barrel outer membrane proteins. Bioinformatics 32(17): I665-I671
Peng, Y.; Yang, L.; Li, H.; Zou, Y.; Deng, L.; Wu, A.; Du, X.; Wang, D.; Shu, Y.; Jiang, T. 2016: PREDAC-H3: a user-friendly platform for antigenic surveillance of human influenza a(H3N2) virus based on hemagglutinin sequences. Bioinformatics 32(16): 2526-2527
Mugoša, S.ža.; Djordjević, N.ša.; Bukumirić, Z.; Djukanović, N.; Cukić, J.; Radosavljević, I.; Baskić, D.; Protić, D.; Zdravković, M.; Todorović, Z. 2016: PREDICT score and CYP2C19 polymorphism independently predict lack of efficacy of clopidogrel in cardiology patients. Clinical and Experimental Pharmacology and Physiology 43(3): 379-381
Kerkmeijer, L.G.W.; Monninkhof, E.M.; van Oort, I.M.; van der Poel, H.G.; de Meerleer, G.; van Vulpen, M. 2016: PREDICT: model for prediction of survival in localized prostate cancer. World Journal of Urology 34(6): 789-795
Htay, H.; Cho, Y.; Pascoe, E.M.; Darssan, D.; Hawley, C.; Johnson, D.W. 2017: Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: the balANZ Trial. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 37(3): 283-289
León-Sanz, M.; Brosa, M.; Planas, M.; García-de-Lorenzo, A.; Celaya-Pérez, S.án.; Hernández, J.Ál.; Baró, F.M.; Izquierdo, F.J.E.; Fuster, G.O.; Brier, F.át.L.R.; Murillo, A.Z.; Vázquez, M.J.é M.ín.; Bretón, J.O.ón.; Romero, F.B.; Pomar, M.ía.D.B.; Martinez, C.V.áz.; Hernández, M.V.C.; De Agredos, V.áz.; García-Manzanares, Ál.; Urgelés Planella, J.R.ón.; Peláez, R.B.; Gómez, M.F.; Arizmendi, A.M.; Garcia, M.áx.M.; Roca, S.M.; De Cabrera, E.D.P.; Simeón, R.M.G.; González, J.O.óñe.; Lobo, R.M.; Rocamora, J.é A.I.; Felipe, V.F.; Pola, G.E.; Ramirez, M.J.é M.ín.; Soria, J.B.M.; Sánchez, C.B.; Carrasco, C.M.án.; Socias, J.é M. 2015: PREDyCES study: the cost of hospital malnutrition in Spain. Nutrition 31(9): 1096-1102
Jacobson, R.K.; Antia, C.; Sharaf, M.A. 2019: Disseminated interstitial granuloma annulare associated with hepatocellular carcinoma. Clinical and Experimental Dermatology 44(1): 110-112
Cyr, D.P.; Mehta, V.B. 1969: Disseminated intravascular clotting. Medical Clinics of North America 53(2): 301-307
Watts, C. 1977: Disseminated intravascular coagulation. Surgical Neurology 8(4): 258-262
Carter, D.; Papps, B.; Brook, N.R. 2018: Disseminated Intravascular Coagulation After Embolization to Treat Acutely Bleeding Bilateral Massive Angiomyolipoma: A Case Report. Journal of Endourology Case Reports 4(1): 117-119
Hage, A.; Chick, J.F.B.; Srinivasa, R.N.; Kuo, K.W.; Kohne, J.G.; Campbell, A.D.; Gemmete, J.J. 2018: Disseminated Intravascular Coagulation and Acute Liver Injury from Ethanol Embolization of an Arteriovenous Malformation. Journal of Vascular and Interventional Radiology: Jvir 29(3): 437-439
Levi, M.; Sivapalaratnam, S. 2018: Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Review of Hematology 11(8): 663-672
Davis, J.A.; Morin, D.P. 2018: To the Editor- Disseminated intravascular coagulation as a cause of shock related to device extraction. Heart rhythm 15(3): e35
Ohlmann, C.-H.; Stöckle, M.; Albers, P.; Schmidberger, H.; Härter, M.; Kristiansen, G.; Martus, P.; Wellek, S.; Bussar-Maatz, R.; Wiegel, T. 2016: PREFERE - Study on the rise. Der Urologe. Ausg. a 55(3): 313-317
Perros, P.; Žarković, Mš.; Azzolini, C.; Ayvaz, Göksun.; Baldeschi, L.; Bartalena, L.; Boschi, A.; Bournaud, C.; Brix, T.Heiberg.; Covelli, D.; Ćirić, S.; Daumerie, C.; Eckstein, A.; Fichter, N.; Führer, D.; Hegedüs, L.; Kahaly, G.J.; Konuk, O.; Lareida, Jürg.; Lazarus, J.; Leo, M.; Mathiopoulou, L.; Menconi, F.; Morris, D.; Okosieme, O.; Orgiazzi, J.; Pitz, S.; Salvi, M.; Vardanian-Vartin, C.; Wiersinga, W.; Bernard, M.; Clarke, L.; Currò, N.; Dayan, C.; Dickinson, J.; Knežević, M.; Lane, C.; Marcocci, C.; Marinò, M.; Möller, L.; Nardi, 2015: PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. British Journal of Ophthalmology 99(11): 1531-1535
Wang Xiaoping; Wei, Z.; Huang, J.; Chen, L.; Hu, S.; Wu, W.; Tu, Y.; Guo, S.; Xu, G.; Deng, Z. 2016: Preliminary Application of Virtual Preoperative Reconstruction Planning in Pilon Fractures. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 30(1): 44-49
Gunia-Krzyzak, A.; Pytka, K.; Słoczyńska, K.; Waszkielewicz, A.M.; Satała, G.; Bojarski, A.J.; Sapa, J.; Filipek, B.; Cegła, M.; Pekala, E.; Marona, H. 2016: Preliminary Evaluation of Central Nervous System Activity of (E)-N-2-Methyl-3-Phenylprop-2-Enyl ((E)-N- Α-Methylcinnamyl) Derivatives of Selected Aminoalkanols. Acta Poloniae Pharmaceutica 73(2): 345-357
Li, H.; Cui, Y.; Luan, J.; Zhang, X.; Li, C.; Zhou, X.; Shi, L.; Wang, H.; Han, J. 2016: PRELP (proline/arginine-rich end leucine-rich repeat protein) promotes osteoblastic differentiation of preosteoblastic MC3T3-E1 cells by regulating the β-catenin pathway. Biochemical and Biophysical Research Communications 470(3): 558-562
Lai, M.M.; D'Acunto, G.; Guzzetta, A.; Boyd, R.N.; Rose, S.E.; Fripp, J.; Finnigan, S.; Ngenda, N.; Love, P.; Whittingham, K.; Pannek, K.; Ware, R.S.; Colditz, P.B. 2016: PREMM: preterm early massage by the mother: protocol of a randomised controlled trial of massage therapy in very preterm infants. Bmc Pediatrics 16(1): 146
Yakut, S.; Cetin, Z.; Sanhal, C.; Karaman, B.; Mendilcioglu, I.; Karauzum, S.B. 2015: Prenatal Diagnosis of de Novo Pericentric Inversion Inv(2)(P11.2z13). Genetic Counseling 26(2): 243-247
McLoughlin, D. 2001: PREP does not contravene the Human Rights Act. Nursing Standard 1987) 15(26): 31-31
Allen, E.; Stanley, S.; Rhoades, G.; Markman, H. 2015: PREP for Strong Bonds: a review of outcomes from a randomized clinical trial. Contemporary Family Therapy 37(3): 232-246
Anonymous 1995: PREP helpline buzzes. Nursing Standard 1987) 9(32): 6-6
Vile, C. 1993: PREP hindering nurse advancement?. Nursing Standard 1987) 7(37): 42-42
Doult, B.; Canning, S. 1994: PREP plans likely to prove disappointing. Nursing Standard: 8(25): 5
Scott, G. 1993: PREP proposals visionless, says Buttigieg. Nursing Standard: 1987) 8(4): 7
Duffin, C.; Martell, R. 2001: PREP screening must be tightened to protect public. Nursing Standard 1987) 15(36): 6-6
Burnham, N. 1995: Protest at rent rises and mouse-traps. Nursing Standard: 9(28): 12
Rowe, E. 1994: Labour plans for complaints overhaul. Nursing Standard: 8(21): 7
Sullivan-Bolyai, S.; Crawford, S.; Johnson, K.; Ramchandani, N.; Quinn, D.; D'Alesandro, B.; Stern, K.; Lipman, T.; Melkus, G.; Streisand, R. 2016: PREP-T1 (Preteen Re-Education with Parents-Type 1 Diabetes) Feasibility Intervention Results. Journal of Family Nursing 22(4): 579-605
Anonymous 1997: PREP: what's on offer? To help you maintain and develop your professional and clinical practice and meet your UKCC requirements for PREP the RCN is offering free Continuing Education vouchers along with some new CE initiatives starting next week in Nursing Standard. This report explains what will be available. Nursing Standard 1987) 11(27): 32-32
Untch, M.; Fasching, P.A.; Bauerfeind, I.; Conrad, U.; Camara, O.; Fett, W.; Kuzeder, W.; Lück, H.; Loibl, S.; Von Minckwitz, G. 2016: PREPARE trial. A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF with a standard dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer: A preplanned interim analysis of efficacy at surgery. Journal of Clinical Oncology 26(15_Suppl): 517-517
Lindbäck, Y.; Tropp, H.; Enthoven, P.; Abbott, A.; Öberg, B. 2016: PREPARE: Pre-surgery physiotherapy for patients with degenerative lumbar spine disorder: a randomized controlled trial protocol. Bmc Musculoskeletal Disorders 17: 270
Lasocki, S.; Krauspe, R.üd.; von Heymann, C.; Mezzacasa, A.; Chainey, S.; Spahn, D.R. 2015: PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. European Journal of Anaesthesiology 32(3): 160-167
Anonymous 1990: PREPP proposes third level of registration. Nursing Standard: 1987) 4(22): 5
Werner, E.A.; Gustafsson, H.C.; Lee, S.; Feng, T.; Jiang, N.; Desai, P.; Monk, C. 2016: PREPP: postpartum depression prevention through the mother-infant dyad. Archives of Women's Mental Health 19(2): 229-242
Masetti, R.; Cordelli, D.M.; Zama, D.; Vendemini, F.; Biagi, C.; Franzoni, E.; Pession, A. 2015: PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation. Pediatrics 135(5): 890-901
Spencer, D. 2015: PRES-ing for Answers About Long-Term Seizure Risk in Patients With Posterior Reversible Encephalopathy Syndrome. Epilepsy currents 15(6): 317-318
McGowan, J.; Sampson, M.; Salzwedel, D.M.; Cogo, E.; Foerster, V.; Lefebvre, C. 2016: PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. Journal of clinical epidemiology 75: 40-46
Sakka, M.; Tzortzis, G.; Mantzaris, M.D.; Bekas, N.; Kellici, T.F.; Likas, A.; Galaris, D.; Gerothanassis, I.P.; Tzakos, A.G. 2016: PRESS: PRotEin S-Sulfenylation server. Bioinformatics 32(17): 2710-2712
Sun, L.; Dimitromanolakis, A. 2014: PREST-plus identifies pedigree errors and cryptic relatedness in the GAW18 sample using genome-wide SNP data. Bmc Proceedings 8(Suppl 1 Genetic Analysis Workshop 18vanessa Olmo): S23
Perras, F.éd.ér.A.; Kobayashi, T.; Pruski, M. 2015: PRESTO polarization transfer to quadrupolar nuclei: implications for dynamic nuclear polarization. Physical Chemistry Chemical Physics: Pccp 17(35): 22616-22622
Svetina, C.; Cocco, D.; Mahne, N.; Raimondi, L.; Ferrari, E.; Zangrando, M. 2016: PRESTO, the on-line photon energy spectrometer at FERMI: design, features and commissioning results. Journal of Synchrotron Radiation 23(1): 35-42
Wertz, A.; Trenholm, S.; Yonehara, K.; Hillier, D.; Raics, Z.; Leinweber, M.; Szalay, G.; Ghanem, A.; Keller, G.; Rózsa, B.áz.; Conzelmann, K.-K.; Roska, B. 2015: PRESYNAPTIC NETWORKS. Single-cell-initiated monosynaptic tracing reveals layer-specific cortical network modules. Science 349(6243): 70-74
Béchade, C.ém.; Le Maître, B.éa.; Lobbedez, T.; Bouvier, N.; Hurault de Ligny, B.; Châtelet, V.ér. 2016: PRETAGREF study: Prevalence of tobacco use and factors associated with smoking cessation in kidney transplant recipients. Nephrologie and Therapeutique 12(1): 48-55
Qureshi, S.S.; Bhagat, M.; Kembhavi, S.; Vora, T.; Ramadwar, M.; Talole, S. 2015: PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy. Pediatric Surgery International 31(6): 573-579
Dworkin, J.D.; Sweeney, E.M.; Schindler, M.K.; Chahin, S.; Reich, D.S.; Shinohara, R.T. 2016: PREVAIL: Predicting Recovery through Estimation and Visualization of Active and Incident Lesions. Neuroimage. Clinical 12: 293-299
Elbaz, H.; Peto, T.; Butsch, C.; Orouji, E.; Laubert-Reh, D.; Ponto, K.A.; Binder, H.; Pfeiffer, N.; Mirshahi, A. 2016: Prevalence and Associations of Myelinated Retinal Nerve Fibers: Results from the Population-Based Gutenberg Health Study. Retina 36(12): 2364-2370
Sinha, A.; Singh, C.K.; Singh, H.P. 1999: Prevalence of Blood Group Abo and Rh in Scheduled Tribes (St) of South Bihar Region. Indian Journal of Physiology and Pharmacology 43(1): 141-142
Richards, T.; Clevenger, B.; Keidan, J.; Collier, T.; Klein, A.A.; Anker, S.D.; Kelly, J.D. 2015: PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial. Trials 16: 254
Maltais, S.; Kilic, A.; Nathan, S.; Keebler, M.; Emani, S.; Ransom, J.; Katz, J.N.; Sheridan, B.; Brieke, A.; Egnaczyk, G.; Entwistle, J.W.; Adamson, R.; Stulak, J.; Uriel, N.; O'Connell, J.B.; Farrar, D.J.; Sundareswaran, K.S.; Gregoric, I. 2017: PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 36(1): 1-12
Uhrynowska, Młgorzata.Ewa.; Dębska, M.; Guz, K.; Orzińska, A.; Wróbel, A.; Maślanka, K.; Dębski, R.; Brojer, E. 2015: PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program. Ginekologia Polska 86(1): 62-66
Kahlert, D.; Unyi-Reicherz, A.; Stratton, G.; Meinert Larsen, T.; Fogelholm, M.; Raben, A.; Schlicht, W. 2016: PREVIEW Behavior Modification Intervention Toolbox (PREMIT): a Study Protocol for a Psychological Element of a Multicenter Project. Frontiers in Psychology 7: 1136
Barrows, D.; He, J.Z.; Parsons, R. 2016: PREX1 Protein Function Is Negatively Regulated Downstream of Receptor Tyrosine Kinase Activation by p21-activated Kinases (PAKs). Journal of Biological Chemistry 291(38): 20042-20054
Yang, J.; Gong, X.; Ouyang, L.; He, W.; Xiao, R.; Tan, L. 2016: PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway. Oncology Letters 12(2): 1139-1143
Gaci, R.; Cadoz, C.; Barraud, D.; Louis, G. 2019: Disseminated intravascular coagulation in pneumococcemia. Intensive Care Medicine 45(5): 698-699
Chapal, M.; Foucher, Y.; Marguerite, M.; Neau, K.; Papuchon, E.; Daguin, P.; Morélon, E.; Mourad, G.; Cassuto, E.; Ladrière, M.; Legendre, C.; Giral, M. 2015: PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial. Trials 16: 282
Moyer, C.A.; Aborigo, R.A.; Kaselitz, E.B.; Gupta, M.L.; Oduro, A.; Williams, J. 2016: PREventing Maternal And Neonatal Deaths (PREMAND): a study protocol for examining social and cultural factors contributing to infant and maternal deaths and near-misses in rural northern Ghana. Reproductive Health 13: 20
Baadjou, V.A.E.; Verbunt, J.A.M.C.F.; Eijsden-Besseling, M.D.F.van.; Samama-Polak, A.L.W.; Bie, R.A.D.E.; Smeets, R.J.E.M. 2014: PREvention STudy On preventing or reducing disability from musculoskeletal complaints in music school students (PRESTO): protocol of a randomised controlled trial. Journal of PhysioTherapy 60(4): 232; Discussion 232
McNutt, M. 2016: PREview of new products. Science 351(6278): 1119
Liu, X.; Huai, J.; Endle, H.; Schlüter, L.; Fan, W.; Li, Y.; Richers, S.; Yurugi, H.; Rajalingam, K.; Ji, H.; Cheng, H.; Rister, B.; Horta, G.; Baumgart, J.; Berger, H.; Laube, G.; Schmitt, U.; Schmeisser, M.J.; Boeckers, T.M.; Tenzer, S.; Vlachos, A.; Deller, T.; Nitsch, R.; Vogt, J. 2016: PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/β1-Integrin Signaling. Developmental cell 38(3): 275-290
Fan, Z.; Bittermann-Rummel, P.; Yakubov, E.; Chen, D.; Broggini, T.; Sehm, T.; Hatipoglu Majernik, G.ök.; Hock, S.W.; Schwarz, M.; Engelhorn, T.; Doerfler, A.; Buchfelder, M.; Eyupoglu, I.Y.; Savaskan, N.E. 2016: PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget 7(18): 26692-26708
Li, B.; Qiu, T.; Iyer, K.S.; Yan, Q.; Yin, Y.; Xie, L.; Wang, X.; Li, S. 2015: PRGD/PDLLA conduit potentiates rat sciatic nerve regeneration and the underlying molecular mechanism. Biomaterials 55: 44-53
Anitua, E.; Zalduendo, M.; Troya, M.ía.; Orive, G. 2016: PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Clinical Oral Investigations 20(3): 513-521
Anitua, E.; Muruzabal, F.; de la Fuente, M.; Riestra, A.; Merayo-Lloves, J.; Orive, G. 2016: PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model. Experimental Eye Research 151: 115-121
Daulat, A.M.; Bertucci, Fçois.; Audebert, Séphane.; Sergé, A.; Finetti, P.; Josselin, E.; Castellano, Rémy.; Birnbaum, D.; Angers, Séphane.; Borg, J-Paul. 2016: PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2. Developmental Cell 37(4): 311-325
Sandford, E.; Bird, T.D.; Li, J.Z.; Burmeister, M. 2016: PRICKLE2 Mutations Might not be Involved in Epilepsy. American Journal of Human Genetics 98(3): 588-589
Perez-Riverol, Y.; Xu, Q.-W.; Wang, R.; Uszkoreit, J.; Griss, J.; Sanchez, A.; Reisinger, F.; Csordas, A.; Ternent, T.; Del-Toro, N.; Dianes, J.A.; Eisenacher, M.; Hermjakob, H.; Vizcaíno, J.A. 2016: PRIDE Inspector Toolsuite: Moving Toward a Universal Visualization Tool for Proteomics Data Standard Formats and Quality Assessment of ProteomeXchange Datasets. Molecular and Cellular Proteomics: Mcp 15(1): 305-317
Klonoff, D.C.; Draznin, B.; Drincic, A.; Dungan, K.; Gianchandani, R.; Inzucchi, S.E.; Nichols, J.H.; Rice, M.J.; Seley, J.Jeffrie. 2015: PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients. Journal of Clinical Endocrinology and Metabolism 100(10): 3607-3612
Addis, A.; Papini, D.; Bassi, M.Chiara.; Grilli, R. 2015: PRIER II. The Emilia-Romagna Research and Innovation Programme. Recenti Progressi in Medicina 106(9): 409-415
Waltersperger, S.; Olieric, V.; Pradervand, C.; Glettig, W.; Salathe, M.; Fuchs, M.R.; Curtin, A.; Wang, X.; Ebner, S.; Panepucci, E.; Weinert, T.; Schulze-Briese, C.; Wang, M. 2015: PRIGo: a new multi-axis goniometer for macromolecular crystallography. Journal of Synchrotron Radiation 22(4): 895-900
Farhadi, E.; Safa, M.; Sharifi, A.M.; Bashash, D. 2017: PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-Myc. Anti-Cancer Drugs 28(1): 51-58
Teoh, P.J.; Bi, C.; Sintosebastian, C.; Tay, L.S.; Fonseca, R.; Chng, W.J. 2016: PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation. Oncotarget 7(38): 61806-61819
Grellety, T.; Laroche-Clary, A.; Chaire, V.; Lagarde, P.; Chibon, F.éd.ér.; Neuville, A.; Italiano, A. 2015: PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53. Bmc Cancer 15: 684
Yoshikawa, N.; Kajiyama, H.; Nakamura, K.; Utsumi, F.; Niimi, K.; Mitsui, H.; Sekiya, R.; Suzuki, S.; Shibata, K.; Callen, D.; Kikkawa, F. 2016: PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells. Oncology Reports 35(5): 2543-2552
Sobhani, M.; Abdi, J.; Manujendra, S.N.; Chen, C.; Chang, H. 2015: PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53. Cancer Biology and Therapy 16(5): 799-806
Lu, T.; Zou, Y.; Xu, G.; Potter, J.A.; Taylor, G.L.; Duan, Q.; Yang, Q.; Xiong, H.; Qiu, H.; Ye, D.; Zhang, P.; Yu, S.; Yuan, X.; Zhu, F.; Wang, Y.; Xiong, H. 2016: PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK. Oncotarget 7(50): 83017-83030
Li, X.-L.; Zhou, J.; Chan, Z.-L.; Chooi, J.-Y.; Chen, Z.-R.; Chng, W.-J. 2015: PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms. Oncotarget 6(34): 36689-36699
Hildebrand, M.S.; Tankard, R.; Gazina, E.V.; Damiano, J.A.; Lawrence, K.M.; Dahl, H.-H.M.; Regan, B.M.; Shearer, A.E.; Smith, R.J.H.; Marini, C.; Guerrini, R.; Labate, A.; Gambardella, A.; Tinuper, P.; Lichetta, L.; Baldassari, S.; Bisulli, F.; Pippucci, T.; Scheffer, I.E.; Reid, C.A.; Petrou, S.; Bahlo, M.; Berkovic, S.F. 2015: PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy. Annals of Clinical and Translational Neurology 2(8): 821-830
Livne, O.E.; Han, L.; Alkorta-Aranburu, G.; Wentworth-Sheilds, W.; Abney, M.; Ober, C.; Nicolae, D.L. 2015: PRIMAL: Fast and accurate pedigree-based imputation from sequence data in a founder population. Plos Computational Biology 11(3): E1004139
Zhou, M.; Zhang, Q.; Xu, K.; Tian, Z.; Wang, Y.; He, W. 2015: PRIMAL: Page Rank-Based Indoor Mapping and Localization Using Gene-Sequenced Unlabeled WLAN Received Signal Strength. Sensors 15(10): 24791-24817
Holder, H.; Robertson, R. 2015: PRIMARY CARE. Rise to the restructure for better care delivery. Health Service Journal 124(6436): 19-21
Cummings, M.T.; Joh, R.I.; Motamedi, M. 2015: PRIMED: PRIMEr database for deleting and tagging all fission and budding yeast genes developed using the open-source genome retrieval script (GRS). Plos one 10(2): E0116657
Kushwaha, G.; Srivastava, G.P.; Xu, D. 2015: PRIMEGENSw3: a web-based tool for high-throughput primer and probe design. Methods in Molecular Biology 1275: 181-199
Hatherley, R.; Brown, D.K.; Glenister, M.; Tastan Bishop, Öz. 2016: PRIMO: An Interactive Homology Modeling Pipeline. Plos one 11(11): E0166698
Li, J.; Zhang, Q. 2015: PRIMPOL mutation: functional study does not always reveal the truth. Investigative Ophthalmology and Visual Science 56(2): 1181-1182
Staples, J.; Ekunwe, L.; Lange, E.; Wilson, J.G.; Nickerson, D.A.; Below, J.E. 2016: PRIMUS: improving pedigree reconstruction using mitochondrial and y haplotypes. Bioinformatics 32(4): 596-598
Staples, J.; Qiao, D.; Cho, M.H.; Silverman, E.K.; Nickerson, D.A.; Below, J.E. 2014: PRIMUS: rapid reconstruction of pedigrees from genome-wide estimates of identity by descent. American Journal of Human Genetics 95(5): 553-564
Strehlau, R.; Donati, A.P.; Arce, P.M.; Lissens, J.; Yang, R.; Biguenet, S.; Cambilargiu, D.; Hardy, H.él.èn.; Correll, T. 2015: PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years. Journal of the International Aids Society 18: 19467
Széll, M.ár.; Danis, J.; Bata-Csörgő, Z.; Kemény, L. 2016: PRINS, a primate-specific long non-coding RNA, plays a role in the keratinocyte stress response and psoriasis pathogenesis. Pflugers Archiv: European Journal of Physiology 468(6): 935-943
Anonymous 2016: PRION 2016 Tokyo Declaration. Prion 10(4): 267-268
Şahin, Türker. 2016: PRIS may be diagnosed before ICU period for patients undergoing cardiopulmonary bypass. Perfusion 31(4): 281-287
Hammond, F.M.; Alexander, D.N.; Cutler, A.J.; D'Amico, S.; Doody, R.S.; Sauve, W.; Zorowitz, R.D.; Davis, C.S.; Shin, P.; Ledon, F.; Yonan, C.; Formella, A.E.; Siffert, J. 2016: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. Bmc Neurology 16: 89
Sensky, T.; Büchi, S. 2016: PRISM, a Novel Visual Metaphor Measuring Personally Salient Appraisals, Attitudes and Decision-Making: Qualitative Evidence Synthesis. Plos one 11(5): E0156284
Kuzu, G.; Keskin, O.; Nussinov, R.; Gursoy, A. 2016: PRISM-EM: template interface-based modelling of multi-protein complexes guided by cryo-electron microscopy density maps. Acta Crystallographica. Section D Structural Biology 72(Part 10): 1137-1148
Rischin, D.; Spigel, D.R.; Adkins, D.; Wein, R.; Arnold, S.; Singhal, N.; Lee, O.; Murugappan, S. 2016: PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head and Neck 38(Suppl 1): E1756-E1761
Cooksley, T.; Merten, H.; Kellett, J.; Brabrand, M.; Kidney, R.; Nickel, C.H.; Nanayakkara, P.W.B.; Subbe, C.P. 2015: PRISMA Analysis of 30 day Readmissions to a Tertiary Cancer Hospital. Acute Medicine 14(2): 53-56
Zorzela, L.; Loke, Y.K.; Ioannidis, J.P.; Golder, S.; Santaguida, P.; Altman, D.G.; Moher, D.; Vohra, S.; Boon, H.; Clark, J.; Derry, S.; Gallivan, J.; Gardiner, P.; Gøtzsche, P.; Loder, E.; Napoli, M.; Pilkington, K.; Shekelle, P.; Singh, S.; Witt, C.; Lasserson, T.; Wu, T.; Shamseer, L.; Mulrow, C. 2016: PRISMA harms checklist: improving harms reporting in systematic reviews. Bmj 352: I157
Wang, M.C.; Zhang, L.Y.; Han, W.; Shao, Y.; Chen, M.; Ni, R.; Wang, G.N.; Wei, F.X.; Zhang, Y.W.; Xu, X.D.; Zhang, Y.C. 2014: PRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials. Medicine 93(28): E326
Kapadia, M.Z.; Askie, L.; Hartling, L.; Contopoulos-Ioannidis, D.; Bhutta, Z.A.; Soll, R.; Moher, D.; Offringa, M. 2016: PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research. Bmj Open 6(4): E010270
Qu, B-Ge.; Bi, W-Min.; Qu, B-Teng.; Qu, T.; Han, X-Hai.; Wang, H.; Liu, Y-Xun.; Jia, Y-Guo. 2016: PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China. Medicine 95(15): E3399
Xie, S.; Wang, K.; Xu, H.; Hua, R-Xi.; Li, T-Zhu.; Shan, X-Feng.; Cai, Z-Gang. 2015: PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients. Medicine 94(34): E1237
MacAdam, M. 2015: PRISMA: Program of Research to Integrate the Services for the Maintenance of Autonomy. A system-level integration model in Quebec. International Journal of Integrated Care 15: E018
Butcher, L. 2016: Private Insurance Exchanges: Implications for Hospitals. Hospitals and Health Networks 90(2): 28-31; 1
Tuvshinjargal, N.; Lee, W.; Park, B.; Han, K. 2016: PRIdictor: Protein-RNA Interaction predictor. Bio Systems 139: 17-22
Jilg, C.A.; Ketscher, A.; Metzger, E.; Hummel, B.; Willmann, D.; Rüsseler, V.; Drendel, V.; Imhof, A.; Jung, M.; Franz, H.; Hölz, S.; Krönig, M.; Müller, J.M.; Schüle, R. 2014: PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells. Oncotarget 5(24): 12646-12664
Xie, N.; Yuan, K.; Zhou, L.; Wang, K.; Chen, H-Ning.; Lei, Y.; Lan, J.; Pu, Q.; Gao, W.; Zhang, L.; Shen, G.; Li, Q.; Xiao, H.; Tang, H.; Xiang, R.; He, M.; Feng, P.; Nice, E.C.; Wei, Y.; Zhang, H.; Yang, J.; Huang, C. 2016: PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation. Autophagy 12(9): 1507-1520
Rhayem, Y.; Perez-Rivas, L.G.; Dietz, A.; Bathon, K.; Gebhard, C.; Riester, A.; Mauracher, B.; Gomez-Sanchez, C.; Eisenhofer, G.; Schwarzmayr, T.; Calebiro, D.; Strom, T.M.; Reincke, M.; Beuschlein, F. 2016: PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas. Journal of Clinical Endocrinology and Metabolism 101(8): 3010-3017
Thiel, A.; Reis, A.-C.; Haase, M.; Goh, G.; Schott, M.; Willenberg, H.S.; Scholl, U.I. 2015: PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. European Journal of Endocrinology 172(6): 677-685
Berthon, A.S.; Szarek, E.; Stratakis, C.A. 2015: PRKACA: the catalytic subunit of protein kinase a and adrenocortical tumors. Frontiers in Cell and Developmental Biology 3: 26
Aggarwal, V.; Dobrolet, N.; Fishberger, S.; Zablah, J.; Jayakar, P.; Ammous, Z. 2015: PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis. Annals of Pediatric Cardiology 8(2): 153-156
Weng, K.-P.; Yuh, Y.-S.; Huang, S.-H.; Hsiao, H.-C.; Wu, H.-W.; Chien, J.-H.; Chen, B.-H.; Huang, S.-M.; Chien, K.-J.; Ger, L.-P. 2016: PRKAG3 polymorphisms associated with sporadic Wolff-Parkinson-White syndrome among a Taiwanese population. Journal of the Chinese Medical Association: Jcma 79(12): 656-660
Lim, L.Ling.; Kitan, N.; Paramasivam, S.Sunita.; Ratnasingam, J.; Ibrahim, L.; Chan, S.Pheng.; Tan, A.Tong.Boon.; Vethakkan, S.Ratna. 2015: PRKAR1A-negative familial Cushing's syndrome: two case reports. Journal of Medical Case Reports 9: 277
Wang, S.; Cheng, Y.; He, Z.; Zhou, W.; Gao, Y.; Duan, C.; Zhang, C. 2016: PRKAR1α expression in non-small cell lung cancer and 
its clinicopathologic significance. Zhong Nan da Xue Xue Bao. Yi Xue Ban 41(11): 1148-1154
Kovanen, L.; Donner, K.; Kaunisto, M.; Partonen, T. 2017: PRKCDBP (CAVIN3) and CRY2 associate with major depressive disorder. Journal of Affective Disorders 207: 136-140
Scruggs, S.B.; Wang, D.; Ping, P. 2016: PRKCE gene encoding protein kinase C-epsilon-Dual roles at sarcomeres and mitochondria in cardiomyocytes. Gene 590(1): 90-96
Qu, L.; Li, G.; Xia, D.; Hongdu, B.; Xu, C.; Lin, X.; Chen, Y. 2016: PRKCi negatively regulates autophagy via PIK3CA/AKT-MTOR signaling. Biochemical and Biophysical Research Communications 470(2): 306-312
Byerly, J.; Halstead-Nussloch, G.; Ito, K.; Katsyv, I.; Irie, H.Y. 2016: PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Breast Cancer Research: Bcr 18(1): 95
Azoitei, N.; Fröhling, S.; Scholl, C.; Seufferlein, T. 2015: PRKD2: a two-pronged kinase crucial for the tumor-supporting activity of HSP90. Molecular and Cellular Oncology 2(2): E981444
Mathieu, A.-L.; Verronese, E.; Rice, G.I.; Fouyssac, F.; Bertrand, Y.; Picard, C.; Chansel, M.; Walter, J.E.; Notarangelo, L.D.; Butte, M.J.; Nadeau, K.C.; Csomos, K.; Chen, D.J.; Chen, K.; Delgado, A.; Rigal, C.; Bardin, C.; Schuetz, C.; Moshous, D.; Reumaux, H.él.ïs.; Plenat, F.ço.; Phan, A.; Zabot, M.-T.ér.ès.; Balme, B.; Viel, S.éb.; Bienvenu, J.; Cochat, P.; van der Burg, M.; Caux, C.; Kemp, E.H.; Rouvet, I.; Malcus, C.; Méritet, J.-F.; Lim, A.; Crow, Y.J.; Fabien, N.; Ménétrier-Caux, C.; De Villartay, J.-P.; Walzer, T.; Belot, A. 2015: PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. Journal of Allergy and Clinical Immunology 135(6): 1578-88.E5
Gago-Díaz, M.; Blanco-Verea, A.; Teixidó, G.; Huguet, F.; Gut, M.; Laurie, S.; Gut, I.; Carracedo, Án.; Evangelista, A.; Brion, M.ía. 2016: PRKG1 and genetic diagnosis of early-onset thoracic aortic disease. European Journal of Clinical Investigation 46(9): 787-794
Quadri, M.; Olgiati, S.; Sensi, M.; Gualandi, F.; Groppo, E.; Rispoli, V.; Graafland, J.; Breedveld, G.J.; Fabbrini, G.; Berardelli, A.; Bonifati, V. 2016: PRKRA Mutation Causing Early-Onset Generalized Dystonia-Parkinsonism (DYT16) in an Italian Family. Movement Disorders: Official Journal of the Movement Disorder Society 31(5): 765-767
Huang, S.; Li, Q.; Alberts, I.; Li, X. 2016: PRKX, a Novel cAMP-Dependent Protein Kinase Member, Plays an Important Role in Development. Journal of Cellular Biochemistry 117(3): 566-573
Ren, S.; Zhou, Y.; Fang, X.; She, X.; Wu, Y.; Wu, X. 2017: PRL-3 Is Involved in Estrogen- and IL-6-Induced Migration of Endometrial Stromal Cells from Ectopic Endometrium. Reproductive Sciences 24(1): 124-132
Luján, P.; Varsano, G.; Rubio, T.; Hennrich, M.L.; Sachsenheimer, T.; Gálvez-Santisteban, M.; Martín-Belmonte, F.; Gavin, A.-C.; Brügger, B.; Köhn, M. 2016: PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position. Journal of Cell Science 129(21): 4130-4142
Gari, H.H.; DeGala, G.D.; Ray, R.; Lucia, M.S.; Lambert, J.R. 2016: PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion. Cancer Letters 380(2): 505-512
Leung, W.-H.; Vong, Q.P.; Lin, W.; Bouck, D.; Wendt, S.; Sullivan, E.; Li, Y.; Bari, R.; Chen, T.; Leung, W. 2015: PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60. Journal of Immunology 194(6): 2930-2941
Lian, S.; Meng, L.; Xing, X.; Yang, Y.; Qu, L.; Shou, C. 2016: PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer. Oncology Letters 12(3): 1661-1666
Zhang, C.; Tian, W.; Meng, L.; Qu, L.; Shou, C. 2016: PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. Journal of Molecular Medicine 94(4): 401-415
Dong, Q.; Ding, X.; Chang, B.; Wang, H.; Wang, A. 2016: PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 45(2): 111-118
Xiong, J.; Li, Z.; Zhang, Y.; Li, D.; Zhang, G.; Luo, X.; Jie, Z.; Liu, Y.; Cao, Y.; Le, Z.; Tan, S.; Zou, W.; Gong, P.; Qiu, L.; Li, Y.; Wang, H.; Chen, H. 2016: PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncology Reports 36(4): 1819-1828
Ji, H.; Wang, S.; Li, K.; Szakonyi, D.ór.; Koncz, C.; Li, X. 2015: PRL1 modulates root stem cell niche activity and meristem size through WOX5 and PLTs in Arabidopsis. Plant Journal: for Cell and Molecular Biology 81(3): 399-412
Zhang, S.; Liu, Y.; Yu, B. 2014: PRL1, an RNA-binding protein, positively regulates the accumulation of mi RNAs and si RNAs in Arabidopsis. Plos Genetics 10(12): E1004841
Thura, M.; Al-Aidaroos, A.Q.O.; Yong, W.P.; Kono, K.; Gupta, A.; Lin, Y.B.; Mimura, K.; Thiery, J.P.; Goh, B.C.; Tan, P.; Soo, R.; Hong, C.W.; Wang, L.; Lin, S.J.; Chen, E.; Rha, S.Y.; Chung, H.C.; Li, J.; Nandi, S.; Yuen, H.F.; Zhang, S.-D.; Guan, Y.K.; So, J.; Zeng, Q. 2016: PRL3-zumab, a first-in-class humanized antibody for cancer therapy. Jci Insight 1(9): E87607
Avasarala, S.; Van Scoyk, M.; Karuppusamy Rathinam, M.K.; Zerayesus, S.; Zhao, X.; Zhang, W.; Pergande, M.R.; Borgia, J.A.; DeGregori, J.; Port, J.D.; Winn, R.A.; Bikkavilli, R.K. 2015: PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer. Journal of Biological Chemistry 290(21): 13479-13489
Sun, Q.; Liu, L.; Roth, M.; Tian, J.; He, Q.; Zhong, B.; Bao, R.; Lan, X.; Jiang, C.; Sun, J.; Yang, X.; Lu, S. 2015: PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation. Journal of Immunology 195(1): 298-306
Kim, D.-I.; Park, M.-J.; Choi, J.-H.; Kim, I.-S.; Han, H.-J.; Yoon, K.-C.; Park, S.-W.; Lee, M.-Y.; Oh, K.-S.; Park, S.-H. 2015: PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners. Oxidative Medicine and Cellular Longevity 2015: 617919
Lv, L.; Chen, H.; Sun, J.; Lu, D.; Chen, C.; Liu, D. 2015: PRMT1 promotes glucose toxicity-induced β cell dysfunction by regulating the nucleo-cytoplasmic trafficking of PDX-1 in a FOXO1-dependent manner in INS-1 cells. Endocrine 49(3): 669-682
Deng, X.; Von Keudell, G.; Suzuki, T.; Dohmae, N.; Nakakido, M.; Piao, L.; Yoshioka, Y.; Nakamura, Y.; Hamamoto, R. 2015: PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP. Oncotarget 6(34): 35173-35182
Li, L.; Zhang, Z.; Ma, T.; Huo, R. 2016: PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM. Molecular Medicine Reports 14(1): 521-528
Kaehler, C.; Guenther, A.; Uhlich, A.; Krobitsch, S. 2015: PRMT1-mediated arginine methylation controls ATXN2L localization. Experimental Cell Research 334(1): 114-125
Liao, H-Wei.; Hsu, J-Mao.; Xia, W.; Wang, H-Ling.; Wang, Y-Nai.; Chang, W-Chao.; Arold, S.T.; Chou, C-Kai.; Tsou, P-Hsiang.; Yamaguchi, H.; Fang, Y-Fu.; Lee, H-Jen.; Lee, H-Huan.; Tai, S-Kuan.; Yang, M-Hwa.; Morelli, M.P.; Sen, M.; Ladbury, J.E.; Chen, C-Hsuan.; Grandis, J.R.; Kopetz, S.; Hung, M-Chie. 2015: PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. Journal of Clinical Investigation 125(12): 4529-4543
Kim, J.K.; Lim, Y.; Lee, J.O.; Lee, Y.-S.; Won, N.H.; Kim, H.; Kim, H.S. 2015: PRMT4 is involved in insulin secretion via the methylation of histone H3 in pancreatic β cells. Journal of Molecular Endocrinology 54(3): 315-324
Panfil, A.R.; Al-Saleem, J.; Howard, C.M.; Mates, J.M.; Kwiek, J.J.; Baiocchi, R.A.; Green, P.L. 2015: PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival. Viruses 8(1)
Yang, H.; Zhao, X.; Zhao, L.; Liu, L.; Li, J.; Jia, W.; Liu, J.; Huang, G. 2016: PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma. Oncotarget 7(44): 72131-72147
Norrie, J.L.; Li, Q.; Co, S.; Huang, B.-L.; Ding, D.; Uy, J.C.; Ji, Z.; Mackem, S.; Bedford, M.T.; Galli, A.; Ji, H.; Vokes, S.A. 2016: PRMT5 is essential for the maintenance of chondrogenic progenitor cells in the limb bud. Development 143(24): 4608-4619
Li, Y.; Chitnis, N.; Nakagawa, H.; Kita, Y.; Natsugoe, S.; Yang, Y.; Li, Z.; Wasik, M.; Klein-Szanto, A.J.P.; Rustgi, A.K.; Diehl, J.A. 2015: PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discovery 5(3): 288-303
Kim, S.; Günesdogan, U.; Zylicz, J.J.; Hackett, J.A.; Cougot, D.; Bao, S.; Lee, C.; Dietmann, S.; Allen, G.E.; Sengupta, R.; Surani, M.A. 2014: PRMT5 protects genomic integrity during global DNA demethylation in primordial germ cells and preimplantation embryos. Molecular Cell 56(4): 564-579
Ratovitski, T.; Arbez, N.; Stewart, J.C.; Chighladze, E.; Ross, C.A. 2015: PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Cell Cycle 14(11): 1716-1729
Chang, J.C. 2018: Disseminated intravascular coagulation: is it fact or fancy?. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 29(3): 330-337
Li, Y.; Diehl, J.A. 2015: PRMT5-dependent p53 escape in tumorigenesis. Oncoscience 2(8): 700-702
Nakakido, M.; Deng, Z.; Suzuki, T.; Dohmae, N.; Nakamura, Y.; Hamamoto, R. 2015: PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents. Oncotarget 6(31): 30957-30967
Kang, N.; Chen, P.; Chen, Y.; Zeng, H.; He, X.; Zhu, Y. 2015: PRMT6 mediates CSE induced inflammation and apoptosis. International Immunopharmacology 24(1): 95-101
Blanc, R.éo.S.éb.; Vogel, G.; Chen, T.; Crist, C.; Richard, S.ép. 2016: PRMT7 Preserves Satellite Cell Regenerative Capacity. Cell Reports 14(6): 1528-1539
Kim, J.-D.; Park, K.-E.; Ishida, J.; Kako, K.; Hamada, J.; Kani, S.; Takeuchi, M.; Namiki, K.; Fukui, H.; Fukuhara, S.; Hibi, M.; Kobayashi, M.; Kanaho, Y.; Kasuya, Y.; Mochizuki, N.; Fukamizu, A. 2015: PRMT8 as a phospholipase regulates Purkinje cell dendritic arborization and motor coordination. Science Advances 1(11): E1500615
Yan, C.; Li, Q.; Gao, L. 2014: PRN: a preprint service for catalyzing R-fMRi and neuroscience related studies. F1000research 3: 313
Oldoni, E.; Fumagalli, G.G.; Serpente, M.; Fenoglio, C.; Scarioni, M.; Arighi, A.; Bruno, G.; Talarico, G.; Confaloni, A.; Piscopo, P.; Nacmias, B.; Sorbi, S.; Rainero, I.; Rubino, E.; Pinessi, L.; Binetti, G.; Ghidoni, R.; Benussi, L.; Grande, G.; Arosio, B.; Bursey, D.; Kauwe, J.S.; Cioffi, S.M.; Arcaro, M.; Mari, D.; Mariani, C.; Scarpini, E.; Galimberti, D. 2016: PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population. Journal of Alzheimer's Disease: Jad 50(2): 353-357
Madsen-Bouterse, S.A.; Schneider, D.A.; Dassanayake, R.P.; Truscott, T.C.; Zhuang, D.; Kumpula-McWhirter, N.; O'Rourke, K.I. 2015: PRNP variants in goats reduce sensitivity of detection of PrP(Sc) by immunoassay. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 27(3): 332-343
Dias, M.V.S.; Teixeira, B.L.; Rodrigues, B.R.; Sinigaglia-Coimbra, R.; Porto-Carreiro, I.; Roffé, Mín.; Hajj, G.N.M.; Martins, V.R. 2016: PRNP/prion protein regulates the secretion of exosomes modulating CAV1/caveolin-1-suppressed autophagy. Autophagy 12(11): 2113-2128
Brody, K. 2015: Pro Bono > Cpr Certification Liabilities. Jems: a Journal of Emergency Medical Services 40(12): 19
Everson, G.T. 2015: PRO view: treat to prevent recurrence of HCV. Liver International: Official Journal of the International Association for the Study of the Liver 35(1): 5-6
Schmidt, H.; Merkel, D.; Koehler, M.; Flechtner, H-Henning.; Sigle, Jörg.; Klinge, B.; Jordan, K.; Vordermark, D.; Landenberger, M.; Jahn, P. 2016: PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 24(6): 2503-2512
Jensen, R.E.; Snyder, C.F. 2016: PRO-cision Medicine: Personalizing Patient Care Using Patient-Reported Outcomes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(6): 527-529
Patel, J.; Kozeniecki, M. 2015: PRO-viding Additional Evidence for Enteral Nutrition in Septic Shock. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition 30(6): 844-845
Prysyazhnyuk, V. 2015: Pro12ala Polymorphism Association of Ppar-Γ Gene with Biochemical Parameters of the Blood in Patients with Chronic Diffuse Liver Diseases. Georgian medical news 2015(246): 35-40
Cannesson, M.; Gan, T.J. 2016: PRO: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol. Anesthesia and Analgesia 122(5): 1258-1260
Hakone, A.; Harrison, L.; Ottley, A.; Winters, N.; Gutheil, C.; Han, P.K.J.; Chang, R. 2017: PROACT: Iterative Design of a Patient-Centered Visualization for Effective Prostate Cancer Health Risk Communication. IEEE Transactions on Visualization and Computer Graphics 23(1): 601-610
Robeznieks, A. 2016: PROCEDURAL CHANGE. Specialists can build their own medical homes, gastroenterologist says. Hospitals and Health Networks 90(7): 20; 22
Yoon, J.S.; Suh, J.H.; Kim, D.Y.; Park, C.B. 2017: Disseminated intravascular coagulopathy caused by type Ii endoleak after endovascular aneurysm repair in severe aortic stenosis. Journal of Thoracic Disease 9(11): E994-E996
Senan, S.; Brade, A.; Wang, L-Hua.; Vansteenkiste, J.; Dakhil, S.; Biesma, B.; Martinez Aguillo, M.; Aerts, J.; Govindan, R.; Rubio-Viqueira, Bén.; Lewanski, C.; Gandara, D.; Choy, H.; Mok, T.; Hossain, A.; Iscoe, N.; Treat, J.; Koustenis, A.; San Antonio, Bélen.; Chouaki, N.; Vokes, E. 2016: PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 34(9): 953-962
De Koning, M.B.; van Duin, E.D.A.; Boot, E.; Bloemen, O.J.N.; Bakker, J.A.; Abel, K.M.; van Amelsvoort, T.ér.ès.A.M.J. 2015: PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome. Psychopharmacology 232(17): 3111-3122
Aparicio, T.; Francois, E.; Cristol-Dalstein, L.; Carola, E.; Maillard, E.; Paillaud, E.; Retornaz, F.éd.ér.; Faroux, R.; André, T.; Bedenne, L.; Seitz, J.-F.ço. 2016: PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage IIi colon cancer: a randomized phase 3 trial. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 48(2): 206-207
Xue, L.C.; Rodrigues, J.ão.P.; Kastritis, P.L.; Bonvin, A.M.; Vangone, A. 2016: PRODIGY: a web server for predicting the binding affinity of protein-protein complexes. Bioinformatics 32(23): 3676-3678
Thabrany, H.; Liastuti, L.D. 2014: PROF DR Hasbullah Thabrany. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A758
Zhang, P.; Tao, L.; Zeng, X.; Qin, C.; Chen, S.Y.; Zhu, F.; Yang, S.Y.; Li, Z.R.; Chen, W.P.; Chen, Y.Z. 2017: PROFEAT Update: A Protein Features Web Server with Added Facility to Compute Network Descriptors for Studying Omics-Derived Networks. Journal of Molecular Biology 429(3): 416-425
Noonan, S.A.; Camidge, D.R. 2015: PROFILE 1014: lessons for the new era of lung cancer clinical research. Translational Lung Cancer Research 4(5): 642-648
Gol, J.M.; Burger, H.; Janssens, K.A.M.; Slaets, J.P.J.; Gans, R.O.B.; Rosmalen, J.G.M. 2014: PROFSS: a screening tool for early identification of functional somatic symptoms. Journal of Psychosomatic Research 77(6): 504-509
Walicka, M.; Jóźwiak, J.; Rzeszotarski, J.; Zarzycka-Lindner, G.ży.; Zonenberg, A.; Bijoś, P.ł; Masierek, M.łg.; Franek, E. 2016: PROGENS-HbA1c study: safety and effectiveness of premixed recombinant human insulin (Gensulin M30). Archives of Medical Science: Ams 12(5): 985-991
Škunca, Z.; Planinc-Peraica, A. 2015: Prognostic Role of Nf-Κb Expression in Diffuse Large B-Cell Lymphoma Subgroups. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 69(1): 25-32
Soderini, A. 2015: Prognostic Significance of Tumor Size in Squamous cell Carcinoma of the Vulva: Igcs-0107 Vulvar and Vaginal Cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 25(Suppl 1): 76
Ogurtsov, P.P.; Kukhareva, E.I. 2016: Prognostic Value of the Combination of Blood Group Specificity and Interleukin 28b Gene Polymorphism for Estimation of Efficiency of Therapy with the use of Pegylated Interferon Α-2 and Ribavarin in Patients with Chronic Genotype 1 Hepatitis C. Klinicheskaia Meditsina 94(3): 224-230
Ahnert, P.; Creutz, P.; Scholz, M.; Schütte, H.; Engel, C.; Hossain, H.; Chakraborty, T.; Bauer, M.; Kiehntopf, M.; Völker, U.; Hammerschmidt, S.; Loeffler, M.; Suttorp, N. 2016: PROGRESS - prospective observational study on hospitalized community acquired pneumonia. Bmc Pulmonary Medicine 16(1): 108
Li, X.; Liu, L.; Chai, J. 2015: Progress of Mesenchymal Stem Cell-Derived Exosomes in Tissue Repair. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 29(2): 234-238
Menighan, T.E. 2015: PROGRESS REPORT: Provider Status Continues to Gain Strength!. International Journal of Pharmaceutical Compounding 19(5): 437
Goswami, C.P.; Nakshatri, H. 2014: PROGgeneV2: enhancements on the existing database. Bmc Cancer 14: 970
Derkach, K.V.; Shpakova, E.A.; Tarasenko, I.I.; Shpakov, A.O. 2015: Proinsulin C-Peptide and its C-Terminal Fragments Stimulate Gi/O-Proteins but do not Influence Adenylyl Cyclase Activity. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 51(5): 383-385
Duke, P. 2015: Project Success Factors. Considerations that Apply to all Delivery Models. Health Facilities Management 28(8): 28-31
Alfaidy, N.; Hoffmann, P.; Gillois, P.; Gueniffey, A.; Lebayle, C.; Garçin, H.él.ïs.; Thomas-Cadi, C.; Bessonnat, J.; Coutton, C.; Villaret, L.; Quenard, N.; Bergues, U.; Feige, J.-J.; Hennebicq, S.; Brouillet, S. 2016: PROK1 Level in the Follicular Microenvironment: a new Noninvasive Predictive Biomarker of Embryo Implantation. Journal of Clinical Endocrinology and Metabolism 101(2): 435-444
Esmaeili, A.; Davison, T.; Wu, A.; Alcantara, J.; Jacob, C. 2015: PROKARYO: an illustrative and interactive computational model of the lactose operon in the bacterium Escherichia coli. Bmc Bioinformatics 16: 311
Rexer, H.; Graefen, M. 2016: PROKOMB - prostate-cooperative MRi project Berlin-study AP 95/16 of the AUO. Der Urologe. Ausg. a 55(12): 1613-1614
Howell, J.; Ladep, N.G.; Nayagam, S.; Lemoine, M.; Garside, D.A.; Crossey, M.M.E.; Okeke, E.; Njie, R.; Ka, M.M.; Taal, M.; Thursz, M.R.; Taylor-Robinson, S.D. 2016: PROLIFICA: a story of West African clinical and research collaborations to target hepatitis B-related hepatocellular carcinoma in West Africa. Qjm: Monthly Journal of the Association of Physicians 109(6): 373-375
Wiestner, A. 2015: PROLONGing remissions in patients with CLL. LANCET. Oncology 16(13): 1282-1284
Rasche, N.; Tonillo, J.; Rieker, M.; Becker, S.; Dorr, B.; Ter-Ovanesyan, D.; Betz, U.A.K.; Hock, B.ör.; Kolmar, H. 2016: PROLink-Single Step Circularization and Purification Procedure for the Generation of an Improved Variant of Human Growth Hormone. Bioconjugate Chemistry 27(5): 1341-1347
Karpov, Y.; Khomitskaya, Y. 2015: PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia. Cardiovascular Diabetology 14: 115
Kim, C.-Y.; Wiznia, D.H.; Averbukh, L.; Torres, A.; Kong, E.; Kim, S.; Leslie, M.P. 2016: PROMIS Computer Adaptive Tests Compared with time to Brake in Patients with Complex Lower Extremity Trauma. Journal of Orthopaedic Trauma 30(11): 592-596
Cella, D.; Lai, J.-S.; Jensen, S.E.; Christodoulou, C.; Junghaenel, D.U.; Reeve, B.B.; Stone, A.A. 2016: PROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic Conditions. Journal of Clinical Epidemiology 73: 128-134
Morgan, J.H.; Kallen, M.A.; Okike, K.; Lee, O.C.; Vrahas, M.S. 2015: PROMIS Physical Function Computer Adaptive Test Compared with other Upper Extremity Outcome Measures in the Evaluation of Proximal Humerus Fractures in Patients Older than 60 Years. Journal of Orthopaedic Trauma 29(6): 257-263
Stone, A.A.; Broderick, J.E.; Junghaenel, D.U.; Schneider, S.; Schwartz, J.E. 2016: PROMIS fatigue, pain intensity, pain interference, pain behavior, physical function, depression, anxiety, and anger scales demonstrate ecological validity. Journal of Clinical Epidemiology 74: 194-206
Bingener, J.; Sloan, J.A.; Seisler, D.K.; McConico, A.L.; Skaran, P.E.; Farley, D.R.; Truty, M.J. 2015: PROMIS for Laparoscopy. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 19(5): 917-926
Brodke, D.J.; Saltzman, C.L.; Brodke, D.S. 2016: PROMIS for Orthopaedic Outcomes Measurement. Journal of the American Academy of Orthopaedic Surgeons 24(11): 744-749
Cook, K.F.; Jensen, S.E.; Schalet, B.D.; Beaumont, J.L.; Amtmann, D.; Czajkowski, S.; Dewalt, D.A.; Fries, J.F.; Pilkonis, P.A.; Reeve, B.B.; Stone, A.A.; Weinfurt, K.P.; Cella, D. 2016: PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. Journal of Clinical Epidemiology 73: 89-102
DeWalt, D.A.; Gross, H.E.; Gipson, D.S.; Selewski, D.T.; DeWitt, E.Morgan.; Dampier, C.D.; Hinds, P.S.; Huang, I-Chan.; Thissen, D.; Varni, J.W. 2015: PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation 24(9): 2195-2208
El-Shater Bosaily, A.; Parker, C.; Brown, L.C.; Gabe, R.; Hindley, R.G.; Kaplan, R.; Emberton, M.; Ahmed, H.U. 2015: PROMIS--Prostate MR imaging study: a paired validating cohort study evaluating the role of multi-parametric MRi in men with clinical suspicion of prostate cancer. Contemporary Clinical Trials 42: 26-40
Thomas, D.M.; Branch, K.R.; Cury, R.C. 2016: PROMISE of Coronary CT Angiography: Precise and Accurate Diagnosis and Prognosis in Coronary Artery Disease. Southern Medical Journal 109(4): 242-247
Patel, B.; Smith, D.; Siddiqui, F. 2016: PROMISE, OASIS, and SWAT: Evaluating the Future of Sepsis Care. American Journal of Respiratory and Critical Care Medicine 194(7): 907-908
Ray, M.K.; Rae, S.; Agius, M. 2015: PROMISE. Beyond frontiers. Psychiatria Danubina 27(Suppl 1): S497-S498
Coomarasamy, A.; Williams, H.; Truchanowicz, E.; Seed, P.T.; Small, R.; Quenby, S.; Gupta, P.; Dawood, F.; Koot, Y.E.; Atik, R.Bender.; Bloemenkamp, K.Wm.; Brady, R.; Briley, A.; Cavallaro, R.; Cheong, Y.C.; Chu, J.; Eapen, A.; Essex, H.; Ewies, A.; Hoek, A.; Kaaijk, E.M.; Koks, C.A.; Li, T-Chiu.; MacLean, M.; Mol, B.W.; Moore, J.; Parrott, S.; Ross, J.A.; Sharpe, L.; Stewart, J.; Trépel, D.; Vaithilingam, N.; Farquharson, R.G.; Kilby, M.David.; Khalaf, Y.; Goddijn, Mëtte.; Regan, L.; Rai, R. 2016: PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation. Health Technology Assessment 20(41): 1-92
Alfakih, K.; Plein, S. 2015: PROMISE: where now for CT coronary angiography. European Heart Journal. Cardiovascular Imaging 16(11): 1187-1188
Jacoby, V.L.; Kohi, M.P.; Poder, L.; Jacoby, A.; Lager, J.; Schembri, M.; Rieke, V.; Grady, D.; Vittinghoff, E.; Coakley, F.V. 2016: PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertility and Sterility 105(3): 773-780
Brodke, D.S.; Goz, V.; Voss, M.W.; Lawrence, B.D.; Spiker, W.R.; Hung, M. 2017: PROMIS PF CAT Outperforms the Odi and SF-36 Physical Function Domain in Spine Patients. Spine 42(12): 921-929
Hensel, K.L.; Roane, B.M.; Chaphekar, A.Vikas.; Smith-Barbaro, P. 2016: PROMOTE Study: Safety of Osteopathic Manipulative Treatment During the Third Trimester by Labor and Delivery Outcomes. Journal of the American Osteopathic Association 116(11): 698-703
Anonymous 2014: PROMPT to detail breast cancer risk. Cancer discovery 4(12): 1362
Zschaeck, S.; Simon, M.; Löck, S.; Troost, E.G.C.; Stützer, K.; Wohlfahrt, P.; Appold, S.; Makocki, S.; Bütof, R.; Richter, C.; Baumann, M.; Krause, M. 2016: PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Trials 17(1): 543
Wijtzes, A.I.; Jansen, W.; Bouthoorn, S.H.; Kiefte-de Jong, J.C.; Jansen, P.W.; Franco, O.H.; Jaddoe, V.W.V.; Hofman, A.; Raat, H. 2017: PROP taster status, food preferences and consumption of high-calorie snacks and sweet beverages among 6-year-old ethnically diverse children. Maternal and Child Nutrition 13(2)
Pérez Millán, M.ía.I.és.; Brinkmeier, M.L.; Mortensen, A.H.; Camper, S.A. 2016: PROP1 triggers epithelial-mesenchymal transition-like process in pituitary stem cells. Elife 5
Kaur, H.; Naessens, J.M.; Hanson, A.C.; Fryer, K.; Nemergut, M.E.; Tripathi, S. 2018: PROPER: Development of an Early Pediatric Intensive Care Unit Readmission Risk Prediction Tool. Journal of Intensive Care Medicine 33(1): 29-36
Jahandideh, S.; Sharifi, F.; Jaroszewski, L.; Godzik, A. 2015: PROPER: Performance visualization for optimizing and comparing ranking classifiers in MATLAB. Source Code for Biology and Medicine 10: 15
Kazemi, E.; Hassani, H.; Grossglauser, M.; Pezeshgi Modarres, H. 2016: PROPER: global protein interaction network alignment through percolation matching. Bmc Bioinformatics 17(1): 527
Olsson, M.H.M.; Søndergaard, C.R.; Rostkowski, M.; Jensen, J.H. 2011: PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. Journal of Chemical Theory and Computation 7(2): 525-537
Wallace, S.W.; Singhvi, A.; Liang, Y.; Lu, Y.; Shaham, S. 2016: PROS-1/Prospero Is a Major Regulator of the Glia-Specific Secretome Controlling Sensory-Neuron Shape and Function in C. elegans. Cell Reports 15(3): 550-562
Alhenc-Gelas, M.; Plu-Bureau, G.; Horellou, M.H.él.èn.; Rauch, A.; Suchon, P. 2016: PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency. Thrombosis and Haemostasis 115(3): 570-579
Kehler, U.; Kiefer, M.; Eymann, R.; Wagner, W.; Tschan, C.A.; Langer, N.; Rohde, V.; Ludwig, H.C.; Gliemroth, J.; Meier, U.; Lemcke, J.; Thomale, U-W.; Fritsch, M.; Krauss, J.K.; Mirzayan, M.Javad.; Schuhmann, M.; Huthmann, A. 2015: PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting. Clinical Neurology and Neurosurgery 137: 132-136
DeLoss, K.S.; Le, H.-G.; Gire, A.; Chiu, G.B.; Jacobs, D.S.; Carrasquillo, K.G. 2016: PROSE Treatment for Ocular Chronic Graft-Versus-Host Disease as a Clinical Network Expands. Eye and Contact Lens 42(4): 262-266
Chiu, G.B.; Theophanous, C.; Irvine, J.A. 2016: PROSE Treatment in Atypical Ocular Graft-Versus-Host Disease. Optometry and Vision Science: Official Publication of the American Academy of Optometry 93(11): 1444-1448
Schramm, W.; Sailer, F.; Pobiruchin, M.; Weiss, C. 2016: PROSIT Open Source Disease Models for Diabetes Mellitus. Studies in Health Technology and Informatics 226: 115-118
Bossé, D.; Mercer, J.; Raissouni, S.; Dennis, K.; Goodwin, R.; Jiang, D.; Powell, E.; Kumar, A.; Lee-Ying, R.; Price-Hiller, J.; Heng, D.Y.C.; Tang, P.A.; MacLean, A.; Cheung, W.Y.; Vickers, M.M. 2016: PROSPECT Eligibility and Clinical Outcomes: Results from the Pan-Canadian Rectal Cancer Consortium. Clinical Colorectal Cancer 15(3): 243-249
Alekseeva, O.S.; Gusel'nikova, V.V.; Beznin, G.V.; Korzhevskii, D.E. 2015: Prospects of the Nuclear Protein Neun Application as an Index of Functional State of the Vertebrate Nerve cells. Zhurnal evoliutsionnoi biokhimii i fiziologii 51(5): 313-323
Spoth, R.L.; Trudeau, L.S.; Redmond, C.; Shin, C.; Greenberg, M.T.; Feinberg, M.E.; Hyun, G.-H. 2015: PROSPER partnership delivery system: Effects on adolescent conduct problem behavior outcomes through 6.5 years past baseline. Journal of Adolescence 45: 44-55
Nuebling, G.; Hensler, M.; Paul, S.; Zwergal, A.; Crispin, A.; Lorenzl, S. 2016: PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy. Journal of Neurology 263(8): 1565-1574
Raina, K.; Lu, J.; Qian, Y.; Altieri, M.; Gordon, D.; Rossi, A.M.K.; Wang, J.; Chen, X.; Dong, H.; Siu, K.; Winkler, J.D.; Crew, A.P.; Crews, C.M.; Coleman, K.G. 2016: PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 113(26): 7124-7129
De Meyer, D.; Van Damme, N.; Van den Bussche, K.; Van Hecke, A.; Verhaeghe, S.; Beeckman, D. 2017: PROTECT - trial: a multicentre prospective pragmatic RCT and health economic analysis of the effect of tailored repositioning to prevent pressure ulcers - study protocol. Journal of Advanced Nursing 73(2): 495-503
Sirey, J.Anne.; Halkett, A.; Chambers, S.; Salamone, A.; Bruce, M.L.; Raue, P.J.; Berman, J. 2015: PROTECT: A Pilot Program to Integrate Mental Health Treatment Into Elder Abuse Services for Older Women. Journal of Elder Abuse and Neglect 27(4-5): 438-453
Rudall, N.; McKenzie, C.; Landa, J.; Bourne, R.S.; Bates, I.; Shulman, R. 2017: PROTECTED-UK - Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level. International Journal of Pharmacy Practice 25(4): 311-319
Xu, L.; Deng, G.; Wang, W.; Huang, X.; Yang, X.; Ye, X. 2015: Protection effects of Bone Marrow Mesenchymal Stem cells Paracrine on Chondrocytes Injured by Interleukin 1β. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 29(8): 996-1002
Netzer, R.; Fleishman, S.J. 2016: PROTEIN DESIGN. Inspired by nature. Science 352(6286): 657-658
Ren, R.; Zhou, X.; He, Y.; Ke, M.; Wu, J.; Liu, X.; Yan, C.; Wu, Y.; Gong, X.; Lei, X.; Yan, S.F.; Radhakrishnan, A.; Yan, N. 2015: PROTEIN STRUCTURE. Crystal structure of a mycobacterial Insig homolog provides insight into how these sensors monitor sterol levels. Science 349(6244): 187-191
Seung, D.; Soyk, S.; Coiro, M.; Maier, B.A.; Eicke, S.; Zeeman, S.C. 2015: Protein Targeting to Starch is Required for Localising Granule-Bound Starch Synthase to Starch Granules and for Normal Amylose Synthesis in Arabidopsis. Plos Biology 13(2): E1002080
Iwasaki, S.; Ingolia, N.T. 2016: PROTEIN TRANSLATION. Seeing translation. Science 352(6292): 1391-1392
Micas, A.é F.D.; Ferreira, G.A.; Laure, H.J.; Rosa, J.é C.; Bitondi, M.ár.M.G. 2016: Proteins of the Integumentary System of the Honeybee, Apis Mellifera. Archives of Insect Biochemistry and Physiology 93(1): 3-24
Harding, I.; Felmingham, D. 2004: PROTEKT Years 1-3 (1999-2002): Study Design and Methodology. Journal of ChemoTherapy 16(Sup 6): 9-18
Crappé, J.; Ndah, E.; Koch, A.; Steyaert, S.; Gawron, D.; De Keulenaer, S.; De Meester, E.; De Meyer, T.; Van Criekinge, W.; Van Damme, P.; Menschaert, G. 2015: PROTEOFORMER: deep proteome coverage through ribosome profiling and MS integration. Nucleic Acids Research 43(5): E29
Cheng, L.; Du, Y.; Hu, J.; Jiao, D.; Li, J.; Zhou, Z.; Xu, Q.; Li, F. 2015: Proteomic Analysis of Ubiquitinated Proteins from Deltamethrin-Resistant and Susceptible Strains of the Diamondback Moth, Plutella Xylostella L. Archives of Insect Biochemistry and Physiology 90(2): 70-88
Dunn, M.J. 2009: PROTEOMICS - Clinical Applications Reviews 2009. Proteomics. Clinical Applications 3(2): 135-137
Oh, T.H.; Kim, U.J.; Kang, S.J.; Jang, H.C.; Park, K.H.; Jung, S.I.; Ahn, J.H. 2018: Disseminated Invasive Mycobacterium marinum Infection Involving the Lung of a Patient with Diabetes Mellitus. Infection and ChemoTherapy 50(1): 59-64
Dunn, M.J. 2016: PROTEOMICS Reviews 2016--Part 2. Proteomics 16(5): 699
Dunn, M.J. 2015: PROTEOMICS reviews 2015. Proteomics 15(5-6): 843
Dunn, M.J.; Kraus, H.-J. 2016: PROTEOMICS: the first 15 years. PROTEOMICS. Clinical Applications 10(1): 1-3
Moore, A. 2016: PROTEOMICS: the journey ahead… from the principles of life to the development of new therapies. PROTEOMICS. Clinical Applications 10(1): 4-5
Zhou, X.; Updegraff, B.L.; Guo, Y.; Peyton, M.; Girard, L.; Larsen, J.E.; Xie, X-Jin.; Zhou, Y.; Hwang, T.Hyun.; Xie, Y.; Rodriguez-Canales, J.; Villalobos, P.; Behrens, C.; Wistuba, I.I.; Minna, J.D.; O'Donnell, K.A. 2017: PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Cancer research 77(1): 187-197
Martins, H.F.; Pastor-Graells, J.; Cortés, L.R.; Piote, D.; Martin-Lopez, S.; Azaña, J.é; Gonzalez-Herraez, M. 2015: PROUD-based method for simple real-time in-line characterization of propagation-induced distortions in NRZ data signals. Optics Letters 40(18): 4356-4359
Wright, R.S.; Murphy, J. 2016: PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients. Journal of the American College of Cardiology 67(4): 362-364
Choi, Y.; Chan, A.P. 2015: PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31(16): 2745-2747
Mojola, S.A. 2014: PROVIDING WOMEN, KEPT MEN: Doing Masculinity in the wake of the African HIV/AIDS epidemic. Signs 39(2): 341-363
Ishii, J.; Yazawa, T.; Chiba, T.; Shishido-Hara, Y.; Arimasu, Y.; Sato, H.; Kamma, H. 2016: PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells. Endocrinology 157(3): 1289-1298
Saukkonen, K.; Hagström, J.; Mustonen, H.; Juuti, A.; Nordling, S.; Kallio, P.; Alitalo, K.; Seppänen, H.; Haglund, C. 2016: PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma. Bmc Cancer 16: 472
Rodrigues, M.F.S.D.; de Oliveira Rodini, C.; de Aquino Xavier, F.áv.C.; Paiva, K.úc.B.; Severino, P.íc.; Moyses, R.A.; López, R.M.; DeCicco, R.; Rocha, L.íl.A.; Carvalho, M.B.; Tajara, E.H.; Nunes, F.D. 2014: PROX1 gene is differentially expressed in oral cancer and reduces cellular proliferation. Medicine 93(28): E192
Roodakker, K.R.; Elsir, T.; Edqvist, P.-H.D.; Hägerstrand, D.; Carlson, J.; Lysiak, M.; Henriksson, R.; Pontén, F.; Rosell, J.; Söderkvist, P.; Stupp, R.; Tchougounova, E.; Nistér, M.; Malmström, A.; Smits, A. 2016: PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Oncotarget 7(45): 72431-72442
Jernman, J.; Kallio, P.; Hagström, J.; Välimäki, M.J.; Haapasalo, H.; Alitalo, K.; Arola, J.; Haglund, C. 2015: PROX1 is involved in progression of rectal neuroendocrine tumors, NETs. Virchows Archiv: An International Journal of Pathology 467(3): 279-284
Ainy, E.; Bourhis, P.; Davidson, S.B.; Deutch, D.; Milo, T. 2016: PROX: Approximated Summarization of Data Provenance. Advances in Database Technology: Proceedings. International Conference on Extending Database Technology 2016: 620-623
Yousofshahi, M.; Manteiga, S.; Wu, C.; Lee, K.; Hassoun, S. 2015: PROXIMAL: a method for Prediction of Xenobiotic Metabolism. Bmc Systems Biology 9: 94
Campos, A.Pastor. 2016: PROYECTO Decides. Laboratory Animals 50(3): 225-226
Movsas, B. 2015: PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events. JAMA Oncology 1(8): 1059-1060
Crites, J.S.; Chuang, C.; Dimmock, A.; Hwang, W.; Johannes, B.; Paranjape, A.; Wu, A.W. 2016: PROs in the Balance: Ethical Implications of Collecting Patient Reported Outcome Measures in the Electronic Health Record. American Journal of Bioethics: Ajob 16(4): 67-68
Cameron, J.; Rendell, P.G.; Ski, C.F.; Kure, C.E.; McLennan, S.N.; Rose, N.S.; Prior, D.L.; Thompson, D.R. 2015: PROspective MEmory Training to improve HEart fail Ure Self-care (PROMETHEUS): study protocol for a randomised controlled trial. Trials 16: 196
Andriolo, L.; Di Matteo, B.; Kon, E.; Filardo, G.; Venieri, G.; Marcacci, M. 2015: PRP Augmentation for ACL Reconstruction. Biomed Research International 2015: 371746
Lee, T-Kyu.; Jung, T-Young.; Baek, H-Jo.; Kim, S-Kee.; Lee, K-Hwa.; Yun, S.Jung. 2018: Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 34(4): 765-770
Reider, B. 2016: PRP Therapies-Is It Time for Potency Assays? Response. American Journal of Sports Medicine 44(11): Np64
Zhou, Y.; Wang, J.H.-C. 2016: PRP Treatment Efficacy for Tendinopathy: a Review of Basic Science Studies. Biomed Research International 2016: 9103792
Basra, P.; Paramo, J.; Alexis, J. 2018: Disseminated Kaposi sarcoma with epithelioid morphology in an HIV/AIDS patient: A previously unreported variant. Journal of Cutaneous Pathology 45(7): 526-529
Dallari, D.; Tschon, M.; Sabbioni, G.; Giavaresi, G. 2016: PRP and HA for Hip Osteoarthritis: Response. American Journal of Sports Medicine 44(9): Np44-Np46
Marmotti, A.; Rossi, R.; Castoldi, F.; Roveda, E.; Michielon, G.; Peretti, G.M. 2015: PRP and articular cartilage: a clinical update. Biomed Research International 2015: 542502
Teoh, S.; Hofer, M.; Kerr, R.; Warner, N.; Kueker, W.; Rothwell, P.M.; Zamboni, G. 2019: Disseminated leptomeningeal tumour mimicking a subarachnoid haemorrhage. Neuroradiology Journal 32(1): 53-56
Jo, C.Hyunchul.; Shin, J.Sun.; Shin, W.Hyoung.; Lee, S.Yeon.; Yoon, K.Sup.; Shin, S. 2016: PRP for Arthroscopic Repair of Medium to Large Rotator Cuff Tears: Response. American Journal of Sports Medicine 44(2): Np7-Np8
Corkery, D.P.; Le Page, Cécile.; Meunier, L.; Provencher, D.; Mes-Masson, A-Marie.; Dellaire, G. 2015: PRP4K is a HER2-regulated modifier of taxane sensitivity. Cell Cycle 14(7): 1059-1069
Filardo, G.; Kon, E. 2016: PRP: Product Rich in Placebo?. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 24(12): 3702-3703
Stuck, M.W.; Conley, S.M.; Naash, M.I. 2016: PRPH2/RDS and ROM-1: Historical context, current views and future considerations. Progress in Retinal and Eye Research 52: 47-63
Lei, B.; Wan, B.; Peng, J.; Yang, Y.; Lv, D.; Zhou, X.; Shu, F.; Li, F.; Zhong, L.; Wu, H.; Mao, X. 2015: PRPS2 Expression Correlates with Sertoli-Cell only Syndrome and Inhibits the Apoptosis of TM4 Sertoli Cells. Journal of Urology 194(5): 1491-1497
Sellge, G.; Kufer, T.A. 2015: PRR-signaling pathways: Learning from microbial tactics. Seminars in Immunology 27(2): 75-84
Song, Z.; Liu, W.; Xiao, Y.; Zhang, M.; Luo, Y.; Yuan, W.; Xu, Y.; Yu, G.; Hu, Y. 2015: PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer. Plos one 10(8): E0128943
Zhang, C.; Zhang, Y.; Li, Y.; Zhu, H.; Wang, Y.; Cai, W.; Zhu, J.; Ozaki, T.; Bu, Y. 2015: PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC). Biochemical and Biophysical Research Communications 458(3): 501-508
Grau, J.; Grosse, I.; Keilwagen, J. 2015: PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R. Bioinformatics 31(15): 2595-2597
Zhang, Q.; Yoo, D. 2015: PRRS virus receptors and their role for pathogenesis. Veterinary Microbiology 177(3-4): 229-241
Shi, C.; Liu, Y.; Ding, Y.; Zhang, Y.; Zhang, J. 2015: PRRSV receptors and their roles in virus infection. Archives of Microbiology 197(4): 503-512
Kappes, M.A.; Faaberg, K.S. 2015: PRRSV structure, replication and recombination: Origin of phenotype and genotype diversity. Virology 479-480: 475-486
Rodríguez-Gómez, I.M.; Käser, T.; Gómez-Laguna, J.; Lamp, B.; Sinn, L.; Rümenapf, T.; Carrasco, L.; Saalmüller, A.; Gerner, W. 2015: PRRSV-infected monocyte-derived dendritic cells express high levels of SLA-DR and CD80/86 but do not stimulate PRRSV-naïve regulatory T cells to proliferate. Veterinary Research 46: 54
Valente, P.; Castroflorio, E.; Rossi, P.; Fadda, M.; Sterlini, B.; Cervigni, R.I.; Prestigio, C.; Giovedì, S.; Onofri, F.; Mura, E.; Guarnieri, F.C.; Marte, A.; Orlando, M.; Zara, F.; Fassio, A.; Valtorta, F.; Baldelli, P.; Corradi, A.; Benfenati, F. 2016: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery. Cell Reports 15(1): 117-131
Li, M.; Niu, F.; Zhu, X.; Wu, X.; Shen, N.; Peng, X.; Liu, Y. 2015: PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling. International Journal of Molecular Sciences 16(5): 9134-9151
He, Z.-W.; Qu, J.; Zhang, Y.; Mao, C.-X.; Wang, Z.-B.; Mao, X.-Y.; Deng, Z.-Y.; Zhou, B.-T.; Yin, J.-Y.; Long, H.-Y.; Xiao, B.; Zhang, Y.; Zhou, H.-H.; Liu, Z.-Q. 2014: PRRT2 mutations are related to febrile seizures in epileptic patients. International Journal of Molecular Sciences 15(12): 23408-23417
Liu, Y.-T.; Nian, F.-S.; Chou, W.-J.; Tai, C.-Y.; Kwan, S.-Y.; Chen, C.; Kuo, P.-W.; Lin, P.-H.; Chen, C.-Y.; Huang, C.-W.; Lee, Y.-C.; Soong, B.-W.; Tsai, J.-W. 2016: PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects. Oncotarget 7(26): 39184-39196
Wu, L.; Tang, H.-D.; Huang, X.-J.; Zheng, L.; Liu, X.-L.; Wang, T.; Wang, J.-Y.; Cao, L.; Chen, S.-D. 2014: PRRT2 truncated mutations lead to nonsense-mediated mRNA decay in Paroxysmal Kinesigenic Dyskinesia. Parkinsonism and Related Disorders 20(12): 1399-1404
Valtorta, F.; Benfenati, F.; Zara, F.; Meldolesi, J. 2016: PRRT2: from Paroxysmal Disorders to Regulation of Synaptic Function. Trends in Neurosciences 39(10): 668-679
Guo, J.; Fu, Z.; Wei, J.; Lu, W.; Feng, J.; Zhang, S. 2015: PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer. Medical Oncology 32(1): 393
Higuchi, M.; Kato, T.; Yoshida, S.; Ueharu, H.; Nishimura, N.; Kato, Y. 2015: PRRX1- and PRRX2-positive mesenchymal stem/progenitor cells are involved in vasculogenesis during rat embryonic pituitary development. Cell and Tissue Research 361(2): 557-565
Juang, Y.-L.; Jeng, Y.-M.; Chen, C.-L.; Lien, H.-C. 2016: PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer. Molecular Carcinogenesis 55(12): 2247-2259
Chow, J.; Franz, K.M.; Kagan, J.C. 2015: PRRs are watching you: Localization of innate sensing and signaling regulators. Virology 479-480: 104-109
Rohrich, R.; Weinstein, A. 2016: PRS Global Open's Evolution: Logo, Growth, and Mission. Plastic and Reconstructive Surgery. Global Open 4(7): E807
Oranges, C.M.; Gohritz, A.; Schaefer, D.J. 2016: PRS Short Articles: how do They Impact our Practice?. Plastic and Reconstructive Surgery: -
Yi, Q.; Dong, F.; Lin, L.; Liu, Q.; Chen, S.; Gao, F.; He, Q. 2016: PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(5): 5805-5810
Cho, S.M.; Shin, S.; Lee, K.A. 2016: PRSS1, SPINK1, CFTR, and CTRC Pathogenic Variants in Korean Patients with Idiopathic Pancreatitis. Annals of Laboratory Medicine 36(6): 555-560
Ma, R.; Ye, X.; Cheng, H.; Ma, Y.; Cui, H.; Chang, X. 2015: PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Gynecologic Oncology 137(3): 546-552
Zhang, L.; Jia, G.; Shi, B.; Ge, G.; Duan, H.; Yang, Y. 2016: PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 40(3-4): 757-769
Bao, Y.; Wang, Q.; Guo, Y.; Chen, Z.; Li, K.; Yang, Y.; Zhang, H.; Dong, H.; Shen, K.; Yang, W. 2016: PRSS8 methylation and its significance in esophageal squamous cell carcinoma. Oncotarget 7(19): 28540-28555
Euesden, J.; Lewis, C.M.; O'Reilly, P.F. 2015: PRSice: Polygenic Risk Score software. Bioinformatics 31(9): 1466-1468
Coffey, G.; Rani, A.; Betz, A.; Pak, Y.; Haberstock-Debic, H.; Pandey, A.; Hollenbach, S.; Gretler, D.D.; Mant, T.; Jurcevic, S.; Sinha, U. 2017: PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers. Journal of Clinical Pharmacology 57(2): 194-210
Bernton, E.; Gannon, W.; Kramer, W.; Kranz, E. 2014: PRTX-100 and methotrexate in patients with active rheumatoid arthritis: a Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study. Clinical Pharmacology in Drug Development 3(6): 477-486
Salameh, A.; Lee, A.K.; Cardó-Vila, M.; Nunes, D.N.; Efstathiou, E.; Staquicini, F.I.; Dobroff, A.S.; Marchiò, S.; Navone, N.M.; Hosoya, H.; Lauer, R.C.; Wen, S.; Salmeron, C.C.; Hoang, A.; Newsham, I.; Lima, L.A.; Carraro, D.M.; Oliviero, S.; Kolonin, M.G.; Sidman, R.L.; Do, K.-A.; Troncoso, P.; Logothetis, C.J.; Brentani, R.R.; Calin, G.A.; Cavenee, W.K.; Dias-Neto, E.; Pasqualini, R.; Arap, W. 2015: PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proceedings of the National Academy of Sciences of the United States of America 112(27): 8403-8408
He, T.; Hatem, E.; Vernis, L.; Lei, M.; Huang, M.-E. 2015: PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug. Journal of Experimental and Clinical Cancer Research: Cr 34: 152
Ortega-Del Vecchyo, D.; Marsden, C.D.; Lohmueller, K.E. 2016: PReFerSim: fast simulation of demography and selection under the Poisson Random Field model. Bioinformatics 32(22): 3516-3518
Liverani, S.; Hastie, D.I.; Azizi, L.; Papathomas, M.; Richardson, S. 2015: PReMiuM: An R Package for Profile Regression Mixture Models Using Dirichlet Processes. Journal of Statistical Software 64(7): 1-30
De Brún, A.; Heavey, E.; Waring, J.; Dawson, P.; Scott, J. 2017: PReSaFe: A model of barriers and facilitators to patients providing feedback on experiences of safety. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy 20(4): 771-778
Simonis, F.D.; Binnekade, J.M.; Braber, A.; Gelissen, H.P.; Heidt, J.; Horn, J.; Innemee, G.; de Jonge, E.; Juffermans, N.P.; Spronk, P.E.; Steuten, L.M.; Tuinman, P.Roel.; Vriends, M.; de Vreede, G.; de Wilde, R.B.; Serpa Neto, A.; Gama de Abreu, M.; Pelosi, P.; Schultz, M.J. 2015: PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial. Trials 16: 226
Basaran, O.; Filiz Basaran, N.; Cekic, E.G.; Altun, I.; Dogan, V.; Mert, G.O.; Mert, K.U.; Akin, F.; Soylu, M.O.; Memic Sancar, K.; Biteker, M. 2017: PRescription PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study). Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 23(4): 384-391
Walsh, T.S.; Salisbury, L.; Donaghy, E.; Ramsay, P.; Lee, R.; Rattray, J.; Lone, N. 2016: PReventing early unplanned hOspital readmission aFter critical ILlnEss (PROFILE): protocol and analysis framework for a mixed methods study. Bmj Open 6(6): E012590
Keillor, M.E.; Arrigo, L.M.; Baciak, J.E.; Chipman, V.; Detwiler, R.S.; Emer, D.F.; Kernan, W.J.; Kirkham, R.R.; MacDougall, M.R.; Milbrath, B.D.; Rishel, J.P.; Seifert, A.; Seifert, C.E.; Smart, J.E. 2016: PRex: An Experiment to Investigate Detection of Near-field Particulate Deposition from a Simulated Underground Nuclear Weapons Test Vent. Health Physics 110(5): 533-547
Grellety, T.; Cousin, S.; Letinier, L.; Bosco-Lévy, P.; Hoppe, S.ép.; Joly, D.; Penel, N.; Mathoulin-Pelissier, S.; Italiano, A. 2016: PRognostic factor of Early Death in phase Ii Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model). Bmc Cancer 16(1): 768
Byatt, N.; Pbert, L.; Hosein, S.; Swartz, H.A.; Weinreb, L.; Allison, J.; Ziedonis, D. 2016: PRogram In Support of Moms (PRISM): Development and Beta Testing. Psychiatric Services 67(8): 824-826
Yates, T.; Griffin, S.; Bodicoat, D.H.; Brierly, G.; Dallosso, H.; Davies, M.J.; Eborall, H.; Edwardson, C.; Gillett, M.; Gray, L.; Hardeman, W.; Hill, S.; Morton, K.; Sutton, S.; Troughton, J.; Khunti, K. 2015: PRomotion of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial. Trials 16: 289
Klimiec, E.; Dziedzic, T.; Kowalska, K.; Szyper, A.; Pera, J.; Potoczek, P.; Slowik, A.; Klimkowicz-Mrowiec, A. 2015: PRospective Observational POLIsh Study on post-stroke delirium (PROPOLIS): methodology of hospital-based cohort study on delirium prevalence, predictors and diagnostic tools. Bmc Neurology 15: 94
Shi, S.-B.; Chen, W.-J.; Shi, R.; Li, M.; Zhang, H.-G.; Sun, Y.-N. 2014: PS Ii photochemical efficiency in flag leaf of wheat varieties and its adaptation to strong sun- light intensity on farmland of Xiangride in Qinghai Province, Northwest China. Ying Yong Sheng Tai Xue Bao 25(9): 2613-2622
Smith, L. 1998: PS Mr Blair... Nursing Standard 1987) 13(11): 11-11
Strappaveccia, G.; Bianchi, L.; Ziarelli, S.; Santoro, S.; Lanari, D.; Pizzo, F.; Vaccaro, L. 2016: PS-BEMP as a basic catalyst for the phospha-Michael addition to electron-poor alkenes. Organic and Biomolecular Chemistry 14(14): 3521-3525
Zhang, T.; Xu, G.; Li, Z.-F.; Regev, O.; Maddumaarachchi, M.; Blum, F.D. 2015: PS/CTAB/silica composites from room temperature polymerization of high internal phase emulsion gels. Journal of Colloid and Interface Science 451: 161-169
Spate, L.D.; Brown, A.; Redel, B.K.; Whitworth, K.M.; Prather, R.S. 2015: PS48 can replace bovine serum albumin in pig embryo culture medium, and improve in vitro embryo development by phosphorylating AKT. Molecular Reproduction and Development 82(4): 315-320
Haiduk, J.; Brockstedt, L.A.; Mitter, D.; Hiemisch, A.; Merkenschlager, A.; Simon, J.C.; Kunz, M. 2018: Disseminated linear and irregular pigmentation of the skin. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 69(10): 870-873
Sharma, U. 2018: Disseminated Lyme disease presenting as multiple non-target cellulitic-appearing skin lesions and oral pseudomembrane. BMJ Case Reports
Fisher, M.; Kapur, K.; Soo, S.; Lyou, Y.; Schreiber, S.S.; Kim, M.J. 2018: Disseminated Microinfarctions with Cerebral Microbleeds. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 27(6): E95-E97
Tansir, G.; Rastogi, N.; Ramteke, P.; Kumar, P.; Soneja, M.; Biswas, A.; Kumar, S.; Jorwal, P.; Baitha, U. 2017: Disseminated mucormycosis: a sinister cause of neutropenic fever syndrome. Intractable and Rare Diseases Research 6(4): 310-313
Heidegger, I.; Klocker, H.; Pichler, R.; Horninger, W.; Bektic, J. 2015: PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer. Anticancer Research 35(6): 3567-3570
Quaas, J. 2015: PSA Screening for Prostate Cancer. American Family Physician 91(9): Online
Wilt, T.J.; Dahm, P. 2015: PSA Screening for Prostate Cancer: Why Saying no is a High-Value Health Care Choice. Journal of the National Comprehensive Cancer Network: Jnccn 13(12): 1566-1574
Saini, S. 2016: PSA and beyond: alternative prostate cancer biomarkers. Cellular Oncology 39(2): 97-106
Seikkula, H.; Pettersson, K.; Boström, P.J. 2015: PSA and blood test diagnostics of prostate cancer. Duodecim; Laaketieteellinen Aikakauskirja 131(17): 1547-1552
Engeler, D.S.; Schwab, C.; Thöni, A.F.; Hochreiter, W.; Prikler, L.; Suter, S.; Stucki, P.; Schiefer, J.; Plasswilm, L.; Schmid, H.-P.; Putora, P.M. 2015: PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 191(10): 787-791
Makarewicz, R.; Lebioda, A.; Terlikiewicz, J.; Biedka, M.; Wiśniewski, T. 2009: PSA bouncing after brachytherapy HDR and external beam radiation therapy: a study of 121 patients with minimum 5-years follow-up. Journal of Contemporary BrachyTherapy 1(2): 92-96
Smaletz, O.; Moreira, F.R.; Simon, S.D.; Katz, A.; Gansl, R.C.; Tabacof, J. 2016: PSA decline does not correlate with overall survival in clinical trials with docetaxel for androgen independent prostate cancer (AIPC). Journal of Clinical Oncology 23(16_Suppl): 4673-4673
Lin, Y.-R.; Wei, X.-H.; Uhlman, M.; Lin, X.-T.; Wu, S.-F.; Diao, P.-F.; Xie, H.-Q.; Xie, K.-J.; Tang, P. 2015: PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml (-1) and 10.1-20.0 ng ml (-1) : a multicenter study. Asian Journal of Andrology 17(3): 503-507
Stojković, I.; Todorović, N.ša.; Nikolov, J.; Tenjović, B. 2016: PSA discriminator influence on (222)Rn efficiency detection in waters by liquid scintillation counting. Applied Radiation and Isotopes: Including Data Instrumentation and Methods for use in Agriculture Industry and Medicine 112: 80-88
Howlander, N.; Tam, S.; Etzioni, R.; Higano, C.S. 2016: PSA doubling time (PSA-DT) during the "off treatment" interval in men with biochemical relapse of prostate cancer treated with intermittent androgen suppression (IAS). Journal of Clinical Oncology 23(16_Suppl): 4670-4670
Sahi, D.; Ohlmann, C.H.; Cordia, I.; Engelmann, U.; Heidenreich, A. 2016: PSA flare-up in patients with hormone-refractory prostate cancer (HRPCA) receiving docetaxel-based chemotherapy: Incidence and differentiation from progressive disease. Journal of Clinical Oncology 24(18_Suppl): 14523-14523
Lobanovskaya, N.; Zharkovsky, T.; Jaako, K.ül.; Jürgenson, M.; Aonurm-Helm, A.; Zharkovsky, A. 2015: PSA modification of NCAM supports the survival of injured retinal ganglion cells in adulthood. Brain Research 1625: 9-17
Candas, B.; Labrie, F. 2016: PSA screening rate and prostate cancer mortality reduction in the province of Quebec. Journal of Clinical Oncology 23(16_Suppl): 1023-1023
Makis, W.; Palayew, M.; Rush, C.; Probst, S. 2018: Disseminated Multi-system Sarcoidosis Mimicking Metastases on 18F-FDG PET/CT. Molecular Imaging and Radionuclide Therapy 27(2): 91-95
Schafbuch, R.; Tinkler, S.; Lim, C.Kin.; Wolking, R.; Ramos-Vara, Jé. 2018: Disseminated mycobacteriosis caused by Mycobacterium kansasii in a pot-bellied pig. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 30(4): 646-650
Lawrentschuk, N. 2016: PSA testing and early management of test-detected prostate cancer--consensus at last. Bju International 117 Suppl. 4: 5-6
Castle, P.E. 2015: PSA testing for prostate cancer screening. LANCET. Oncology 16(1): E2-E3
Miyashita, K.; Matsuura, S.; Tajima, K.; Tajima, S.; Aoki, A.; Sakagami, T.; Koshimizu, N.; Toyoshima, M.; Suda, T. 2018: Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies. Internal Medicine 57(20): 3041-3045
Simpson, P. 2015: PSA tests and cancer: keeping men fully informed. British Journal of Nursing 24(13): 664
Ayyıldız, S.N.; Ayyıldız, A. 2014: PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer. Turkish Journal of Urology 40(2): 82-88
Spek, A.; Stief, C. 2016: PSA--recent recommendations of the S3 guideline. Deutsche Medizinische Wochenschrift 141(1): 8
Job, M.O.; Cooke, B.M. 2015: PSA-NCAM in the posterodorsal medial amygdala is necessary for the pubertal emergence of attraction to female odors in male hamsters. Hormones and Behavior 75: 91-99
Butenschön, J.; Zimmermann, T.; Schmarowski, N.; Nitsch, R.; Fackelmeier, B.; Friedemann, K.; Radyushkin, K.; Baumgart, J.; Lutz, B.; Leschik, J. 2016: PSA-NCAM positive neural progenitors stably expressing BDNF promote functional recovery in a mouse model of spinal cord injury. Stem Cell Research and Therapy 7: 11
Lee, D.R.; Yoo, J.-E.; Lee, J.S.; Park, S.; Lee, J.; Park, C.-Y.; Ji, E.; Kim, H.-S.; Hwang, D.-Y.; Kim, D.-S.; Kim, D.-W. 2015: PSA-NCAM-negative neural crest cells emerging during neural induction of pluripotent stem cells cause mesodermal tumors and unwanted grafts. Stem Cell Reports 4(5): 821-834
Dietlein, F.; Kobe, C.; Neubauer, S.; Schmidt, M.; Stockter, S.; Fischer, T.; Schomäcker, K.; Heidenreich, A.; Zlatopolskiy, B.D.; Neumaier, B.; Drzezga, A.; Dietlein, M. 2017: PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 58(6): 947-952
Barkin, J. 2015: PSA: the Little Kallikrein that 'COULD' and 'SHOULD'. Canadian Journal of Urology 22(3): 7767
Steffensen, J.L.; Dufault-Thompson, K.; Zhang, Y. 2016: PSAMM: a Portable System for the Analysis of Metabolic Models. Plos Computational Biology 12(2): E1004732
Hou, X.; Fu, A.; Garcia, V.J.; Buchanan, B.B.; Luan, S. 2015: PSB27: a thylakoid protein enabling Arabidopsis to adapt to changing light intensity. Proceedings of the National Academy of Sciences of the United States of America 112(5): 1613-1618
Zhang, L.-Y.; Wu, J.-L.; Qiu, H.-B.; Dong, S.-S.; Zhu, Y.-H.; Lee, V.H.-F.; Qin, Y.-R.; Li, Y.; Chen, J.; Liu, H.-B.; Bi, J.; Ma, S.; Guan, X.-Y.; Fu, L. 2016: PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma. Carcinogenesis 37(3): 320-332
Kupcinskas, J.; Wex, T.; Link, A.; Bartuseviciute, R.; Dedelaite, M.; Kevalaite, G.; Leja, M.; Skieceviciene, J.; Kiudelis, G.; Jonaitis, L.; Kupcinskas, L.; Malfertheiner, P. 2014: PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected. Anticancer Research 34(12): 7167-7175
Qiu, L.-X.; Cheng, L.; He, J.; Zhou, Z.-R.; Wang, M.-Y.; Zhou, F.; Guo, W.-J.; Li, J.; Sun, M.-H.; Zhou, X.-Y.; Wang, Y.-N.; Yang, Y.-J.; Wang, J.-C.; Jin, L.; Zhu, X.-D.; Wei, Q.-Y. 2016: PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population. Oncotarget 7(8): 9420-9428
Wang, M.; Wang, X-Jing.; Ma, Y-Feng.; Ma, X-Bin.; Dai, Z-Ming.; Lv, Y.; Lin, S.; Liu, X-Han.; Yang, P-Tao.; Dai, Z-Jun. 2015: PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk. Therapeutics and Clinical Risk Management 11: 237-245
Geng, P.; Li, J.; Wang, N.; Ou, J.; Xie, G.; Liu, C.; Zhao, X.; Xiang, L.; Liao, Y.; Liang, H. 2015: PSCA rs2294008 Polymorphism with Increased Risk of Cancer. Plos one 10(8): E0136269
Gu, Y.; Dai, Q-Sheng.; Hua, R-Xi.; Zhang, B.; Zhu, J-Hong.; Huang, J-Wen.; Xie, B-Hui.; Xiong, S-Qiu.; Tan, G-Sheng.; Li, H-Ping. 2015: PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies. Genes and Cancer 6(5-6): 254-264
Kim, S.Han.; Park, W.Seo.; Park, B.Ram.; Joo, J.; Joung, J.Young.; Seo, H.Kyung.; Chung, J.; Lee, K.Hyun. 2017: PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study. Asian Journal of Andrology 19(4): 458-462
De Sanctis, S.; Wenzler, M.; Kröger, N.; Malloni, W.M.; Sumper, M.; Deutzmann, R.; Zadravec, P.; Brunner, E.; Kremer, W.; Kalbitzer, H.R. 2016: PSCD Domains of Pleuralin-1 from the Diatom Cylindrotheca fusiformis: NMR Structures and Interactions with other Biosilica-Associated Proteins. Structure 24(7): 1178-1191
Chen, X.; Levy, J.M.; Hou, A.; Winters, C.; Azzam, R.; Sousa, A.A.; Leapman, R.D.; Nicoll, R.A.; Reese, T.S. 2015: PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density. Proceedings of the National Academy of Sciences of the United States of America 112(50): E6983-E6992
Dunn, H.A.; Chahal, H.S.; Caetano, F.A.; Holmes, K.D.; Yuan, G.Y.; Parikh, R.; Heit, B.; Ferguson, S.S.G. 2016: PSD-95 regulates CRFR1 localization, trafficking and β-arrestin2 recruitment. Cellular Signalling 28(5): 531-540
Suzuki, E.; Kamiya, H. 2016: PSD-95 regulates synaptic kainate receptors at mouse hippocampal mossy fiber-CA3 synapses. Neuroscience Research 107: 14-19
Won, S.; Incontro, S.; Nicoll, R.A.; Roche, K.W. 2016: PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61. Proceedings of the National Academy of Sciences of the United States of America 113(32): E4736-E4744
Kucharz, K.; Søndergaard Rasmussen, I.; Bach, A.; Strømgaard, K.; Lauritzen, M. 2017: PSD-95 uncoupling from NMDA receptors by Tat- N-dimer ameliorates neuronal depolarization in cortical spreading depression. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 37(5): 1820-1828
Mayanagi, T.; Yasuda, H.; Sobue, K. 2015: PSD-Zip70 Deficiency Causes Prefrontal Hypofunction Associated with Glutamatergic Synapse Maturation Defects by Dysregulation of Rap2 Activity. Journal of neuroscience: the official journal of the Society for Neuroscience 35(42): 14327-14340
Malekpour, S.A.; Pezeshk, H.; Sadeghi, M. 2016: PSE-HMM: genome-wide CNV detection from NGS data using an HMM with Position-Specific Emission probabilities. Bmc Bioinformatics 18(1): 30
Bagyinszky, E.; Park, S.A.; Kim, H.J.; Choi, S.H.; An, S.S.A.; Kim, S.Y. 2016: PSEN1 L226F mutation in a patient with early-onset Alzheimer's disease in Korea. Clinical Interventions in Aging 11: 1433-1440
Liu, Y.; Miao, T.; Ma, J.; Shao, L.; Luo, S.; Li, Y.; Liu, Q. 2016: PSENEN c.66delG in sporadic acne inversa. European Journal of Dermatology: Ejd 26(3): 298-299
Hajj, B.; El Beheiry, M.; Dahan, M. 2016: PSF engineering in multifocus microscopy for increased depth volumetric imaging. Biomedical Optics Express 7(3): 726-731
In, M-Ho.; Posnansky, O.; Speck, O. 2016: PSF mapping-based correction of eddy-current-induced distortions in diffusion-weighted echo-planar imaging. Magnetic Resonance in Medicine 75(5): 2055-2063
Rao, Q.; Shen, Q.; Xia, Q.-y.; Wang, Z.-y.; Liu, B.; Shi, S.-s.; Shi, Q.-l.; Yin, H.-l.; Wu, B.; Ye, S.-b.; Li, L.; Chen, J.-Y.; Pan, M.-h.; Li, Q.; Li, R.; Wang, X.; Zhang, R.-s.; Yu, B.; Ma, H.-h.; Lu, Z.-f.; Zhou, X.-j. 2015: PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. American Journal of Surgical Pathology 39(9): 1181-1196
Kanzaki, R.; Naito, H.; Kise, K.; Takara, K.; Eino, D.; Minami, M.; Shintani, Y.; Funaki, S.; Kawamura, T.; Kimura, T.; Okumura, M.; Takakura, N. 2016: PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy. Annals of Surgical Oncology 23(12): 4093-4100
Fei Wang; Sun, J. 2015: PSF: A Unified Patient Similarity Evaluation Framework Through Metric Learning With Weak Supervision. IEEE Journal of Biomedical and Health Informatics 19(3): 1053-1060
Yarosh, C.A.; Iacona, J.R.; Lutz, C.S.; Lynch, K.W. 2015: PSF: nuclear busy-body or nuclear facilitator?. Wiley Interdisciplinary Reviews. Rna 6(4): 351-367
Nersisyan, L.; Johnson, G.; Riel-Mehan, M.; Pico, A.; Arakelyan, A. 2015: PSFC: a Pathway Signal Flow Calculator App for Cytoscape. F1000research 4: 480
Jones, K.; Ballesteros, A.; Mentink-Kane, M.; Warren, J.; Rattila, S.; Malech, H.; Kang, E.; Dveksler, G. 2016: PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-β1 Pathway. Plos one 11(7): E0158050
Tinoco, R.; Carrette, F.; Barraza, M.L.; Otero, D.C.; Magaña, J.; Bosenberg, M.W.; Swain, S.L.; Bradley, L.M. 2016: PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion. Immunity 44(6): 1470
Ramos-Sevillano, E.; Urzainqui, A.; de Andrés, B.én.; González-Tajuelo, R.; Domenech, M.; González-Camacho, F.; Sánchez-Madrid, F.; Brown, J.S.; García, E.; Yuste, J. 2016: PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease. Plos Pathogens 12(3): E1005500
Umut, İl. 2016: PSGMiner: a modular software for polysomnographic analysis. Computers in Biology and Medicine 73: 1-9
Saver, C. 2016: PSH Learning Collaborative gains participants in phase two. Or Manager 32(6): 1; 11-13
Saver, C. 2016: PSH provides affordable, reliable care for adult and pediatric patients. Or Manager 32(6): 14-17
Kohl, M.; Plischke, M.; Leffondré, K.; Heinze, G. 2015: PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression. Computer Methods and Programs in Biomedicine 118(2): 218-233
Pribanic, K.A.; Fogarty, M.C.; Heil, D.P. 2016: PSI As A Determinant Of Half-marathon Running Characteristics In Full Firefighting Kit: A Case Study: 2084 Board #236 June 2, 2: 00 PM - 3: 30 PM. Medicine and Science in Sports and Exercise 48(5 Suppl 1): 585-586
Calliess, T.; Bauer, K.; Stukenborg-Colsman, C.; Windhagen, H.; Budde, S.; Ettinger, M. 2017: PSi kinematic versus non-PSi mechanical alignment in total knee arthroplasty: a prospective, randomized study. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 25(6): 1743-1748
Huang, W.; Yang, Y.-J.; Zhang, J.-L.; Hu, H.; Zhang, S.-B. 2016: PSi photoinhibition is more related to electron transfer from PSIi to PSi rather than PSi redox state in Psychotria rubra. Photosynthesis Research 129(1): 85-92
Tuite, M.F.; Staniforth, G.L.; Cox, B.S. 2015: PSI(+)] turns 50. Prion 9(5): 318-332
Le Quiniou, C.; Tian, L.; Drop, B.; Wientjes, E.; van Stokkum, I.H.M.; van Oort, B.; Croce, R. 2015: PSI-LHCI of Chlamydomonas reinhardtii: Increasing the absorption cross section without losing efficiency. Biochimica et Biophysica Acta 1847(4-5): 458-467
Floden, E.W.; Tommaso, P.D.; Chatzou, M.; Magis, C.; Notredame, C.; Chang, J.-M. 2016: PSI/TM-Coffee: a web server for fast and accurate multiple sequence alignments of regular and transmembrane proteins using homology extension on reduced databases. Nucleic Acids Research 44(W1): W339-W343
Lee, C.-K.; Pao, C.-W.; Smit, B. 2015: PSII-LHCIi supercomplex organizations in photosynthetic membrane by coarse-grained simulation. Journal of Physical Chemistry. B 119(10): 3999-4008
Popescu, A.-A.; Huber, K.T. 2015: PSIKO2: a fast and versatile tool to infer population stratification on various levels in GWAS. Bioinformatics 31(21): 3552-3554
Yadav, A.; Marcolino, L.S.; Rice, E.; Petering, R.; Winetrobe, H.; Rhoades, H.; Tambe, M.; Carmichael, H. 2016: PSINET: Assisting HIV Prevention Amongst Homeless Youth by Planning Ahead. Ai Magazine 37(2): 47-62
Gao, J.; Cui, W.; Sheng, Y.; Ruan, J.; Kurgan, L. 2016: PSIONplus: Accurate Sequence-Based Predictor of Ion Channels and their Types. Plos one 11(4): E0152964
Armbruster, N.S.; Richardson, J.R.; Schreiner, J.; Klenk, J.; Günter, M.; Kretschmer, D.; Pöschel, S.; Schenke-Layland, K.; Kalbacher, H.; Clark, K.; Autenrieth, S.E. 2016: PSM Peptides of Staphylococcus aureus Activate the p38-CREB Pathway in Dendritic Cells, Thereby Modulating Cytokine Production and T Cell Priming. Journal of Immunology 196(3): 1284-1292
Qin, L.; McCausland, J.W.; Cheung, G.Y.C.; Otto, M. 2016: PSM-Mec-A Virulence Determinant that Connects Transcriptional Regulation, Virulence, and Antibiotic Resistance in Staphylococci. Frontiers in Microbiology 7: 1293
Taywade, S.K.; Damle, N.A.; Bal, C. 2016: PSMA Expression in Papillary Thyroid Carcinoma: Opening a new Horizon in Management of Thyroid Cancer?. Clinical Nuclear Medicine 41(5): E263-E265
Lütje, S.; Heskamp, S.; Cornelissen, A.S.; Poeppel, T.D.; van den Broek, S.A.M.W.; Rosenbaum-Krumme, S.; Bockisch, A.; Gotthardt, M.; Rijpkema, M.; Boerman, O.C. 2015: PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status. Theranostics 5(12): 1388-1401
Bouchelouche, K.; Turkbey, B.; Choyke, P.L. 2016: PSMA PET and Radionuclide Therapy in Prostate Cancer. Seminars in Nuclear Medicine 46(6): 522-535
Jadvar, H. 2015: PSMA PET in Prostate Cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 56(8): 1131-1132
Giesel, F.L.; Fiedler, H.; Stefanova, M.; Sterzing, F.; Rius, M.; Kopka, K.; Moltz, J.H.; Afshar-Oromieh, A.; Choyke, P.L.; Haberkorn, U.; Kratochwil, C. 2015: PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 42(12): 1794-1800
Maurer, T.; Schwamborn, K.; Schottelius, M.; Wester, H.-J.ür.; Schwaiger, M.; Gschwend, J.ür.E.; Eiber, M. 2016: PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer. Clinical Genitourinary Cancer 14(5): E549-E552
Tsourlakis, M.C.; Klein, F.; Kluth, M.; Quaas, A.; Graefen, M.; Haese, A.; Simon, R.; Sauter, G.; Schlomm, T.; Minner, S. 2015: PSMA expression is highly homogenous in primary prostate cancer. Applied Immunohistochemistry and Molecular Morphology: Aimm 23(6): 449-455
Nagesh, P.K.B.; Johnson, N.R.; Boya, V.K.N.; Chowdhury, P.; Othman, S.F.; Khalilzad-Sharghi, V.; Hafeez, B.B.; Ganju, A.; Khan, S.; Behrman, S.W.; Zafar, N.; Chauhan, S.C.; Jaggi, M.; Yallapu, M.M. 2016: PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids and Surfaces. B Biointerfaces 144: 8-20
Rowe, S.P.; Mana-Ay, M.; Javadi, M.S.; Szabo, Z.; Leal, J.P.; Pomper, M.G.; Pienta, K.J.; Ross, A.E.; Gorin, M.A. 2016: PSMA-Based Detection of Prostate Cancer Bone Lesions with ¹⁸F-DCFPyL PET/CT: a Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?. Clinical Genitourinary Cancer 14(1): E115-E118
Kulkarni, H.R.; Singh, A.; Schuchardt, C.; Niepsch, K.; Sayeg, M.; Leshch, Y.; Wester, H.-J.; Baum, R.P. 2016: PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: the Bad Berka Experience Since 2013. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(Suppl 3): 97s
Rowe, S.P.; Macura, K.J.; Mena, E.; Blackford, A.L.; Nadal, R.; Antonarakis, E.S.; Eisenberger, M.; Carducci, M.; Fan, H.; Dannals, R.F.; Chen, Y.; Mease, R.C.; Szabo, Z.; Pomper, M.G.; Cho, S.Y. 2016: PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Molecular Imaging and Biology 18(3): 411-419
Ben Jemaa, A.; Bouraoui, Y.; Sallami, S.; Banasr, A.; Nouira, Y.; Horchani, A.; Oueslati, R. 2015: PSMA-PSA clones controlled by full Akt phosphorylation (T308+,S473+) recapitulate molecular features of human prostate cancer. La Tunisie Medicale 93(8-9): 556-564
Gorin, M.A.; Rowe, S.P.; Hooper, J.E.; Kates, M.; Hammers, H.-J.; Szabo, Z.; Pomper, M.G.; Allaf, M.E. 2017: PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy. European Urology 71(1): 145-146
Kratochwil, C.; Giesel, F.L.; Stefanova, M.; Benešová, M.; Bronzel, M.; Afshar-Oromieh, A.; Mier, W.; Eder, M.; Kopka, K.; Haberkorn, U. 2016: PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(8): 1170-1176
Rauscher, I.; Eiber, M.; Jilg, C.A.; Gschwend, J.E.; Maurer, T. 2017: PSMA-radioguided surgery in localized recurrent prostate cancer : Current and future aspects. Der Urologe. Ausg. a 56(1): 18-23
Chen, Z.; Penet, M.-F.; Krishnamachary, B.; Banerjee, S.R.; Pomper, M.G.; Bhujwalla, Z.M. 2016: PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer. Biomaterials 80: 57-67
Gorin, M.A.; Pomper, M.G.; Rowe, S.P. 2016: PSMA-targeted imaging of prostate cancer: the best is yet to come. Bju International 117(5): 715-716
Heck, M.M.; Retz, M.; Tauber, R.; Knorr, K.; Kratochwil, C.; Eiber, M. 2017: PSMA-targeted radioligand therapy in prostate cancer. Der Urologe. Ausg. a 56(1): 32-39
Sjakste, T.; Paramonova, N.; Wu, L.S.-S.; Zemeckiene, Z.; Sitkauskiene, B.; Sakalauskas, R.; Wang, J.-Y.; Sjakste, N. 2014: PSMA6 (rs2277460, rs1048990), PSMC6 (rs2295826, rs2295827) and PSMA3 (rs2348071) genetic diversity in Latvians, Lithuanians and Taiwanese. Meta Gene 2: 283-298
Liu, R.; Lu, S.; Deng, Y.; Yang, S.; He, S.; Cai, J.; Qiang, F.; Chen, C.; Zhang, W.; Zhao, S.; Qian, L.; Mao, G.; Wang, Y. 2016: PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis. Archives of Gynecology and Obstetrics 293(6): 1297-1307
Zheng, P.; Guo, H.; Li, G.; Han, S.; Luo, F.; Liu, Y. 2015: PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling. Biochemical and Biophysical Research Communications 458(2): 328-333
Kwon, C.H.; Park, H.J.; Choi, Y.R.; Kim, A.; Kim, H.W.; Choi, J.H.; Hwang, C.S.; Lee, S.J.; Choi, C.I.; Jeon, T.Y.; Kim, D.H.; Kim, G.H.; Park, D.Y. 2016: PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis. Oncotarget 7(16): 21454-21468
Liu, S.; Hansen, M.M. 2017: PSMC (pairwise sequentially Markovian coalescent) analysis of RAD (restriction site associated DNA) sequencing data. Molecular Ecology Resources 17(4): 631-641
Nadachowska-Brzyska, K.; Burri, R.; Smeds, L.éa.; Ellegren, H. 2016: PSMC analysis of effective population sizes in molecular ecology and its application to black-and-white Ficedula flycatchers. Molecular Ecology 25(5): 1058-1072
Song, M.; Wang, Y.; Zhang, Z.; Wang, S. 2017: PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration. Oncotarget 8(1): 933-953
Ohnishi, Y.H.; Ohnishi, Y.N.; Nakamura, T.; Ohno, M.; Kennedy, P.J.; Ohkawa, Y.; Yasuyuki, O.; Nishi, A.; Neve, R.; Tsuzuki, T.; Nestler, E.J. 2015: PSMC5, a 19S Proteasomal ATPase, Regulates Cocaine Action in the Nucleus Accumbens. Plos one 10(5): E0126710
Luo, T.; Fu, J.; Xu, A.; Su, B.; Ren, Y.; Li, N.; Zhu, J.; Zhao, X.; Dai, R.; Cao, J.; Wang, B.; Qin, W.; Jiang, J.; Li, J.; Wu, M.; Feng, G.; Chen, Y.; Wang, H. 2016: PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression. Autophagy 12(8): 1355-1371
Trobisch, P.D.; Hwang, S.W.; Drange, S. 2016: PSO without neuromonitoring: analysis of peri-op complication rate after lumbar pedicle subtraction osteotomy in adults. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 25(8): 2629-2632
Mohamed, M.A.; Eltamaly, A.M.; Alolah, A.I. 2016: PSO-Based Smart Grid Application for Sizing and Optimization of Hybrid Renewable Energy Systems. Plos one 11(8): E0159702
Long, Y.; Du, Z.-J.; Wang, W.-D.; Zhao, G.-Y.; Xu, G.-Q.; He, L.; Mao, X.-W.; Dong, W. 2016: PSO-SVM-Based Online Locomotion Mode Identification for Rehabilitation Robotic Exoskeletons. Sensors 16(9)
Hayat, M.; Tahir, M. 2015: PSOFuzzySVM-TMH: identification of transmembrane helix segments using ensemble feature space by incorporated fuzzy support vector machine. Molecular Biosystems 11(8): 2255-2262
Liu, Y.; Peng, J.; Jiao, L.; Liu, Y. 2016: PSOLA: a Heuristic Land-Use Allocation Model Using Patch-Level Operations and Knowledge-Informed Rules. Plos one 11(6): E0157728
Mahil, S.K. 2015: Psoriasis: From Gene to Clinic Congress Reportinternational Conference Showcases Cutting-Edge Psoriasis Research. Journal of Clinical and Aesthetic Dermatology 8(7 Suppl. 3): 17-22
Peabody, M.A.; Laird, M.R.; Vlasschaert, C.; Lo, R.; Brinkman, F.S.L. 2016: PSORTdb: expanding the bacteria and archaea protein subcellular localization database to better reflect diversity in cell envelope structures. Nucleic Acids Research 44(D1): D663-D668
Ng, M.C.K.; Fong, S.; Siu, S.W.I. 2015: PSOVina: The hybrid particle swarm optimization algorithm for protein-ligand docking. Journal of Bioinformatics and Computational Biology 13(3): 1541007
Petitpas, C.M.; Turner, J.T.; Deeds, J.R.; Keafer, B.A.; McGillicuddy, D.J.; Milligan, P.J.; Shue, V.; White, K.D.; Anderson, D.M. 2014: PSP toxin levels and plankton community composition and abundance in size-fractionated vertical profiles during spring/summer blooms of the toxic dinoflagellate Alexandrium fundyense in the Gulf of Maine and on Georges Bank, 2007, 2008, and 2010: 2. Plankton community composition and abundance. Deep-Sea Research. Part Ii Topical Studies in Oceanography 103: 350-367
Paucar, M.; Beniaminov, S.; Paslawski, W.; Svenningsson, P. 2016: PSP-CBS with Dopamine Deficiency in a Female with a FMR1 Premutation. Cerebellum 15(5): 636-640
Bonner, C. 2015: PSP/reg: a potent and enigmatic trophic factor, which is upregulated during the pathogenesis of diabetes. Endocrine 48(3): 725-727
Andalo, F.A.; Taubin, G.; Goldenstein, S. 2017: PSQP: Puzzle Solving by Quadratic Programming. IEEE Transactions on Pattern Analysis and Machine Intelligence 39(2): 385-396
Bajhaiya, A.K.; Dean, A.P.; Zeef, L.A.H.; Webster, R.E.; Pittman, J.K. 2016: PSR1 Is a Global Transcriptional Regulator of Phosphorus Deficiency Responses and Carbon Storage Metabolism in Chlamydomonas reinhardtii. Plant Physiology 170(3): 1216-1234
Cantarella, C.; D'Agostino, N. 2015: PSR: polymorphic SSR retrieval. Bmc Research Notes 8: 525
Li, J.; Xu, C.; Wang, L.; Liang, H.; Feng, W.; Cai, Z.; Wang, Y.; Cong, W.; Liu, Y. 2016: PSRna: Prediction of small RNA secondary structures based on reverse complementary folding method. Journal of Bioinformatics and Computational Biology 14(4): 1643001
Chen, X.; Shi, X.; Hilakivi-Clarke, L.; Shajahan-Haq, A.N.; Clarke, R.; Xuan, J. 2017: PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification. Bioinformatics 33(2): 177-183
Gaillard, T.; Stote, R.H.; Dejaegere, A. 2016: PSSweb: protein structural statistics web server. Nucleic Acids Research 44(W1): W401-W405
Zheng, D.; Li, C.; Wang, S.; Cang, Y.; Song, Y.; Liu, X.; Li, X.; Mohan, C.; Wu, T.; Hu, D.; Peng, A. 2015: PSTK is a novel gene associated with early lung injury in Paraquat Poisoning. Life Sciences 123: 9-17
Calderón-Castrat, X.; Bancalari-Díaz, D.; Román-Curto, C.; Romo-Melgar, A.; Amorós-Cerdán, D.; Alcaraz-Mas, L.A.; Fernández-López, E.; Cañueto, J. 2016: PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. British Journal of Dermatology 175(1): 194-198
Drobek, A.; Kralova, J.; Skopcova, T.; Kucova, M.; Novák, P.; Angelisová, P.; Otahal, P.; Alberich-Jorda, M.; Brdicka, T. 2015: PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk. Journal of Immunology 195(7): 3416-3426
Cheng, Y.; Wu, K.; Yao, J.; Li, S.; Wang, X.; Huang, L.; Kang, Z. 2017: PSTha5a23, a candidate effector from the obligate biotrophic pathogen Puccinia striiformis f. sp. tritici, is involved in plant defense suppression and rust pathogenicity. Environmental Microbiology 19(5): 1717-1729
Mariano, M.Theresa.; Brooks, V.; DiGiacomo, M. 2016: PSYCH: A Mnemonic to Help Psychiatric Residents Decrease Patient Handoff Communication Errors. Joint Commission journal on quality and patient safety 42(7): 316-320
Timári, I.án.; Szilágyi, L.ás.ó; Kövér, K.E. 2015: PSYCHE CPMG-HSQMBC: An NMR Spectroscopic Method for Precise and Simple Measurement of Long-Range Heteronuclear Coupling Constants. Chemistry 21(40): 13939-13942
Zirulnik, J.L.; Alba, P. 2015: Psychiatry and Hiv. a Field that Demands its Place. Coordination. Vertex 26(121): 190-194
Aarts, A.A.; Anderson, J.E.; Anderson, C.J.; Attridge, P.R.; Attwood, A.; Axt, J.; Babel, M.; Bahník, Št.ěp.án.; Baranski, E.; Barnett-Cowan, M.; Bartmess, E.; Beer, J.; Bell, R.; Bentley, H.; Beyan, L.; Binion, G.; Borsboom, D.; Bosch, A.; Bosco, F.A.; Bowman, S.D.; Brandt, M.J.; Braswell, E.; Brohmer, H.; Brown, B.T.; Brown, K.; Brüning, J.; Calhoun-Sauls, A.; Callahan, S.P.; Chagnon, E.; Chandler, J.; Chartier, C.R.; Cheung, F.; Christopherson, C.D.; Cillessen, L.; Clay, R.; Cleary, H.; Cloud, M.D.; Cohn, M.; Cohoon, J.; Columbus, S.; Cordes, A.; Costantini, G.; Cramblet Alvarez, L.D.; Cremata, E.; Crusius, J.; DeCoster, J.; DeGaetano, M.A.; Della Penna, N.ás.; den Bezemer, B.; Deserno, M.K.; Devitt, O.; Dewitte, L.; Dobolyi, D.G.; 2015: PSYCHOLOGY. Estimating the reproducibility of psychological science. Science 349(6251): Aac4716
Paluck, E.L. 2016: PSYCHOLOGY. how to overcome prejudice. Science 352(6282): 147
Bohannon, J. 2016: PSYCHOLOGY. Mechanical Turk upends social sciences. Science 352(6291): 1263-1264
Golub-Victor, A.C.; Dumas, H. 2015: PT graduates' perceptions of a higher education early intervention training program on employment and practice. Pediatric physical therapy: the official publication of the Section on Pediatrics of the American Physical Therapy Association 27(2): 152-159
Longhi, S. 2016: PT phase control in circular multi-core fibers. Optics Letters 41(9): 1897-1900
Zhou, X.; Chong, Y.D. 2016: PT symmetry breaking and nonlinear optical isolation in coupled microcavities. Optics Express 24(7): 6916-6930
Huang, C.; Ye, F.; Kartashov, Y.V.; Malomed, B.A.; Chen, X. 2014: PT symmetry in optics beyond the paraxial approximation. Optics Letters 39(18): 5443-5446
Ibrahim, F.; Calmette, L.; Layka, A.; Horellou, M.-H.él.èn.; Mazoyer, Él.; Gouin-Thibault, I.; Flaujac, C. 2016: PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxaban. Annales de Biologie Clinique 74(4): 457-464
Jensen, T.E.; Ross, F.A.; Kleinert, M.; Sylow, L.; Knudsen, J.R.; Gowans, G.J.; Hardie, D.G.; Richter, E.A. 2015: PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain. Biochemical Journal 467(3): 461-472
Lü, X.-Y.; Jing, H.; Ma, J.-Y.; Wu, Y. 2015: PT-Symmetry-Breaking Chaos in Optomechanics. Physical Review Letters 114(25): 253601
Sánchez-Luceros, Aía.; Woods, A.I.; Bermejo, E.; Shukla, S.; Acharya, S.; Lavin, M.; Rydz, N.; Othman, M. 2017: PT-VWD posing diagnostic and therapeutic challenges - small case series. Platelets 28(5): 484-490
Burlak, G.; Garcia-Paredes, S.; Malomed, B.A. 2016: PT-symmetric couplers with competing cubic-quintic nonlinearities. Chaos 26(11): 113103
Longhi, S. 2016: PT-symmetric mode-locking. Optics Letters 41(19): 4518-4521
Chern, G.-W.; Saxena, A. 2015: PT-symmetric phase in kagome-based photonic lattices. Optics Letters 40(24): 5806-5809
Morozkova, T.S.; Bogdanova, L.A.; Semenov, D.E.; Zhukova, N.A.; Popova, N.A. 2015: PT/Y Mice Are Sensitive to the Inhibitory Effect of o-Aminoazotoluene on Glucocorticoid Induction of Tyrosine Aminotransferase and its Hepatocarcinogenic Effect. Bulletin of Experimental Biology and Medicine 158(6): 789-793
Fred, R.G.; Mehrabi, S.; Adams, C.M.; Welsh, N. 2016: PTB and TIAR binding to insulin mRNA 3'- and 5'UTRs; implications for insulin biosynthesis and messenger stability. Heliyon 2(9): E00159
Dong, L.; Nian, H.; Shao, Y.; Zhang, Y.; Li, Q.; Yi, Y.; Tian, F.; Li, W.; Zhang, H.; Zhang, X.; Wang, F.; Li, X. 2015: PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy. Cell and Tissue Research 360(2): 233-243
Hamann, C.P. 2016: PTBP-FR and TRUE Test®. Contact Dermatitis 74(2): 128-129
Frederikse, P.; Nandanoor, A.; Kasinathan, C. 2014: PTBP-dependent PSD-95 and CamKIIα alternative splicing in the lens. Molecular Vision 20: 1660-1667
Ling, J.P.; Chhabra, R.; Merran, J.D.; Schaughency, P.M.; Wheelan, S.J.; Corden, J.L.; Wong, P.C. 2016: PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons. Cell Reports 17(1): 104-113
Vuong, J.K.; Lin, C.-H.; Zhang, M.; Chen, L.; Black, D.L.; Zheng, S. 2016: PTBP1 and PTBP2 Serve Both Specific and Redundant Functions in Neuronal Pre-mRNA Splicing. Cell Reports 17(10): 2766-2775
Yang, B.; Hu, P.; Lin, X.; Han, W.; Zhu, L.; Tan, X.; Ye, F.; Wang, G.; Wu, F.; Yin, B.; Bao, Z.; Jiang, T.; Yuan, J.; Qiang, B.; Peng, X. 2015: PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas. Cellular and Molecular Life Sciences: Cmls 72(22): 4383-4397
Taniguchi, K.; Sakai, M.; Sugito, N.; Kumazaki, M.; Shinohara, H.; Yamada, N.; Nakayama, T.; Ueda, H.; Nakagawa, Y.; Ito, Y.; Futamura, M.; Uno, B.; Otsuki, Y.; Yoshida, K.; Uchiyama, K.; Akao, Y. 2016: PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors. Oncotarget 7(14): 18940-18952
Graci, J.D.; Jung, S.P.; Pichardo, J.; Lahser, F.; Tong, X.; Gu, Z.; Colacino, J.M. 2016: PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined Experimentally. Antimicrobial Agents and ChemoTherapy 60(12): 7060-7066
Anonymous 2003: PTCA has better outcomes than thrombolysis in MI. Nursing Standard 1987) 17(22): 10-10
Gurung, B.; Hua, X.; Runske, M.; Bennett, B.; LiVolsi, V.; Roses, R.; Fraker, D.A.; Metz, D.C. 2015: PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target. Cancer Biology and Therapy 16(2): 219-224
Udeabor, S.E.; Adisa, A.O.; Lawal, A.O.; Barbeck, M.; Booms, P.; Sader, R.A.; Ghanaati, S. 2015: PTCH-1 and MDM2 expression in ameloblastoma from a West African sub-population: implication for chemotherapeutics. Pan African Medical Journal 20: 140
Jendrzejewski, J.; Thomas, A.; Liyanarachchi, S.; Eiterman, A.; Tomsic, J.; He, H.; Radomska, H.S.; Li, W.; Nagy, R.; Sworczak, K.; de la Chapelle, A. 2015: PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression. Journal of clinical endocrinology and metabolism 100(10): E1370-E1377
Shin, M.C.; Zhang, J.; Min, K.A.; He, H.; David, A.E.; Huang, Y.; Yang, V.C. 2015: PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An in Vivo Proof-of-Concept Study. Pharmaceutical Research 32(8): 2690-2703
Chu, X.; Wu, B.; Fan, H.; Hou, J.; Hao, J.; Hu, J.; Wang, B.; Liu, G.; Li, C.; Meng, S. 2016: PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression. Antiviral Research 127: 41-49
Liu, X.-W.; Yuan, P.; Tian, J.; Li, L.-J.; Wang, Y.; Huang, S.-C.; Liu, L.; Backendorf, C.; Noteborn, M.H.M.; Sun, J. 2016: PTD4-apoptin induces Bcl-2-insensitive apoptosis in human cervical carcinoma in vitro and in vivo. Anti-Cancer Drugs 27(10): 979-987
Ziegler, J.; Ho, J.; Gibson, I.W.; Nayak, J.G.; Stein, M.; Walkty, A.; Orr, P. 2018: Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer. Transplant Infectious Disease: An Official Journal of the Transplantation Society 20(5): E12931
Huque, M.H.; Bondell, H.D.; Carroll, R.J.; Ryan, L.M. 2016: Spatial regression with covariate measurement error: a semiparametric approach. Biometrics 72(3): 678-686
Thanapprapasr, D.; Previs, R.A.; Hu, W.; Ivan, C.; Armaiz-Pena, G.N.; Dorniak, P.L.; Hansen, J.M.; Rupaimoole, R.; Huang, J.; Dalton, H.J.; Ali-Fehmi, R.; Coleman, R.L.; Sood, A.K. 2015: PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer. Molecular Cancer Therapeutics 14(6): 1466-1475
Bertsch, E.C.; Magi-Galluzzi, C.; Cheng, L.; Osunkoya, A.O. 2016: PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multiinstitutional Study of 92 Cases. Applied Immunohistochemistry and Molecular Morphology: Aimm 2016
Xing, L.; Liu, Q.; Fu, S.; Li, S.; Yang, L.; Liu, S.; Hao, J.; Yu, L.; Duan, H. 2015: PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes. Journal of Cellular Biochemistry 116(8): 1776-1784
Chiang, K.-C.; Hsu, S.-Y.; Lin, S.-J.; Yeh, C.-N.; Pang, J.-H.S.; Wang, S.-Y.; Hsu, J.-T.; Yeh, T.-S.; Chen, L.-W.; Kuo, S.-F.; Cheng, Y.-C.; Juang, H.-H. 2016: PTEN Insufficiency Increases Breast Cancer Cell Metastasis in Vitro and in Vivo in a Xenograft Zebrafish Model. Anticancer Research 36(8): 3997-4005
Stern, H.M.; Gardner, H.; Burzykowski, T.; Elatre, W.; O'Brien, C.; Lackner, M.R.; Pestano, G.A.; Santiago, A.; Villalobos, I.; Eiermann, W.; Pienkowski, T.; Martin, M.; Robert, N.; Crown, J.; Nuciforo, P.; Bee, V.; Mackey, J.; Slamon, D.J.; Press, M.F. 2015: PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is not Associated with Trastuzumab Resistance. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 21(9): 2065-2074
Lotan, T.L.; Wei, W.; Morais, C.L.; Hawley, S.T.; Fazli, L.; Hurtado-Coll, A.; Troyer, D.; McKenney, J.K.; Simko, J.; Carroll, P.R.; Gleave, M.; Lance, R.; Lin, D.W.; Nelson, P.S.; Thompson, I.M.; True, L.D.; Feng, Z.; Brooks, J.D. 2016: PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. European Urology Focus 2(2): 180-188
Boelens, M.C.; Nethe, M.; Klarenbeek, S.; de Ruiter, J.R.; Schut, E.; Bonzanni, N.; Zeeman, A.L.; Wientjens, E.; van der Burg, E.; Wessels, L.; van Amerongen, R.ée.; Jonkers, J. 2016: PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma. Cell Reports 16(8): 2087-2101
Guedes, L.B.; Tosoian, J.J.; Hicks, J.; Ross, A.E.; Lotan, T.L. 2017: PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy. Journal of Urology 197(4): 1054-1059
Lee, S.H.; Roh, M.R.; Kang, B.; Park, K.H.; Kim, S.H.; Lee, S.E.; Rha, S.Y. 2016: PTEN Methylation Dependent Sinonasal Mucosal Melanoma. Cancer Research and Treatment 48(2): 853-858
de Araujo, W.Martins.; Robbs, B.Kaufmann.; Bastos, L.G.; de Souza, W.F.; Vidal, Fávia.C.B.; Viola, Jão.P.B.; Morgado-Diaz, J.A. 2016: PTEN Overexpression Cooperates With Lithium to Reduce the Malignancy and to Increase Cell Death by Apoptosis via PI3K/Akt Suppression in Colorectal Cancer Cells. Journal of Cellular Biochemistry 117(2): 458-469
Lee, J.E.; Lim, M.S.; Park, J.H.; Park, C.H.; Koh, H.C. 2016: PTEN Promotes Dopaminergic Neuronal Differentiation Through Regulation of ERK-Dependent Inhibition of S6K Signaling in Human Neural Stem Cells. Stem Cells Translational Medicine 5(10): 1319-1329
Zhu, L.; Zhao, S.; Liu, S.; Liu, Q.; Li, F.; Hao, J. 2016: PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus. Journal of Cellular Biochemistry 117(5): 1187-1198
Fujita, T.; Kawasaki, K.; Takabatake, D.; Takahashi, H.; Ogasawara, Y.; Doihara, H. 2016: PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer. Journal of Clinical Oncology 24(18_Suppl): 10026-10026
Wartenberg, M.; Centeno, I.; Haemmig, S.; Vassella, E.; Zlobec, I.; Galván, J.é A.; Neuenschwander, M.; Schlup, C.; Gloor, B.; Lugli, A.; Perren, A.; Karamitopoulou, E. 2016: PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. European Journal of Cancer 65: 80-90
Ji, Y.; Zheng, M.; Ye, S.; Chen, J.; Chen, Y. 2014: PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer. Journal of Biomedical Research 28(6): 462-467
Wu, Y.; Jiang, B.; Dai, X.; Hu, X.; Wang, S.; Jiang, P.; Hu, Y.; Huang, J. 2016: PTEN and NBS1 gene mutations in familial breast cancer and early-onset breast cancer from Hunan Province in China. Zhong Nan da Xue Xue Bao. Yi Xue Ban 41(2): 121-126
Chen, Y.; van de Vijver, M.J.; Hibshoosh, H.; Parsons, R.; Saal, L.H. 2016: PTEN and NEDD4 in Human Breast Carcinoma. Pathology Oncology Research: Por 22(1): 41-47
Pérez-Ramírez, C.; Cañadas-Garre, M.; Molina, M.Án.; Faus-Dáder, M.ía.J.é; Calleja-Hernández, M.Án. 2015: PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 16(16): 1843-1862
Wei, S.; LiVolsi, V.A.; Montone, K.T.; Morrissette, J.J.D.; Baloch, Z.W. 2015: PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma. Endocrine Pathology 26(4): 365-369
Zhou, X.; Zhu, H.; Lu, J. 2015: PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma. Pathology Research and Practice 211(4): 316-319
Sushma, P.S.; Jamil, K.; Kumar, P.U.; Satyanarayana, U.; Ramakrishna, M.; Triveni, B. 2016: PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 7625-7632
Gorbenko, O.; Stambolic, V. 2016: PTEN at 18: Still Growing. Methods in Molecular Biology 1388: 13-19
Poliseno, L.; Pandolfi, P.P. 2015: PTEN ceRNA networks in human cancer. Methods 77-78: 41-50
Armstrong, C.W.D.; Maxwell, P.J.; Ong, C.W.; Redmond, K.M.; McCann, C.; Neisen, J.; Ward, G.A.; Chessari, G.; Johnson, C.; Crawford, N.T.; LaBonte, M.J.; Prise, K.M.; Robson, T.; Salto-Tellez, M.; Longley, D.B.; Waugh, D.J.J. 2016: PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy. Oncotarget 7(7): 7885-7898
LaSarge, C.L.; Santos, V.R.; Danzer, S.C. 2015: PTEN deletion from adult-generated dentate granule cells disrupts granule cell mossy fiber axon structure. Neurobiology of Disease 75: 142-150
Chandrasekaran, S.; Deng, H.; Fang, Y. 2015: PTEN deletion potentiates invasion of colorectal cancer spheroidal cells through 3D Matrigel. Integrative Biology: Quantitative Biosciences from Nano to Macro 7(3): 324-334
Phadngam, S.; Castiglioni, A.; Ferraresi, A.; Morani, F.; Follo, C.; Isidoro, C. 2016: PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells. Oncotarget 7(51): 84999-85020
Zhang, R.; Zhu, L.; Zhang, L.; Xu, A.; Li, Z.; Xu, Y.; He, P.; Wu, M.; Wei, F.; Wang, C. 2016: PTEN enhances G2/M arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway. Oncology Reports 35(5): 2707-2714
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: PTEN expression in Palestinian women with breast cancer, particularly in triple-negative subtype. Journal of Clinical Oncology 29(27_Suppl): 27-27
Janisch, L.A.; Desai, A.A.; Mita, M.; Parsons, R.; Goldston, M.; Knowles, H.L.; Bedrosian, C.L.; Rowinsky, E.K.; Tolcher, A.W.; Ratain, M.J. 2016: PTEN expression in archival tumor samples in patients (pts) with advanced malignancies in two phase I studies of AP23573 (AP), an mTOR inhibitor. Journal of Clinical Oncology 23(16_Suppl): 9661-9661
Yang, H.P.; Meeker, A.; Guido, R.; Gunter, M.J.; Huang, G.S.; Luhn, P.; d'Ambrosio, L.; Wentzensen, N.; Sherman, M.E. 2015: PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes and Control: Ccc 26(12): 1729-1736
Bendib, M.; Badescu, A.; Handra-Luca, A. 2015: PTEN expression in colorectal adenomas: relationship to morphology and cell heterogeneity. Pathology Research and Practice 211(3): 248-251
Unseld, M.; Chilla, A.; Pausz, C.; Mawas, R.; Breuss, J.; Zielinski, C.; Schabbauer, G.; Prager, G.W. 2015: PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis. Thrombosis and Haemostasis 114(2): 379-389
Xiao, J.; Hu, C-Ping.; He, B-Xiu.; Chen, X.; Lu, X-Xiao.; Xie, M-Xuan.; Li, W.; He, S-Ya.; You, S-Jin.; Chen, Q. 2016: PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature. Oncotarget 7(36): 57832-57840
Gu, J.; Ou, W.; Huang, L.; Wu, J.; Li, S.; Xu, J.; Feng, J.; Liu, B.; Zhou, Y. 2016: PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis. Minerva Medica 107(5): 342-351
Naguib, A.; Bencze, G.; Cho, H.; Zheng, W.; Tocilj, A.; Elkayam, E.; Faehnle, C.R.; Jaber, N.; Pratt, C.P.; Chen, M.; Zong, W.-X.; Marks, M.S.; Joshua-Tor, L.; Pappin, D.J.; Trotman, L.C. 2015: PTEN functions by recruitment to cytoplasmic vesicles. Molecular Cell 58(2): 255-268
Sun, Z.; Ji, N.; Bi, M.; Wang, S.; Liu, X.; Wang, Z. 2015: PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(8): 5849-5857
Han, F.; Hu, R.; Yang, H.; Liu, J.; Sui, J.; Xiang, X.; Wang, F.; Chu, L.; Song, S. 2016: PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis. Oncotargets and Therapy 9: 3485-3492
Yang, X.-D.; Zhao, S.-F.; Zhang, Q.; Li, W.; Wang, Y.-X.; Hong, X.-W.; Hu, Q.-G. 2016: PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(1): 577-582
Wang, Y.; Dai, B. 2015: PTEN genomic deletion defines favorable prognostic biomarkers in localized prostate cancer: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine 8(4): 5430-5437
Mester, J.; Charis, E. 2015: PTEN hamartoma tumor syndrome. Handbook of Clinical Neurology 132: 129-137
Ngeow, J.; Eng, C. 2015: PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 77-78: 11-19
Ragos, V.; Fotiades, P.P.; Tsiambas, E.; Peschos, D. 2016: PTEN in laryngeal carcinomas. Journal of BUON: Official Journal of the Balkan Union of Oncology 21(4): 1024-1025
Ohtake, Y.; Hayat, U.; Li, S. 2015: PTEN inhibition and axon regeneration and neural repair. Neural Regeneration Research 10(9): 1363-1368
Qin, G.; Xie, J.; Chen, L.; Wu, B.; Gui, B.; Zhou, J. 2016: PTEN inhibition preserves trigeminal nucleus caudalis neuron activation through tyrosine phosphorylation of the NR2B subunit at Tyr1472 of the NMDA receptor in a rat model of recurrent migraine. Neurological Research 38(4): 320-326
Spinelli, L.; Lindsay, Y.E.; Leslie, N.R. 2015: PTEN inhibitors: an evaluation of current compounds. Advances in Biological Regulation 57: 102-111
Mense, S.M.; Barrows, D.; Hodakoski, C.; Steinbach, N.; Schoenfeld, D.; Su, W.; Hopkins, B.D.; Su, T.; Fine, B.; Hibshoosh, H.; Parsons, R. 2015: PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion. Science Signaling 8(370): Ra32
Li, N.; Qin, J.; Lan, L.; Zhang, H.; Liu, F.; Wu, Z.; Ni, H.; Wang, Y. 2015: PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. Cancer Biology and Therapy 16(2): 297-306
Chiang, K.-C.; Chen, H.-Y.; Hsu, S.-Y.; Pang, J.-H.S.; Wang, S.-Y.; Hsu, J.-T.; Yeh, T.-S.; Chen, L.-W.; Kuo, S.-F.; Sun, C.-C.; Lee, J.-M.; Yeh, C.-N.; Juang, H.-H. 2015: PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo. Drug Design Development and Therapy 9: 4631-4638
Briercheck, E.L.; Trotta, R.; Chen, L.; Hartlage, A.S.; Cole, J.P.; Cole, T.D.; Mao, C.; Banerjee, P.P.; Hsu, H.-T.; Mace, E.M.; Ciarlariello, D.; Mundy-Bosse, B.L.; Garcia-Cao, I.; Scoville, S.D.; Yu, L.; Pilarski, R.; Carson, W.E.; Leone, G.; Pandolfi, P.P.; Yu, J.; Orange, J.S.; Caligiuri, M.A. 2015: PTEN is a negative regulator of NK cell cytolytic function. Journal of Immunology 194(4): 1832-1840
Shore, A.N.; Chang, C.-H.; Kwon, O.-J.; Weston, M.C.; Zhang, M.; Xin, L.; Rosen, J.M. 2016: PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland. Developmental Biology 409(1): 202-217
Morais, C.L.; Herawi, M.; Toubaji, A.; Albadine, R.; Hicks, J.; Netto, G.J.; De Marzo, A.M.; Epstein, J.I.; Lotan, T.L. 2015: PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas. Prostate 75(14): 1610-1619
Du, G.; Bian, L.; Wang, T.; Xu, X.; Zhang, S.; Guo, Y.; Zhuo, J.; Song, S.; Jiang, Z. 2015: PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance. Zhonghua Yi Xue Za Zhi 95(28): 2264-2267
Westin, S.N.; Ju, Z.; Broaddus, R.R.; Krakstad, C.; Li, J.; Pal, N.; Lu, K.H.; Coleman, R.L.; Hennessy, B.T.; Klempner, S.J.; Werner, H.M.J.; Salvesen, H.B.; Cantley, L.C.; Mills, G.B.; Myers, A.P. 2015: PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. Molecular Oncology 9(8): 1694-1703
Deguchi, Y.; Okabe, H.; Oshima, N.; Hisamori, S.; Minamiguchi, S.; Muto, M.; Sakai, Y. 2017: PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20(3): 416-427
Kocar, M.; Bozkurtlar, E.; Telli, F.; Serdar Turhal, N.; Kaya, H.; Kocar, H.; Yumuk, F. 2014: PTEN loss is not associated with trastuzumab resistance in metastatic breast cancer. Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 900-905
Bingham, V.; Ong, C.W.; James, J.; Maxwell, P.; Waugh, D.; Salto-Tellez, M.; McQuaid, S. 2016: PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry. Human Pathology 47(1): 95-103
Kuramochi, H.; Nakamura, A.; Nakajima, G.; Kaneko, Y.; Araida, T.; Yamamoto, M.; Hayashi, K. 2016: PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study. Bmc Cancer 16: 366
Ghorbani, A.; Zand, H.; Jeddi-Tehrani, M.; Koohdani, F.; Shidfar, F.; Keshavarz, S.A. 2015: PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress. Journal of Natural Medicines 69(4): 507-512
Xu, Z.; Zhu, L.; Yao, M.; Zhong, G.; Dong, Q.; Yu, A. 2015: PTEN plays an important role in thrombin-mediated lung cancer cell functions. Biomed Research International 2015: 459170
Yang, Y.; Xu, W.; Liu, D.; Ding, X.; Su, B.; Sun, Y.; Gao, W. 2016: PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 7785-7796
Ferraldeschi, R.; Nava Rodrigues, D.; Riisnaes, R.; Miranda, S.; Figueiredo, I.; Rescigno, P.; Ravi, P.; Pezaro, C.; Omlin, A.; Lorente, D.; Zafeiriou, Z.; Mateo, J.; Altavilla, A.; Sideris, S.; Bianchini, D.; Grist, E.; Thway, K.; Perez Lopez, R.; Tunariu, N.; Parker, C.; Dearnaley, D.; Reid, A.; Attard, G.; de Bono, J. 2015: PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate. European Urology 67(4): 795-802
Wang, J.; Sinnberg, T.; Niessner, H.; Dölker, R.; Sauer, B.; Kempf, W.E.; Meier, F.; Leslie, N.; Schittek, B. 2015: PTEN regulates IGF-1R-mediated therapy resistance in melanoma. Pigment Cell and Melanoma Research 28(5): 572-589
Zhang, Z.; Hou, S-Qi.; He, J.; Gu, T.; Yin, Y.; Shen, W.H. 2016: PTEN regulates PLK1 and controls chromosomal stability during cell division. Cell Cycle 15(18): 2476-2485
Xing, Y.; Wang, R.; Li, C.; Minoo, P. 2015: PTEN regulates lung endodermal morphogenesis through MEK/ERK pathway. Developmental Biology 408(1): 56-65
Leong, J.W.; Schneider, S.E.; Sullivan, R.P.; Parikh, B.A.; Anthony, B.A.; Singh, A.; Jewell, B.A.; Schappe, T.; Wagner, J.A.; Link, D.C.; Yokoyama, W.M.; Fehniger, T.A. 2015: PTEN regulates natural killer cell trafficking in vivo. Proceedings of the National Academy of Sciences of the United States of America 112(7): E700-E709
Putz, U.; Mah, S.; Goh, C.-P.; Low, L.-H.; Howitt, J.; Tan, S.-S. 2015: PTEN secretion in exosomes. Methods 77-78: 157-163
Gbelcová, H.; Bakeš, P.; Priščáková, P.; Šišovský, V.; Hojsíková, I.; Straka, Ľ; Konečný, M.; Markus, J.; D'Acunto, C.W.; Ruml, T.; Böhmer, D.; Danihel, Ľ; Repiská, V. 2015: PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women. Analytical Cellular Pathology 2015: 746856
Zhu, G.; Rankin, S.L.; Larson, J.D.; Zhu, X.; Chow, L.M.L.; Qu, C.; Zhang, J.; Ellison, D.W.; Baker, S.J. 2017: PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation. Cancer Research 77(1): 123-133
Zhou, W.; Shao, H.; Zhang, D.; Dong, J.; Cheng, W.; Wang, L.; Teng, Y.; Yu, Z. 2015: PTEN signaling is required for the maintenance of spermatogonial stem cells in mouse, by regulating the expressions of PLZF and UTF1. Cell and Bioscience 5: 42
Xu, B.; Washington, A.M.; Hinton, B.T. 2014: PTEN signaling through RAF1 proto-oncogene serine/threonine kinase (RAF1)/ERK in the epididymis is essential for male fertility. Proceedings of the National Academy of Sciences of the United States of America 111(52): 18643-18648
Zhou, M.; Zhang, Y.; Chen, X.; Zhu, J.; Du, M.; Zhou, L.; Zhang, L.; Wang, W.; Sun, G. 2015: PTEN-Foxo1 signaling triggers HMGB1-mediated innate immune responses in acute lung injury. Immunologic Research 62(1): 95-105
Sotelo, N.S.; Schepens, J.T.G.; Valiente, M.; Hendriks, W.J.A.J.; Pulido, R. 2015: PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13. Methods 77-78: 147-156
Guo, X.R.; Hu, Q.Y.; Yuan, Y.H.; Tang, X.J.; Yang, Z.S.; Zou, D.D.; Bian, L.J.; Dai, L.J.; Li, D.S. 2016: PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells. Oncology Letters 11(4): 2733-2740
Aroui, S.; Dardevet, L.; Najlaoui, F.; Kammoun, M.; Laajimi, A.; Fetoui, H.; De Waard, M.; Kenani, A. 2016: PTEN-regulated AKT/FoxO3a/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate. International Journal of Biochemistry and Cell Biology 77(Pt A): 15-22
Tan, W.; Gu, Z.; Shen, B.; Jiang, J.; Meng, Y.; Da, Z.; Liu, H.; Tao, T.; Cheng, C. 2015: PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients. Journal of Cellular Biochemistry 116(8): 1583-1594
Wang, L.-L.; Hao, S.; Zhang, S.; Guo, L.-J.; Hu, C.-Y.; Zhang, G.; Gao, B.; Zhao, J.-J.; Jiang, Y.; Tian, W.-G.; Wang, J.; Luo, D.-L. 2017: PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases. Human Pathology 61: 49-57
Xia, H.-J.; He, B.-L.; Wang, C.-Y.; Zhang, H.-L.; Ge, G.-Z.; Zhang, Y.-X.; Lv, L.-B.; Jiao, J.-L.; Chen, C. 2014: PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews. European Journal of Cancer 50(18): 3230-3242
Salmena, L. 2016: PTEN: History of a Tumor Suppressor. Methods in Molecular Biology 1388: 3-11
Milella, M.; Falcone, I.; Conciatori, F.; Cesta Incani, U.; Del Curatolo, A.; Inzerilli, N.; Nuzzo, C.M.A.; Vaccaro, V.; Vari, S.; Cognetti, F.; Ciuffreda, L. 2015: PTEN: Multiple Functions in Human Malignant Tumors. Frontiers in Oncology 5: 24
Pulido, R. 2015: PTEN: a yin-yang master regulator protein in health and disease. Methods 77-78: 3-10
Gao, L.; Ren, W.; Zhang, L.; Li, S.; Kong, X.; Zhang, H.; Dong, J.; Cai, G.; Jin, C.; Zheng, D.; Zhi, K. 2017: PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma. Molecular Carcinogenesis 56(4): 1322-1334
Johnston, S.B.; Raines, R.T. 2016: PTENpred: a Designer Protein Impact Predictor for PTEN-related Disorders. Journal of Computational Biology: a Journal of Computational Molecular Cell Biology 23(12): 969-975
Izuogu, O.G.; Alhasan, A.A.; Alafghani, H.M.; Santibanez-Koref, M.; Elliott, D.J.; Elliot, D.J.; Jackson, M.S. 2016: PTESFinder: a computational method to identify post-transcriptional exon shuffling (PTES) events. Bmc Bioinformatics 17: 31
Nair, G.G.; Odorico, J.S. 2016: PTF1a Activity in Enriched Posterior Foregut Endoderm, but Not Definitive Endoderm, Leads to Enhanced Pancreatic Differentiation in an In Vitro Mouse ESC-Based Model. Stem cells international 2016: 6939438
Urbani, L.; Balestri, R.; Sidoti, F.; Bernardini, J.Riccardo.; Arces, F.; Licitra, G.; Leoni, C.; Forfori, F.; Colombatto, P.; Boraschi, P.; Castagna, M.; Buccianti, P. 2016: PTFE Graft as a "Bridge" to Communicating Veins Maturation in the Treatment of an Intrahepatic Cholangiocarcinoma Involving the 3 Hepatic Veins. The Minor-but-Complex Liver Resection. Annals of Surgical Oncology 23(Suppl. 5): 911
Guerrini, E.; Grattieri, M.; Faggianelli, A.; Cristiani, P.; Trasatti, S. 2015: PTFE effect on the electrocatalysis of the oxygen reduction reaction in membraneless microbial fuel cells. Bioelectrochemistry 106(Part A): 240-247
Yu, J.; Ke, T.; Tehrim, S.; Sun, F.; Liao, B.; Hua, W. 2015: PTGBase: an integrated database to study tandem duplicated genes in plants. Database: the Journal of Biological Databases and Curation 2015
Rodriguez-Rodriguez, L.; Ivorra-Cortes, J.; Carmona, F.D.; Martín, J.; Balsa, A.; van Steenbergen, H.W.; van der Helm-van Mil, A.H.M.; González-Álvaro, I.; Fernandez-Gutiérrez, B.ín. 2015: PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts. Arthritis Research and Therapy 17: 306
Zhang, P.; Jiang, B.; Xie, L.; Huang, W. 2016: PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma. Current Eye Research 41(12): 1561-1565
Johansson, T. 2016: PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures. A randomized, controlled study of 40 patients. Acta Orthopaedica 87(1): 79-82
Zhang, L.-X.; Gu, W.-J.; Li, Y.-J.; Wang, Y.; Wang, W.-B.; Wang, A.-P.; Shen, L.; Zang, L.; Yang, G.-Q.; Lu, Z.-H.; Dou, J.-T.; Mu, Y.-M. 2016: PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma. American Journal of Hypertension 29(5): 575-581
Esen, E.; Lee, S-Yon.; Wice, B.M.; Long, F. 2015: PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 30(11): 1959-1968
Gardinier, J.D.; Mohamed, F.; Kohn, D.H. 2015: PTH Signaling During Exercise Contributes to Bone Adaptation. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 30(6): 1053-1063
Ricarte, F.; Nakatani, T.; Partridge, N. 2016: PTH Signaling and Epigenetic Control of Bone Remodeling. Current Molecular Biology Reports 2(1): 55-61
Panaroni, C.; Fulzele, K.; Saini, V.; Chubb, R.; Pajevic, P.D.; Wu, J.Y. 2015: PTH Signaling in Osteoprogenitors Is Essential for B-Lymphocyte Differentiation and Mobilization. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 30(12): 2273-2286
Khundmiri, S.J.; Murray, R.D.; Lederer, E. 2016: PTH and Vitamin D. Comprehensive Physiology 6(2): 561-601
Wang, L.; Tran, A.B.; Nociti, F.H.; Thumbigere-Math, V.; Foster, B.L.; Krieger, C.C.; Kantovitz, K.R.; Novince, C.M.; Koh, A.J.; McCauley, L.K.; Somerman, M.J. 2015: PTH and Vitamin D Repress DMP1 in Cementoblasts. Journal of Dental Research 94(10): 1408-1416
Covic, A.; Voroneanu, L.; Apetrii, M. 2016: PTH and/or Bone Histology: Are we Still Waiting for a Verdict from the CKD-MBD Grand Jury?. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 67(4): 535-538
Vasconcelos, D.Fernando.Pereira.; Vasconcelos, A.Carolina.Cardoso.Guimarães. 2016: PTH intermittent administration may be a useful therapeutic agent to avoid premature eruption of the tooth. Medical Hypotheses 88: 27-29
Toapanta Gaibor, N.és.G.; Nava Pérez, N.C.; Martínez Echevers, Y.; Montes Delgado, R.; Guerrero Riscos, M.ía.Án. 2017: PTH levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 37(2): 149-157
Hoover, R.S.; Tomilin, V.; Hanson, L.; Pochynyuk, O.; Ko, B. 2016: PTH modulation of NCC activity regulates TRPV5 Ca2+ reabsorption. American Journal of Physiology. Renal Physiology 310(2): F144-F151
Fukumoto, S. 2015: PTH preparations. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(10): 1696-1700
Gardinier, J.D.; Al-Omaishi, S.; Morris, M.D.; Kohn, D.H. 2016: PTH signaling mediates perilacunar remodeling during exercise. Matrix Biology: Journal of the International Society for Matrix Biology 52-54: 162-175
Murphy, C.M.; Schindeler, A.; Cantrill, L.C.; Mikulec, K.; Peacock, L.; Little, D.G. 2015: PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 30(6): 1022-1029
Bartlow, C.M.; Oest, M.E.; Mann, K.A.; Zimmerman, N.D.; Butt, B.B.; Damron, T.A. 2017: PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 35(8): 1707-1715
Cavani, F.; Ferretti, M.; Smargiassi, A.; Palumbo, C. 2017: PTH(1-34) effects on repairing experimentally drilled holes in rat femur: novel aspects - qualitative vs. quantitative improvement of osteogenesis. Journal of Anatomy 230(1): 75-84
Santonati, A.; Palermo, A.; Maddaloni, E.; Bosco, D.; Spada, A.; Grimaldi, F.; Raggiunti, B.; Volpe, R.; Manfrini, S.; Vescini, F. 2015: PTH(1-34) for Surgical Hypoparathyroidism: a Prospective, Open-Label Investigation of Efficacy and Quality of Life. Journal of Clinical Endocrinology and Metabolism 100(9): 3590-3597
Palermo, A.; Mangiameli, G.; Tabacco, G.; Longo, F.; Pedone, C.; Briganti, S.Irina.; Maggi, D.; Vescini, F.; Naciu, A.; Lauria Pantano, A.; Napoli, N.; Angeletti, S.; Pozzilli, P.; Crucitti, P.; Manfrini, S. 2016: PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial. Journal of Clinical Endocrinology and Metabolism 101(11): 4039-4045
Misof, B.M.; Roschger, P.; Dempster, D.W.; Zhou, H.; Bilezikian, J.P.; Klaushofer, K.; Rubin, M.R. 2016: PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 31(1): 180-189
Cusano, N.E.; Rubin, M.R.; Bilezikian, J.P. 2015: PTH(1-84) replacement therapy for the treatment of hypoparathyroidism. Expert Review of Endocrinology and Metabolism 10(1): 5-13
Shirakawa, J.; Harada, H.; Noda, M.; Ezura, Y. 2016: PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression. Calcified Tissue International 98(3): 306-315
Kir, S.; Komaba, H.; Garcia, A.P.; Economopoulos, K.P.; Liu, W.; Lanske, B.; Hodin, R.A.; Spiegelman, B.M. 2016: PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer. Cell Metabolism 23(2): 315-323
Du, L.; Feng, R.; Ge, S. 2016: PTH/SDF-1α cotherapy promotes proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells. Cell Proliferation 49(5): 599-608
Subramanian, H.; Döring, F.; Kollert, S.; Rukoyatkina, N.; Sturm, J.; Gambaryan, S.; Stellzig-Eisenhauer, A.; Meyer-Marcotty, P.; Eigenthaler, M.; Wischmeyer, E. 2016: PTH1R Mutants Found in Patients with Primary Failure of Tooth Eruption Disrupt G-Protein Signaling. Plos one 11(11): E0167033
Sun, W.; Wu, J.; Huang, L.; Liu, H.; Wang, R.; Karaplis, A.; Goltzman, D.; Miao, D. 2016: PTHrP Nuclear Localization and Carboxyl Terminus Sequences Modulate Dental and Mandibular Development in Part via the Action of p27. Endocrinology 157(4): 1372-1384
Chukkapalli, S.; Levi, E.; Rishi, A.K.; Datta, N.S. 2016: PTHrP attenuates osteoblast cell death and apoptosis induced by a novel class of anti-cancer agents. Endocrine 51(3): 534-544
Carvalho, E.S.M.; Gregório, S.íl.F.; Canário, A.V.M.; Power, D.M.; Fuentes, J. 2015: PTHrP regulates water absorption and aquaporin expression in the intestine of the marine sea bream (Sparus aurata, L.). General and Comparative Endocrinology 213: 24-31
Walkley, C.R.; Walia, M.K.; Ho, P.W.; Martin, T.J. 2014: PTHrP, its receptor, and protein kinase a activation in osteosarcoma. Molecular and Cellular Oncology 1(4): E965624
Maycas, M.; McAndrews, K.A.; Sato, A.Y.; Pellegrini, G.G.; Brown, D.M.; Allen, M.R.; Plotkin, L.I.; Gortazar, A.R.; Esbrit, P.; Bellido, T. 2017: PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 32(3): 486-497
Salahudeen, A.A.; Gupta, A.; Jones, J.C.; Cowan, R.W.; Vusirikala, M.; Kwong, C.; Naina, H.V.K. 2015: PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient with Chronic Lymphocytic Leukemia Responding to Denosumab. Clinical Lymphoma Myeloma and Leukemia 15(9): E137-E140
Donovan, P.J.; Achong, N.; Griffin, K.; Galligan, J.; Pretorius, C.J.; McLeod, D.S.A. 2015: PTHrP-mediated hypercalcemia: causes and survival in 138 patients. Journal of Clinical Endocrinology and Metabolism 100(5): 2024-2029
Kodous, N.; Filler, G.; Sharma, A.P.; Van Hooren, T.A. 2015: PTHrP-related Hypercalcaemia in Infancy and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). Canadian Journal of Kidney Health and Disease 2: 21
Jutras, O.él.B.; Durand, R.; Daneau, C.-O.; Boileau, A. 2015: PTi and DSQ. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 12(2): 25
Wang, J.; Aroumougame, A.; Lobrich, M.; Li, Y.; Chen, D.; Chen, J.; Gong, Z. 2014: PTIP associates with Artemis to dictate DNA repair pathway choice. Genes and Development 28(24): 2693-2698
Craik, R.L. 2015: PTJ Has no Silo. Physical Therapy 95(12): 1602-1604
De Ruiter, E.J.; Willems, S.M. 2016: PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma. Annals of Translational Medicine 4(Suppl 1): S44
Ito, K.; Park, S.H.; Nayak, A.; Byerly, J.H.; Irie, H.Y. 2016: PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation. Cancer Research 76(15): 4406-4417
Ono, H.; Basson, M.D.; Ito, H. 2015: PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer. Molecular cancer research: MCR 13(8): 1174-1184
Park, S.H.; Ito, K.; Olcott, W.; Katsyv, I.; Halstead-Nussloch, G.; Irie, H.Y. 2015: PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim. Breast Cancer Research: Bcr 17: 86
Chen, X.; Song, B.; Lin, Y.; Cao, L.; Feng, S.; Zhang, L.; Wang, F. 2016: PTK6 promotes hepatocellular carcinoma cell proliferation and invasion. American Journal of Translational Research 8(10): 4354-4361
Tian, X.; Yan, L.; Zhang, D.; Guan, X.; Dong, B.; Zhao, M.; Hao, C. 2016: PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance. Oncology Reports 36(4): 1829-1836
Wang, H.; Li, G.; Yin, Y.; Wang, J.; Wang, H.; Wei, W.; Guo, Q.; Ma, H.; Shi, Q.; Zhou, X.; Wang, J. 2014: PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis. International Journal of Clinical and Experimental Pathology 7(11): 7881-7889
Park, M.; Yoon, H.-J.; Kang, M.C.; Kwon, J.; Lee, H.W. 2016: PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 14217-14224
Chauhan, S.K.; Lee, H.Keun.; Lee, H.Soo.; Park, E.Young.; Jeong, E.; Dana, R. 2015: PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1. Arteriosclerosis Thrombosis and Vascular Biology 35(7): 1606-1615
Devegowda, L.; Bhat, P.; Manjunath, C.N.; Rao, P.S.M. 2016: PTMC in post-MV repair status. Indian Heart Journal 68(Suppl 2): S8
Wang-Gillam, A.; Dennis, R.; Kohli, M.; Phooshkooru, V. 2016: PTOV1 gene expression in prostate cancer. Journal of Clinical Oncology 23(16_Suppl): 9632-9632
Kambakam, S.; Bhattacharjee, U.; Petrich, J.; Rodermel, S. 2016: PTOX Mediates Novel Pathways of Electron Transport in Etioplasts of Arabidopsis. Molecular Plant 9(9): 1240-1259